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Redox-triggered carbonyl addition via transfer hydrogenation, which enables direct 
primary alcohol C-H functionalization to form C-C bond, avoids usage of premetalated 
reagents or discrete alcohol to aldehyde redox reactions. Moreover, step-economy could 
be greatly improved by site-selective transformations of polyfunctional molecules due to 
bypassing the need to install and remove protecting groups. However, the redox site-
selective transformations still pose a significant challenge in the area of synthetic organic 
chemistry. Efforts have been focused on the development of iridium catalyzed transfer 
hydrogenative coupling reactions of primary alcohols with different allyl donors through 
carbonyl addition in a site-selective manner as well as ruthenium catalyzed regioselective 
hydrohydroxyalkylation of primary alcohols with a basic feedstock-styrene. Additionally, 
studies towards the total synthesis of type I polyketide natural product (+)-SCH 351448 in 
the most concise route is presented.     
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Chapter 1:  Transition-Metal-Catalyzed Enantioselective Reactions of 
Vinyl aziridines 
1.1 INTRODUCTION 
Due to the strain energy of the three-membered ring, aziridines are one of the most 
versatile intermediates in organic synthesis towards a large number of biologically active 
molecules.1 As useful building blocks, vinyl aziridines (Scheme 1.1) are increasingly being 
exploited comparing to the aziridines with other functional groups.2 Due to the presence of 
the vinyl group substituents, the stabilities of any positive or negative charges and radicals 
generated during the transformations were greatly enhanced.  
The transition-metal-catalyzed reaction of vinyl aziridines has proven to be a useful 
strategy for organic chemical synthesis. In many cases, the highly enantioselective version 
of this transformation can be achieved to generate ring-opening products. This review 
presents developments in transition-metal-catalyzed enantioselective reactions of vinyl 
aziridines, but the Lewis acids catalyzed ring-opening reactions will not be discussed. 
            
 
Scheme 1.1 General methods for synthesizing vinyl aziridines.  
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1.2 TRANSFORMATIONS FROM RACEMIC VINYL AZIRIDINES 
1.2.1 Palladium Catalysis 
The dynamic kinetic asymmetric transformations (DYKATs) of racemic starting 
material are efficient and atom economic synthetic methods in organic synthesis.3 In the 
years before 2003, Trost and co-workers developed a highly efficient enantioselective 
process for the DYKATs of vinyl epoxides. By using Trost ligands (1.3 and 1.4, Figure 
1.1), nucleophiles, such as alcohols, amines, phthalimides and acetoacetates, were utilized 
in these transformations.4 Compared to vinyl epoxides, vinyl aziridines are usually 
considered less reactive in nucleophilic addition reactions. 
  
 
Figure 1.1 Trost ligands for DYKATs process. 
In 2003, Trost and co-workers reported the Pd-catalyzed dynamic kinetic 
asymmetric cycloadditions of isocyanates to vinyl aziridines.5a Initial experiments were 
carried out under the condition of 4 mol% Pd(OAc)2 and 10 mol% (R,R)-1.3 while using 
N-benzyl vinyl aziridine 1.5 and phenyl isocyanate 1.6 as testing system. During a 24 h 
reaction time, the product 1.7 was obtained in 29% yield with 59% ee. After inclusive 
optimizations of the reaction conditions, including palladium precatalysts, ligands, 
additives, solvents, reaction time and temperature, the desired product was obtained with 
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high enantiomeric excess. Under the optimized conditions, the scope of the vinyl aziridines 
and isocyanates was tested (Scheme 1.2). 
 
Scheme 1.2 Selected examples of asymmetric cycloadditions of vinyl aziridines and 
isocyanates. 
One of the differences between the original reaction conditions and the optimized 
reaction condition is the AcOH additive. The reason is that in order to achieve high ee in 
this DYKATs process, the rate of equilibration between the diastereomeric π-allyl 
palladium intermediates (1.5a and 1.5b) must be higher than the cyclization event (Scheme 
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1.3). Upon ring-opening of vinyl aziridine, the nitrogen was protonated by AcOH. As a 
consequence, addition to the isocyanate of the nitrogen slowed down. Thus, the η3- η1- η3 
interconversion of the π-allyl palladium intermediates occurred effectively which leads to 
the products with high enantioselectivity. Similarly, Alper and co-workers also found the 
addition of CeCl3 may possibly increase the rate of interconversion of the π-allyl palladium 
intermediates.5b  
 
 
Scheme 1.3 Interconversion of the diastereomeric π-allyl palladium intermediates. 
 
 
Scheme 1.4 Synthesis of (+)-pseudodistomin D. 
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Two years later in 2005, Trost and Fandrick applied the DYKATs, which is Pd-
catalyzed dynamic kinetic asymmetric cycloadditions of isocyanates to vinyl aziridine, to 
the total synthesis of a pseudodistomin alkaloid natural product.6 It turned out that 
Pseudodistomin D, which was isolated from ascidian Pseudodistormina megalarva, has 
potent cytotoxicity against human epidermoid carcinoma KB cells.7 As shown in Scheme 
1.4, the 1,2-chiral diamine 1.16, which is the key intermediate, was constructed using Pd-
catalyzed DYKATs process. This first total synthesis of pseudodistomin D demonstrated 
the importance of the Pd-catalyzed dynamic kinetic asymmetric cycloadditions of 
isocyanates to vinyl aziridines. 
Bromopyrrole alkaloids are a family of marine natural products which shows 
various biological activities.8 It turned out that pyrrolopiperazinone derivatives are the key 
substructures of a number of bromopyrrole alkaloids. In 2007, using the similar strategy, 
Trost and co-workers developed the Pd-catalyzed asymmetric alkylation-annulation 
reactions of methyl 5-bromopyrrole-2-carboxylate (1.17) and vinyl aziridine (1.14) to 
prepare pyrrolopiperazinone (1.18, Scheme 1.5).9  
 
 
Scheme 1.5 Pd-catalyzed asymmetric alkylation-annulation of methyl 5-
bromopyrrole-2-carboxylate and vinyl aziridine. 
The mechanism of the asymmetric alkylation-annulation is shown in Scheme 1.6.9 
In the presence of Pd(0) complex, both enantiomers of vinyl aziridine were ionized while 
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the hydrogen on the nitrogen of the pyrrole serves as a proton source to assist the ring-
opening event. The asymmetric induction was achieved due to the interconversion between 
the two diastereomeric π-allyl palladium intermediates (1.14a and 1.14b) was faster than 
the following nucleophilic addition. Thus, a Curtin-Hammett situation was generated 
wherein the enantiodiscriminating event was the amination reaction.   
   
 
 
Scheme 1.6 Mechanism of the Pd-catalyzed asymmetric alkylation-annulation. 
In the same year, instead of taking pyrrole as nitrogen source, Trost and co-workers 
reported the Pd-catalyzed asymmetric amination of vinyl aziridines by using benzoyl imido 
carboxylates as nitrogen source.10 In these transformations, the desired products, 
orthogonally protected chiral vicinal diamines, were obtained with excellent yields and 
good to excellent enantioselectivities through amination and in situ acyl migration (step 1 
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in Scheme 1.7). The authors also demonstrated the utility of the asymmetric amination 
reaction by doing a formal synthesis of (+)-balanol. As shown in Scheme 1.7, the key 
intermediate 1.21, chiral vicinal diamine, was prepared by the Pd-catalyzed asymmetric 
amination with good yield and enantioselectivity. By far, the Pd-catalyzed DYKATs of 
vinyl aziridines have proven to be powerful tools for the construction of stereocenters and 
have produced various methods for the synthesis of natural products.    
 
 
Scheme 1.7 Formal synthesis of (+)-balanol. 
In 2015, Hou and Ding showed the highly diastereo- and enantioselective 
palladium-catalyzed [3+2] cycloaddition of vinyl aziridines and α,β-unsaturated ketones.11 
One of the strategies to prepare pyrrolidines, which is an important substructure of a 
number of natural products and biologically active molecules,12 is transition-metal-
catalyzed [3+2] cycloaddition of vinyl aziridines and alkenes with electron withdrawing 
groups.13 Before 2015, there was no enantioselective version of the transformation 
aforementioned although a number of methods have been developed by chemists.14 By 
using palladium catalyst modified by ferrocene-based ligand, Hou and Ding developed the 
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first enantioselective version of tandem Michael addition/intramolecular cyclization of 
vinyl aziridines with α,β-unsaturated ketones (Table 1.1). In general, the substituent group 
R1 has been played an important role in the cis/trans selectivity. 
Table 1.1 [3+2] cycloaddition of vinyl aziridine and α,β-unsaturated ketones. 
 
 
With the absolute configuration of products 1.25 in hand, the authors proposed a 
stereochemical model to explain the diastereo- and enantioselectivity of the asymmetric 
cycloaddition (Scheme 1.8). After the tosyl-protected nitrogen anion generation due to the 
π-allyl palladium formation, the nitrogen anion attacks the vinyl ketone to form an enolate 
intermediate. Following that, the enolate attacks the π-allyl palladium complex to form the 
desired cycloaddition product. Compared to the endo transition state 1.29, the author 
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proposed the exo transition state 1.27 should be favored according to the X-ray diffraction 
analysis of the π-phenylallyl palladium complex with ligand 1.26. At the same time, the 
methyl group at C2 position of the allyl substructure is of great importance to improve the 
diastereoselectivity. As shown in the complex 1.30, the steric congestion between the 
enolate moiety and methyl group leads to a higher energy in complex 1.30. In contrast, 
there is no severe steric congestion in the structure of complex 1.28, which makes it 
favored.      
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Scheme 1.8 Proposed stereochemical model for the diastereo- and enantioselectivity. 
One year later, Lu and co-workers continued the studies of Pd-catalyzed [3+2] 
cycloaddition of vinyl aziridine with methyleneindolinones in 2016.15 Spirooxindole 
derivatives exist in many natural products and biologically active compounds as 
substructure.16 Using Pd2(dba)3 as precatalyst, Lu and co-workers optimized the different 
chiral phosphoramidate ligands for the transformations to form spirooxindole products. 
Eventually, as shown in Scheme 1.9, ligand (R,S,S)-1.32 was the best ligand for the [3+2] 
cycloaddition reactions. 
 
 
 
Scheme 1.9 [3+2] cycloaddition of vinyl aziridine with methyleneindolinones. 
To gain insight into the catalytic mechanism, the authors proposed a catalytic cycle 
for the [3+2] cycloaddition reaction (Scheme 1.10). The chiral π-allyl palladium species 
1.34 was generated from vinyl aziridine 1.23a upon ring-opening by Pd(0) catalyst. 
Michael addition to methyleneindolinone 1.31 occurred to generate the zwitterionic 
intermediate 1.35. Then, intramolecular asymmetric allylic alkylation reaction happened 
to form the spirooxindole product 1.33, at the same time regenerated the Pd(0) complex.  
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Scheme 1.10 Proposed catalytic mechanism for [3+2] cycloaddition reactions. 
Synergistic catalysis, which was developed by combining aminocatalysis with 
transition-metal catalysis, is an attractive topic in organic chemical synthesis.17 Inspired by 
the previous works of synergistic catalysis, Jørgensen and co-workers reported the 
synergistic catalysis for the asymmetric [3+2] cycloaddition of vinyl aziridines with α,β-
unsaturated aldehydes in 2017.18 Under the condition of co-catalysts diphenylprolinolsilyl 
ether 1.38 and Tetrakis(triphenylphosphine)palladium (Pd(PPh3)4), in the presence of 
tetrabutylammonium chloride (TBAC) and benzoic acid, the desired [3+2] cycloaddition 
products can be obtained in good yields, good diastereoselectivity and excellent 
enantioselectivity (Scheme 1.11). As shown in Scheme 1.11, both aromatic substituted and 
aliphatic substituted α,β-unsaturated aldehydes worked well under the optimized reaction 
conditions.   
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Scheme 1.11 Synergistic catalysis for the asymmetric [3+2] cycloaddition. 
As shown in Scheme 1.12, Jørgensen and co-workers proposed a catalytic 
mechanism for the aforementioned asymmetric [3+2] cycloaddition reactions. After the 
event of ring-opening of vinyl aziridine 1.5 by Pd(0) catalyst through oxidative addition, 
the zwitterionic π-allyl palladium (II) complex 1.41 was formed. On the other hand, the 
iminium ion intermediate 1.42 was formed from the organocatalyst 1.38 and α,β-
unsaturated aldehyde 1.37 through condensation. Then, a reversible aza-Michael addition 
process occurred between intermediates 1.41 and 1.42 to generate a pair of diastereomeric 
intermediates 1.43 and 1.44. Due to the steric congestion of the π-allyl palladium moiety 
and the bulky group on the C2 position of the organocatalyst, cyclization of intermediate 
1.43 was much slower than intermediate 1.44. As a consequence, the Si face of the chiral 
enamine of intermediate 1.44 underwent cyclization. To complete the synergistic catalytic 
cycle, upon decomplexation of the Pd(0) and hydrolysis of iminium ion, both catalysts 
were regenerated.      
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Scheme 1.12 Proposed mechanism of the synergistic catalysis for the asymmetric [3+2] 
cycloaddition. 
1.2.2 Copper Catalysis 
In 2003, Pineschi and co-workers reported the regio- and enantioselective copper 
catalyzed addition of dialkylzinc reagents to cyclic vinyl aziridines.19 When the Cu(OTf)2 
was employed as catalyst, the addition of Et2Zn to vinyl aziridine 1.45 occurred smoothly 
to produce allylic amine product 1.47 with 78% ee for the trans-isomer (Scheme 1.13).  
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Scheme 1.13 Copper catalyzed addition of organozinc reagent to vinyl aziridine. 
1.2.3 Iridium Catalysis 
Redox-triggered carbonyl addition via transfer hydrogenation enables direct 
primary alcohol C−H functionalization in the absence of premetalated reagents or discrete 
alcohol to aldehyde redox reactions.20 Functionalized piperidines appear frequently as 
substructures in a number of natural alkaloids and pharmaceutical ingredients.21 In fact, the 
piperidine ring is the third most frequently used ring system in small molecule drugs listed 
in the FDA orange book.22 Therefore, developing methods to diastereoselectively 
synthesize piperidine has drawn a great deal of attention.23  
Because of the competing electrophilic of O-allylation of the resulting π-
allyliridium complexes,24 along with the propensity of vinyl aziridines to participate in 
metal catalyzed ring expansion, the feasibility of engaging vinyl aziridines in metal 
catalyzed C-C couplings with primary alcohols was rendered uncertain. Despite these 
potential liabilities, Krische and co-workers developed the diastereo- and enantioselective 
iridium catalyzed coupling of vinyl aziridines with alcohols in 2015.25 As shown in Table 
1.2, diverse primary alcohols 1.48-1.50 (100 mol%) were exposed to vinyl aziridine 1.51 
(300 mol%) in the presence of complex 1.52 (5 mol%) and substoichiometric potassium 
phosphate (5 mol%) in THF (0.5 M) at 60 oC, in which the desired products 1.53-1.55 were 
obtained with good yields, good anti-diastereoselectivity and excellent enantioselectivity.  
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Table 1.2 Diastereo- and enantioselective iridium catalyzed (α-aminomethyl)allylation 
of alcohols with vinyl aziridine. 
 
Having demonstrated the feasibility and scope of the coupling of primary alcohols, 
the catalyst-directed diastereo- and site-selective C-C coupling of unprotected diols with 
vinyl aziridine 1.51 was investigated. As shown in Scheme 1.14, the product of (α-
aminomethyl)allylation 1.58 was formed in good yield and with good level of catalyst-
directed diastereoselectivity. Conditions used in the coupling of primary alcohols were not 
directly transferable. Longer reaction times were required. In addition, the optimal pairing 
of diols and catalyst was case dependent. For example, in the coupling of diol 1.56 with 
vinyl aziridines 1.51, the iridium catalyst 1.57, which is modified by (R)-Cl,MeO-BIPHEP, 
gave slightly better results than catalyst 1.52, which is modified by (R)-MeO-BIPHEP. 
Similarly, the iridium catalysts derived from the enantiomeric ligands have also been used 
in the aforementioned conversion of unprotected diols. In each case, the products of (α-
aminomethyl)allylation were formed in good yield and with good level of catalyst-directed 
diastereoselectivity.    
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Scheme 1.14 Diastereoselective iridium catalyzed (α-aminomethyl)allylation of diol 
1.56 with vinyl aziridine 1.51. 
1.3 CHIRALITY TRANSFER STRATEGY: TRANSFORMATIONS FROM CHIRAL VINYL 
AZIRIDINES 
1.3.1 Palladium Catalysis 
One of the most useful methods to prepare β-lactams is ring expansion of vinyl 
aziridines with carbon monoxide. In 1993, Tanner and Somfai26 reported the palladium 
catalyzed transformation of a chiral vinyl aziridine to a β-lactam. Using this strategy, 
Tanner and Somfai succeeded in synthesizing (+)-PS-5 (Scheme 1.15). The optically pure 
vinyl aziridine 1.59 was utilized in the carbonylation reaction which was catalyzed by the 
Pd2(dba)3 and in the presence of excess amount of triphenylphosphine in benzene. The 
desired trans-3-vinylazetidinone 1.62 was obtained in 46% yield. Stabilized by the 
intermolecular coordination of the nitrogen anion, the π-allyl palladium complex 1.60 was 
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formed through inversion. Upon the insertion of carbon monoxide with retention, ring-
closure and regeneration of Pd(0) species occurred. 
 
        
Scheme 1.15 Pd-catalyzed carbonylative ring expansion to β-lactam. 
Interestingly, in 2001, Aggarwal and co-workers reported a similar transformation 
but with different regioselectivity.27 Under the reaction conditions, in the presence of Pd(0) 
catalyst and triphenylphosphine, the γ-lactam 1.65 was formed in moderate yield with 93% 
enantiomeric excess when using optically pure vinyl aziridine 1.63 as starting material 
(Scheme 1.16). The origins of the selectivity for the γ-lactam is under further investigation.  
 
 
Scheme 1.16 Pd-catalyzed carbonylative ring expansion to γ-lactam. 
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1.3.2 Rhodium Catalysis 
Although a number of methodologies have been developed for the formation of the 
seven-membered azaheterocycle structures,28 the development of new cycloaddition 
transformations to achieve substituted, ring-fused azepines from acyclic starting material 
remains highly desirable. In 2015, Zhang and co-workers developed the rhodium catalyzed 
intramolecular formal hetero-[5+2] cycloaddition of vinyl aziridines and alkynes.29 Based 
on the chiral center preinstalled in vinyl aziridines, Zhang and co-workers could synthesize 
fused azepine derivatives in excellent enantioselectivity (Table 1.3). In the presence of the 
[Rh(NBD)2]BF4 catalyst, the intramolecular formal hetero-[5+2] cycloaddition process 
occurred smoothly at 30 oC in 1,2-dichloroethane. It turns out that the alkyne substitution 
could be an aryl, heteroaryl, alkyl or cyclohexenyl group. Remarkably, terminal alkynes 
have also been used in this transformation and excellent enantioselectivity was obtained. 
In addition, the substitutions on the vinyl aziridine ring were allowed to change from 
methyl, n-propyl to i-propyl group in which the reaction conditions were modified from 
the standard optimal conditions.           
Table 1.3 Rh-catalyzed intramolecular reaction of vinyl aziridines with alkynes. 
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Scheme 1.17 Stereochemical model for Rh-catalyzed intramolecular cycloaddition of 
vinyl aziridines with alkynes. 
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The proposed stereochemical model was proposed by Zhang and co-workers 
(Scheme 1.17), in which both faces of the C-C double bond in (S)-1.66 could coordinate to 
the rhodium complex (1.72 and 1.73). In order to form a Z-olefin in 1.78 and 1.79, protons 
Hb and Hc have to have a syn alignment relationship which was achieved through bond 
rotation to give 1.76 and 1.77. However, only in 1.77 the C-N bond in the aziridine could 
suitably overlap with the C-Rh bond as required for the concerted ring expansion reaction. 
Thus, upon reductive elimination, the optically pure product (R)-1.69 was obtained. 
Inspired by the Rh-catalyzed cycloaddition reaction aforementioned, the Zhang 
group reported a similar intramolecular cycloaddition reaction of vinyl aziridines with 
alkenes.30 As shown in Scheme 1.18, using chiral vinyl aziridines as starting material, in 
the presence of Rh catalyst, the desired cycloaddition products were formed in moderate 
to good yield with excellent enantioselectivity (up to 99% ee). Notably, using the chirality 
transfer strategy, three contiguous chiral stereocenters were formed in one step.    
 
 
Scheme 1.18 Rh-catalyzed intramolecular reaction of vinyl aziridines with alkenes. 
After that, Zhang and co-workers started to explore the intermolecular version of 
the rhodium catalyzed cycloaddition reactions of vinyl aziridines with alkynes.31 As shown 
in Scheme 1.19, in the presence of rhodium catalyst, the chiral vinyl aziridines (R)-1.84 
reacted with alkynes 1.83 to provide cycloaddition products 1.85 with excellent 
enantioselectivity (up to 99% ee). Additionally, the substrate scope is broad, for instance, 
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R1 could be alkyl, aryl or silyl groups, while R5 could be alkyl, aryl or oxygen atom with 
silyl groups.   
 
 
Scheme 1.19 Rh-catalyzed intermolecular reaction of vinyl aziridines with alkynes. 
Later in the same year 2016, Zhang and co-workers applied substituted allenes in 
the rhodium catalyzed [3+2] cycloaddition reactions with chiral vinyl aziridines to 
synthesize chiral pyrrolidines (Scheme 1.20).32 Remarkably, different regioselectivities 
were achieved in this rhodium catalyzed [3+2] cycloaddition. 
 
 
Scheme 1.20 Rh-catalyzed intermolecular reaction of vinyl aziridines with allenes. 
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The mechanism was shown in Scheme 1.21, both alkene and amin coordinate to 
the rhodium catalyst to give rhodium complex 1.90. Then oxidative addition occurred to 
provide complex 1.91 with retention of configuration. Subsequently, species 1.91 could be 
captured by the proximal C=C bond of 1.86 regioselectively which gave complex 1.92. 
Upon reductive elimination, the rhodium(I) catalyst was regenerated while release the 
desired product 1.87. Alternatively, the distal C=C bond of allene 1.88 was captured by 
complex 1.91, which was followed by reductive elimination to provide product 1.89.     
 
 
Scheme 1.21 Proposed mechanism for Rh-catalyzed intermolecular reaction of vinyl 
aziridines with allenes. 
Continuing the chirality transfer strategy, Zhang group developed intermolecular 
aza-[4+3] cycloaddition of chiral vinyl aziridines with silyl dienol ethers by using rhodium 
catalyst (Table 1.4).33 Using optically pure vinyl aziridines as starting material, in the 
presence of rhodium(I) catalyst and silver salt, the desired azepine derivative products were 
formed in good yields with excellent enantioselectivity. Different from the previous 
reports, net inversion of the absolute configuration was observed in this process.    
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Table 1.4 Rh-catalyzed intermolecular reaction of vinyl aziridines with silyl dienol 
ethers. 
 
 
More recently, Zhang and co-workers developed rhodium catalyzed intermolecular 
[3+3] cycloaddition of chiral vinyl aziridines with C,N-cyclic azomethine imines (Scheme 
1.22).34 Taking advantages of the chirality transfer strategy, Zhang group developed the 
first rhodium catalyzed [(aza-3C)+(aza-3C)] cycloaddition reaction, which provided the 
chiral fused tricyclic 1,2,4-hexahydrotriazines in good yields with excellent 
diastereoselectivity and enantioselectivity.  
 
 
Scheme 1.22 Rh-catalyzed intermolecular [3+3] cycloaddition of vinyl aziridines with 
C,N-cyclic azomethine imines. 
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Another example of chirality transfer strategy by using chiral vinyl aziridines is 
rhodium catalyzed chemoselective and regioselective allylic alkylation of hydroxyarenes 
with chiral vinyl aziridines, which from Zhang group in 2017.35 As shown in Table 1.5, 
either naphthols or phenols could be applied in this transformation to serve as C-
nucleophiles rather than O-nucleophiles. By using chirality transfer strategy, this reaction 
provide a useful, efficient way to synthesize 2-arylethylamine derivatives in an 
enantioselective manner. 
Table 1.5 Rh-catalyzed intermolecular reaction of vinyl aziridines with naphthols and 
phenols. 
 
 
More recently this year, Zhang group disclosed work of enantioselective rhodium 
catalyzed allylic substitutions of vinyl aziridines and indoles.36 As shown in Table 1.6, 
different substituted indoles were applied in this enantioselective transformation. The 
desired products β-vinyltryptamines, were obtained in good to excellent yields with 
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excellent enentioselectivity when the optically pure vinyl aziridines were utilized as allyl 
donors. 
Table 1.6 Rh-catalyzed allylic substitutions of vinyl aziridines and indoles. 
 
 
1.4 CONCLUSION 
This review summarizes transition-metal-catalyzed enantioselective reactions of 
vinyl aziridines. Vinyl aziridines are versatile building blocks for synthesis of many 
different compounds which contain nitrogen atoms. The ring strain of aziridines at the 
reactive allylic position greatly enhanced the reactivity towards a number of transition-
metal-catalyzed enantioselective transformations, including cycloaddition, carbonyl 
addition, as well as alkylation reactions to provide a range of useful molecules which 
contain nitrogen. The transition-metal-catalyzed enantioselective transformations of vinyl 
aziridines will be increasingly useful and important since the growing of interest in 
nitrogen-containing compounds from organic and medicinal chemistry. It’s reasonable to 
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expect that new efficient enantioselective methodologies involving vinyl aziridines will be 
disclosed in the near future, which could provide other approaches to a variety of optically 
pure nitrogen-containing molecules.   
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Chapter 2:  Catalyst-Directed Diastereo- and Site-Selectivity in 
Successive Nucleophilic and Electrophilic Allylations of Chiral 1,3-
Diols: Protecting-Group-Free Synthesis of Substituted Pyrans*  
2.1 INTRODUCTION         
The site-selective transformation of polyfunctional molecules greatly enhances the 
step-economy since no protecting groups is needed.1 A number of methods2 were 
developed for the site-selective modification of carbohydrates and other natural polyols 
which provides direct access to compounds that otherwise would require numerous steps 
to prepare. The cyclometalated π-allyliridium catalysts used in the redox-triggered alcohol 
C-H functionalization demonstrate a distinct kinetic preference for primary alcohol 
dehydrogenation,3 facilitating site-selective C-H functionalization of unprotected diols and 
triols with high levels of catalyst-directed diastereoselectivity.4  
 
 
Figure 2.1 Representative natural products containing 4-hydroxy-2,6-disubstituted 
tetrahydropyran motif.8 
                                                 
* This chapter is based on the published work: 
Shin, I.; Wang, G.; Krische, M. J. Chem. Eur. J. 2014, 20, 13382. 
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The 4-hydroxy-2,6-cis- or trans-disubstituted tetrahydropyrans are common 
moities incorporated in polyketide natural products (Figure. 2.1).5 Complex poly-
substituted pyrans are often formed via Prins cyclization, cycloetherification of olefinic 
alcohols triggered by electrophilic reagents (e.g. haloetherification), and oxa-Michael 
cyclization.5 As documented in the literature,6 the monoallylic alcohol cyclization can be 
catalyzed by carbophilic metals to form the pyran ring. 
 
 
Scheme 2.1 Iridium catalyzed diastereo- and site-selectivity in successive nucleophilic 
and electrophilic allylations of chiral 1,3-diols. 
2.2 REACTION DEVELOPMENT AND SCOPE 
We disclose a strategy for pyran formation involving iridium-catalyzed diastereo- 
and site-selective C-allylation of chiral 1,3-diols, which followed by Grubbs metathesis 
and metal-catalyzed diastereo- and site-selective metal catalyzed O-allylation to furnish 
the pyran ring (Scheme 2.1). This approach was challenging due to the methods for 
intramolecular metal catalyzed allylic alkylation to form pyrans via O-allylation was 
limited. For instance, the 2,6-cis-disubstituted pyran formation, which catalyzed by 
palladium through allylic alkylation, gave poor selectivities to the corresponding trans-
isomers.7  
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To identify an efficient catalyst for the diastereo- and site-selective C-allylation of 
chiral 1,3-diols, the commercial available diol 2.1a was exposed to allyl acetate in the 
presence of [Ir(cod)Cl]2, different 4-substituted-3-nitro-benzoic acids, and various axially 
chiral chelating phosphine ligands (selected results are showed in Scheme 2.2). It turned 
out that catalyst (S)-2-Ir-Va, which prepared from 4-chloro-3-nitro-benzoic acid and (S)-
Cl,MeO-BIPHEP, gave the product syn-2.2a in 79% isolated yield as a single diastereomer, 
as determined by 1H NMR analysis of the crude reaction mixture. 
 
 
Scheme 2.2 Selected optimization experiments for in situ generation of iridium 
catalysts for the diastereo- and site-selective C-allylation of chiral 1,3-diol 
2.1a.a 
Using the best condition showed in Scheme 2.2, the catalysts (R)- or (S)-2-Ir-Va 
were used to convert chiral 1,3-diols 2.1a-2.1c to the diastereomeric products of C-
allylation syn-2.2a, 2.2b, 2.2c and anti-2.2a, 2.2b, 2.2c, respectively (Scheme 2.3). In each 
case, good isolated yields and complete levels of catalyst-directed diastereoselectivity were 
observed. 
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Scheme 2.3 Diastereo- and site-selective C-allylations of chiral 1,3-diols 2.1a-2.1c 
catalyzed by iridium. 
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In the presence of cis-1,4-diacetoxy-2-butene and second generation Grubbs 
catalyst, the diastereomeric diols syn-2.2a, 2.2b, 2.2c and anti-2.2a, 2.2b, 2.2c were 
converted to the corresponding allylic acetates syn-2.3a, 2.3b, 2.3c and anti-2.3a, 2.3b, 
2.3c. Although the unprotected 1,3-diol moieties evident in syn-2.2a, 2.2b, 2.2c and anti-
2.2a, 2.2b, 2.2c produced some concerns regarding functional group compatibility, the 
desired allylic acetates syn-2.3a, 2.3b, 2.3c and anti-2.3a, 2.3b, 2.3c were obtained with 
excellent yield (up to 82%), albeit with incomplete control of alkene geometry (up to 14:1 
E:Z, Scheme 2.4).9 
 
Scheme 2.4 Cross-metathesis of chiral diols syn-2.2a-c and anti-2.2a-c to form allylic 
acetates syn-2.3a-c and anti-2.3a-c. 
With the diastereomeric allylic acetates syn-2.3a, 2.3b, 2.3c and anti-2.3a, 2.3b, 
2.3c in hand, which possessing the unprotected diol moieties, both 6-endo and 6-exo-O-
allylation pathways are possible under the conditions of palladium catalyzed cyclization. 
The 2,6-cis-pyrans were formed selectively via 6-exo-O-allylation when we used an achiral 
palladium catalyst modified by 1,1'-bis(diphenylphosphino)ferrocene (dppf) although with 
incomplete levels of diastereoselectivity and in highly variable yields. 
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Scheme 2.5 Diastereo- and site-selective palladium catalyzed O-allylation reaction to 
form 4-hydroxy-2,6-cis-disubstituted tetrahydropyrans.  
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Next, to amplify the intrinsic stereochemical bias toward the 2,6-cis-diastereomers, 
a chiral palladium catalyst modified by (S,S)-1,2-diaminocyclohexane-N,N’-bis(2'-
diphenylphosphinobenzoyl), DPPBA (Figure 2.2), were applied to catalyze this 
transformation (Scheme 2.5).7b The desired 4-hydroxy-2,6-cis-disubstituted pyrans 2,6-cis-
2.4a, 2.4b, 2.4c and 4-epi-2,6-cis-2.4a, 2.4b, 2.4c were formed in excellent yield with 
complete levels of 2,6-cis-diastereoselectivity. These results reveal that pure olefin 
geometrical isomers are not required to achieve diastereoselective cyclization via O-
allylation under the conditions of palladium catalysis due to rapid equilibration of the π-
allyl haptomers with respect to cyclization.10 
 
 
Figure 2.2 Structures of (S,S,aS)-L and (S,S)-DPPBA. 
Preparation of the 4-hydroxy-2,6-trans-disubstituted pyrans was expected to be a 
far more formidable challenge, since the intrinsic bias of chiral 1,3-diols is to form the 2,6-
cis-isomers. Palladium catalysts modified by diverse chiral phosphine ligands, including 
(R,R)-DPPBA, provided highly variable diastereoselectivities in the O-allylation of chiral 
1,3-diols (Scheme 2.6). At best, using (R,R)-DPPBA as ligand, a 4:1 diastereoselectivity 
was observed in the O-allylation of the methyl-substituted diol anti-2.3a and the isobutyl-
substituted diol anti-2.3b. However, for the remaining diols, use of palladium based 
catalysts modified by (R,R)-DPPBA led to relatively poor 2,6-trans-diastereoselectivities. 
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Scheme 2.6 Diastereo- and site-selective Pd- and Ir-catalyzed O-allylation to form 4-
hydroxy-2,6-trans-disubstituted tetrahydropyrans. 
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The Tsuji-Trost allylation of chiral 1,3-diols syn-2.3a, 2.3b, 2.3c and anti-2.3a, 
2.3b, 2.3c was carried out using chiral iridium catalysts to improve the catalyst-directed 
diastereoselectivity (Scheme 2.6, conditions B).11 After extensive reaction conditions 
screening to balance conversion and 2,6-trans-diastereoselectivity, we found that the 
cyclometalated iridium complex modified by the indicated chiral phosphoramidite ligand 
(S,S,aS)-L (Figure 2.2) provided optimal results. However, in several cases, incomplete 
conversion was observed, even though certain additives, such as tetrahydrothiophene, and 
triphenylphosphine with copper(I) iodide or Pb(II) acetate which were reported to enhance 
both stereoselectivity and conversion in such iridium catalyzed Tsuji-Trost allylations.12 
2.3 MECHANISM AND DISCUSSION 
 
 
Scheme 2.7 Stereochemical features accounting for the trends in diastereoselectivity 
observed in the formation of 2,6-cis-2.4a and 2,6-trans-2.4a via Tsuji-
Trost allylation. 
To understand the trends in diastereoselectivity observed in the present cyclizations, 
a stereochemical model was provided to illustrate the cyclization process of anti-2.3a 
(Scheme 2.7). Rapid interconversion of the diastereomeric π-allyl intermediates A/B and 
C/D is anticipated.10 For the diastereomers A/B, the reactive conformer B is pseudo-
equatorially disposed, and cyclization occurs readily to furnish 2,6-cis-2.4a. For the 
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diastereomers C/D, the reactive conformer D is pseudo-axially disposed and, hence, the 
transition state for cyclization is anticipated to be higher in energy due to developing 1,3-
diaxial interactions with the relatively large metal-bound vinyl moiety. Hence, reactions 
that form the 2,6-cis-diastereomers are intrinsically more facile. 
2.4 CONCLUSION 
A new strategy for protecting-group-free synthesis of 4-hydroxy-2,6-cis- or trans-
tetrahydropyrans through successive nucleophilic and electrophilic allylations of chiral 
1,3-diols 2.1a-2.1c was developed. Using a cyclometalated iridium catalyst generated in 
situ, the redox-triggered C-allylation of chiral 1,3-diols 2.1a-2.1c occurs with complete 
levels of catalyst-directed diastereoselectivity without using protecting groups to provide 
the chiral homoallylic diols 2.2a-2.2c. In the presence of second-generation Grubbs 
catalyst, these homoallylic diols were converted to allylic acetates 2.3a-2.3c, which were 
then undergo Tsuji-Trost cyclization to deliver the 4-hydroxy-2,6-cis- or trans-
tetrahydropyrans. In the case of forming 4-hydroxy-2,6-cis-tetrahydropyrans, a chiral 
palladium catalyst gave complete levels of catalyst-directed diastereoselectivity. 
Meanwhile, upon using of chiral palladium or iridium catalysts, serviceble 
diastereoselectivityies could be obtained in the formation of 4-hydroxy-2,6-trans-
tetrahydropyrans.   
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2.5 EXPERIMENTAL DETAILS 
General Information 
All reactions were run under an atmosphere of argon. Sealed tubes (13x100 mm) 
were purchased from Fischer Scientific (catalog number 14-959-35C) and were flame dried 
followed by cooling in a desiccator. Tetrahydrofuran, toluene, and dioxanes were distilled 
from sodium-benzophenone immediately prior to use. Dichloromethane was distilled from 
calcium hydride under a nitrogen atmosphere prior to use. Anhydrous solvents were 
transferred by oven-dried syringes. Analytical thin-layer chromatography (TLC) was 
carried out using 0.25 mm commercial silica gel plates (Dynanmic Absorbents F254). 
Visualization was accomplished with UV light followed by dipping in p-anisaldehyde stain 
solution then heating. Purification of reactions was carried out by flash chromatography 
using Silacycle silica gel (40-63 μm, unless indicated specifically). Potassium phosphate 
was purchased through Acros Organics, flame dried prior to use, and stored in a desiccator. 
 
Spectroscopy, Spectrometry, and Data Collection 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. Low-
resolution mass spectra (LRMS) were obtained on a Karatos MS9 and are reported as m/z 
(relative intensity). High-resolution mass spectra (HRMS) were obtained on an Agilent 
Technologies 6530 Accurate Mass Q-TOF LC/MS instrument and are reported as m/z 
(relative intensity). Accurate masses are reported for the molecular ion (M, M+H, or M-
H), or a suitable fragment ion. 1H nuclear magnetic resonance spectra were recorded using 
a 400 MHz spectrometer. Chemical shifts are reported as parts per million (ppm) relative 
to residual CHCl3 δH (7.26 ppm). 13C nuclear magnetic resonance spectra were recorded 
using a 100 MHz spectrometer for CDCl3 solutions, and chemical shifts are reported as 
parts per million (ppm) relative to residual CDCl3 δC (77.16 ppm).  
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General Procedure for Ir-Catalyzed Allylation of Alcohols. 
To a sealed tube under an argon atmosphere charged with alcohol (100 mol%), (R)-
2-Ir-preformed catalyst (5.0 mol%), Cs2CO3 (100 mol%) and 4-Cl-3-NO2-BzOH (10 
mol%) was added freshly distilled THF (0.2 M), H2O (500 mol%), and allyl acetate (200 
mol%). The septum was quickly replaced with a screw cap and the reaction mixture was 
allowed to stir in an oil bath at 100 °C for 24 h. The reaction mixture was allowed to cool 
to ambient temperature, and was concentrated in vacuo. The 
residue was subjected to flash column chromatography to furnish 
title compound. 
 
(S)-6-Methyl-1-hepten-4-ol (2-S-1). 
 
According to general procedure for Ir-catalyzed allylation of alcohols with 3-methylbutan-
1-ol (44.1 mg, 0.50 mmol, 100 mol%), the product 2-S-1 was obtained as a colorless oil in 
70% yield (45.0 mg, 0.35 mmol, ee = >99%) after flash column chromatography 
(hexanes/EtOAc = 20:1). 
1H NMR (400 MHz, CDCl3) δ 6.00–5.67 (m, 1H), 5.28–4.98 (m, 2H), 3.87–3.57 (m, 1H), 
2.36–2.21 (m, 1H), 2.20–2.05 (m, 1H), 1.88–1.71 (m, 1H), 1.55 (d, J = 4.1 Hz, 1H), 1.42 
(ddd, J = 14.2, 8.8, 5.5 Hz, 1H), 1.25 (m, 1H), 0.93 (d, J = 6.7 Hz, 3H), 0.92 (d, J = 6.6 Hz, 
3H). 
13C NMR (100 MHz, CDCl3) δ 135.0, 118.2, 68.7, 46.1, 42.6, 24.7, 23.5, 22.2.  
[]25D = –31.78 ° (c = 1.50, CHCl3). 
Data is consistent with that reported in the literature.13 
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(R)-1-Phenylbut-3-en-1-ol (2-S-2). 
 
According to general procedure for Ir-catalyzed allylation of alcohols with benzyl alcohol 
(59.0 mg, 0.54 mmol, 100 mol%), the product 2-S-2 was obtained as a colorless oil in 75% 
yield (64.0 mg, 0.41 mmol, ee = 94%) after flash column chromatography (hexanes/EtOAc 
= 20:1). 
 
1H NMR (400 MHz, CDCl3) δ 7.39–7.31 (m, 4H), 7.31–7.23 (m, 1H), 5.86–5.74 (m, 1H), 
5.31–5.03 (m, 2H), 4.72 (m, 1H), 2.47–2.43 (m, 2H), 2.11 (s, 1H). 
 
13C NMR (100 MHz, CDCl3) δ 143.9, 134.5, 128.5, 127.6, 125.9, 118.5, 73.4, 43.9. 
 
[]25D = +60.33° (c = 2.00, CHCl3). 
Data is consistent with that reported in the literature.14 
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General Procedure for Preparation of 1,3-Diols. 
To a flask charged with allylic alcohol (100 mol%) was added freshly distilled CH2Cl2 (0.1 
M). Ozone was bubbled through the solution for 15 min at –78 °C, at which point sodium 
borohydride (NaBH4, 500 mol%) was added to the solution. The reaction mixture was 
gradually warmed to ambient temperature and stirred overnight. Saturated NH4Cl solution 
was added at 0 °C to quench the reaction. The organic layer was washed with saturated 
aqueous NaHCO3, dried over MgSO4, filtered, and concentrated in vacuo. The residue was 
subjected to flash column chromatography to furnish the title compound. 
(S)-5-Methylhexane-1,3-diol (2.1b). 
 
According to general procedure for preparation of 1,3-diols with (S)-6-methyl-1-hepten-4-
ol (869.1 mg, 6.79 mmol, 100 mol%), the product 2.1b was obtained as a colorless oil in 
85% yield (763.0 mg, 5.77 mmol, ee = >99%) after flash column chromatography 
(CH2Cl2/MeOH = 20:1). 
 
1H NMR (400 MHz, CDCl3) δ 4.05–3.71 (m, 3H), 2.97 (br s, 1H), 2.81 (br s, 1H), 1.85–
1.56 (m, 3H), 1.53–1.41 (m, 1H), 1.31–1.18 (m, 1H), 0.93 (d, J = 6.6 Hz, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 70.2, 61.8, 47.0, 38.8, 24.5, 23.4, 22.2. 
 
[]25D = –20.67 ° (c = 1.00, CHCl3). 
Data is consistent with that reported in the literature.15 
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(R)-1-Phenylpropane-1,3-diol (2.1c). 
 
According to general procedure for preparation of 1,3-diols with (R)-1-phenylbut-3-en-1-
ol (741.0 mg, 5.0 mmol, 100 mol%), the product 2.1c was obtained as a colorless oil in 
75% yield (580 mg, 3.75 mmol, ee = 94%) after flash column chromatography 
(CH2Cl2/MeOH = 20:1). 
 
1H NMR (400 MHz, CDCl3) δ 7.36–7.30 (m, 4H), 7.29–7.23 (m, 1H), 4.89 (dd, J = 8.7, 
3.8 Hz, 1H), 3.96–3.66 (m, 2H), 3.59 (br s, 1H), 3.09 (br s, 1H), 2.08–1.74 (m, 2H). 
 
13C NMR (100 MHz, CDCl3) δ 144.3, 128.5, 127.6, 125.7, 74.1, 61.2, 40.4. 
 
[]25D = +42.50 ° (c = 0.40, CHCl3). 
Data is consistent with that reported in the literature.16 
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General Procedure for Ir-Catalyzed Allylation of 1,3-Diols. 
To a sealed tube under an argon atmosphere charged with 1,3-diol (100 mol%), [Ir(cod)Cl]2 
(2.5 mol%), (S)- or (R)-Cl, MeO-BIPHEP (5 mol%), Cs2CO3 (20 mol%) and 4-Cl-3-NO2-
BzOH (10 mol%) was added freshly distilled THF (0.2 M) and allyl acetate (10 eq.). The 
septum was quickly replaced with a screw cap and the reaction mixture was allowed to stir 
in an oil bath at 100 °C for 40 h. The reaction mixture was allowed to cool to ambient 
temperature, and was concentrated in vacuo. The residue was subjected to flash column 
chromatography to furnish title compound. 
(2S,4R)-Hept-6-ene-2,4-diol (syn-2.2a). 
 
According to general procedure for Ir-catalyzed allylation of 1,3-diols with (S)-butane-1,3-
diol 2.1a (18 mg, 0.20 mmol, 100 mol%) and (R)-Cl, MeO-BIPHEP, the product syn-2.2a 
was obtained as a light yellow oil in 70% yield (18.3 mg, 0.14 mmol, dr = >20:1) after 
flash column chromatography (hexanes/EtOAc = 1:1). 
 
1H NMR (400 MHz, CDCl3)  5.87–5.73 (m, 1H), 5.18–5.13 (m, 1H), 5.13–5.09 (m, 1H), 
4.11–3.99 (m, 1H), 3.95–3.83 (m, 1H), 3.13 (br s, 2H), 2.31–2.15 (m, 2H), 1.65–1.45 (m, 
2H), 1.20 (d,  J = 6.2 Hz, 3H). 
13C NMR (100 MHz, CDCl3)  134.2, 118.4, 71.8, 68.9, 44.1, 42.6, 24.1. 
IR (neat) 3329, 2969, 2933, 1433, 1324, 1087, 914 cm-1.  
LRMS (CI+) calcd. for C7H15O2 [M+H]
+ 131, found 131. 
[]25D = +2.0 ° (c = 0.50, CHCl3). 
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(2S,4S)-Hept-6-ene-2,4-diol (anti-2.2a). 
 
According to general procedure for Ir-catalyzed allylation of 1,3-diols with (S)-butane-1,3-
diol 2.1a (18 mg, 0.20 mmol, 100 mol%) and (S)-Cl, MeO-BIPHEP, the product anti-2.2a 
was obtained as a light yellow oil in 79% yield (20.6 mg, 0.16 mmol, dr = 1:>20) after 
flash column chromatography (hexanes/EtOAc = 1:1). 
 
1H NMR (400 MHz, CDCl3)  5.29–5.75 (m, 1H), 5.18–5.13 (m, 1H), 5.13–5.08 (m, 1H), 
4.23–4.08 (m, 1H), 4.04–3.93 (m, 1H), 2.75 (br s, 2H), 2.30–2.21 (m, 2H), 1.62–1.57 (m, 
2H), 1.22 (d,  J = 6.2 Hz, 3H).  
 
13C NMR (100 MHz, CDCl3)  134.8, 118.2, 68.3, 65.4, 43.7, 42.1, 23.6. 
 
IR (neat) 3356, 2967, 2933, 1433, 1414, 1374, 1087, 996 cm-1.  
 
LRMS (CI+) calcd. for C7H15O2 [M+H]
+ 131, found 131. 
 
[]25D = +22.4 ° (c = 0.61, CHCl3). 
 
Data is consistent with that reported in the literature.17 
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(4R,6S)-8-Methylnon-1-ene-4,6-diol (syn-2.2b). 
 
According to general procedure for Ir-catalyzed allylation of 1,3-diols with (S)-5-
methylhexane-1,3-diol 2.1b (26.5 mg, 0.20 mmol, 100 mol%) and (R)-Cl, MeO-BIPHEP, 
the product syn-2.2b was obtained as a light yellow oil in 70% yield (24 mg, 0.14 mmol, 
dr = >20:1) after flash column chromatography (hexanes/EtOAc = 4:1). 
 
1H NMR (400 MHz, CDCl3) δ 5.98–5.64 (m, 1H), 5.18–5.09 (m, 2H), 4.00–3.86 (m, 2H), 
3.17 (s, 2H), 2.34-2.15 (m, 2H), 1.84–1.68 (m, 1H), 1.67–1.55 (m, 1H), 1.54–1.37 (m, 2H), 
1.29–1.13 (m, 1H), 0.93 (d, J = 1.6 Hz, 3H), 0.91 (d, J = 1.6 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3) δ 134.5, 118.3, 72.1, 71.0, 47.4, 43.0, 42.7, 24.4, 23.4, 22.3. 
 
IR (neat) 3331, 2954, 2932, 1434, 1081, 914 cm-1.  
 
LRMS (ESI+) calcd. for C10H20O2Na [M+Na]
+ 195, found 195. 
 
[]25D = –10.33 ° (c = 1.00, CHCl3). 
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(4S,6S)-8-Methylnon-1-ene-4,6-diol (anti-2.2b). 
 
According to general procedure for Ir-catalyzed allylation of 1,3-diols with (S)-5-
methylhexane-1,3-diol 2.1b (26.5 mg, 0.20 mmol, 100 mol%) and (S)-Cl, MeO-BIPHEP, 
the product anti-2.2b was obtained as a light yellow oil in 81% yield (28 mg, 0.16 mmol, 
dr = 1: >20) after flash column chromatography (hexanes/EtOAc = 4:1). 
 
1H NMR (400 MHz, CDCl3) δ 5.96–5.66 (m, 1H), 5.19–5.14 (m, 1H), 5.14–5.10 (m, 1H), 
4.18–3.86 (m, 2H), 2.54 (br s, 1H), 2.46 (br s, 1H), 2.36–2.16 (m, 2H), 1.85–1.68 (m, 1H), 
1.68–1.54 (m, 2H), 1.54–1.41 (m, 1H), 1.35–1.16 (m, 1H), 0.92 (d, J = 1.7 Hz, 3H), 0.90 
(d, J = 1.7 Hz, 3H).  
 
13C NMR (100 MHz, CDCl3) δ 134.8, 118.3, 68.3, 67.4, 46.7, 42.5, 42.2, 24.8, 23.4, 22.4. 
 
IR (neat) 3355, 2954, 2933, 1433, 1139, 1049, 913 cm-1.  
 
LRMS (ESI+) calcd. for C10H20O2Na [M+Na]
+ 195, found 195. 
 
[]25D = +16.33 ° (c = 1.00, CHCl3). 
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(1R,3R)-1-Phenylhex-5-ene-1,3-diol (syn-2.2c). 
 
According to general procedure for Ir-catalyzed allylation of 1,3-diols with (R)-1-
phenylpropane-1,3-diol 2.1c (30 mg, 0.20 mmol, 100 mol%) and (R)-Cl, MeO-BIPHEP, 
the product syn-2.2c was obtained as a light yellow solid in 68% yield (26 mg, 0.14 mmol, 
dr = >20:1) after flash column chromatography (hexanes/EtOAc = 4:1). 
 
mp: 61.2–62.5 °C. 
 
1H NMR (400 MHz, CDCl3) δ 7.42–7.07 (m, 5H), 5.87–5.58 (m, 1H), 5.09–5.00 (m, 2H), 
4.85 (dd, J = 8.9, 4.1 Hz, 1H), 3.98–3.83 (m, 1H), 3.04 (br s, 2H), 2.28–2.07 (m, 2H), 1.88–
1.62 (m, 2H). 
 
13C NMR (100 MHz, CDCl3) δ 144.5, 134.2, 128.6, 127.7, 125.8, 118.6, 75.3, 71.7, 45.0, 
42.6. 
 
IR (neat) 3288, 2940, 2914, 1436, 1330, 1025, 917 cm-1.  
 
LRMS (ESI+) calcd. for C12H16O2Na [M+Na]
+ 215, found 215. 
 
[]25D = +17.50 ° (c = 0.40, CHCl3). 
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(1R,3R)-1-Phenylhex-5-ene-1,3-diol (anti-2.2c). 
 
According to general procedure for Ir-catalyzed allylation of 1,3-diols with (R)-1-
phenylpropane-1,3-diol 2.1c (30 mg, 0.20 mmol, 100 mol%) and (S)-Cl, MeO-BIPHEP, 
the product anti-2.2c was obtained as a light yellow solid in 65% yield (25 mg, 0.13 mmol, 
dr = 1:>20) after flash column chromatography (hexanes/EtOAc = 4:1). 
 
mp: 61.6–62.8 °C. 
 
1H NMR (400 MHz, CDCl3) δ 7.46–7.00 (m, 5H), 5.86–5.50 (m, 1H), 5.10–5.01 (m, 2H), 
4.98 (dd, J = 7.9, 3.5 Hz, 1H), 3.95–3.72 (m, 1H), 2.71 (br s, 2H), 2.32–2.07 (m, 2H), 1.92–
1.69 (m, 2H). 
 
13C NMR (100 MHz, CDCl3) δ 144.6, 134.5, 128.6, 127.5, 125.7, 118.6, 71.8, 68.1, 44.2, 
42.1. 
 
IR (neat) 3371, 2912, 1452, 1431, 1335, 1052, 915 cm-1.  
 
LRMS (ESI+) calcd. for C12H16O2Na [M+Na]
+ 215, found 215. 
 
[]25D = +61.67 ° (c = 1.00, CHCl3). 
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General Procedure for Cross Metathesis. 
To a sealed tube under an argon atmosphere charged with diol 2.2 (100 mol%) and cis-1,4-
diacetoxy-2-butene (400 mol%) was added freshly distilled CH2Cl2 (0.18 M). The Grubbs 
second generation catalyst [Cl2(PCy3)(IMes)Ru=CHPh] (3 mol%) was added in one 
portion. Tthe septum was quickly replaced with a screw cap, and the reaction mixture was 
allowed to stir in an oil bath at 50 °C for 20 h. The reaction mixture was allowed to cool to 
ambient temperature, was concentrated in vacuo. The residue was subjected to flash 
column chromatography to furnish title product. 
(5R,7S,E)-5,7-Dihydroxyoct-2-en-1-yl Acetate (syn-2.3a). 
 
According to general procedure for cross metathesis with syn-2.2a (230 mg, 1.77 mmol, 
100 mol%), the product syn-2.3a was obtained as a brown oil in 80% yield (288 mg, 1.42 
mmol, E:Z = 8:1) after flash column chromatography (hexanes/EtOAc = 2:1 to 1:1). 
1H NMR (400 MHz, CDCl3)  5.82–5.55 (m, 2H), 4.50 (dd,  J = 6.2, 0.7 Hz, 2H), 4.09–
3.96 (m, 1H), 3.93–3.83 (m, 1H), 3.52 (br s, 2H), 2.21 (dd,  J = 6.4, 6.4 Hz, 2H), 2.03 (s, 
3H), 1.59–1.41 (m, 2H), 1.17 (d,  J = 6.2 Hz, 3H).  
13C NMR (100 MHz, CDCl3, mixture of E- and Z isomers)  171.3, 171.1, 131.5, 130.6, 
127.3, 126.3, 71.9, 69.0, 65.0, 60.5, 44.2, 44.1, 41.0, 36.2, 24.2, 21.2. 
IR (neat) 3364, 2934, 1736, 1230, 1024, 966 cm-1.  
LRMS (ES+) calcd. for C10H19O4 [M+H]
+ 203, found 203. 
[]25D = +8.06 ° (c = 0.62, CHCl3). 
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(5R,7S,E)-5,7-Dihydroxy-9-methyldec-2-en-1-yl Acetate (syn-2.3b). 
 
According to general procedure for cross metathesis with syn-2.2b (80 mg, 0.46 mmol, 
100 mol%), the product syn-2.3b was obtained as a brown oil in 82% yield (93 mg, 0.38 
mmol, E:Z = 5:1) after flash column chromatography (hexanes/EtOAc = 3:1 to 2:1). 
 
1H NMR (400 MHz, CDCl3) δ 5.85–5.60 (m, 2H), 4.54 (d, J = 6.1 Hz, 2H), 4.01–3.84 (m, 
2H), 3.29 (br s, 1H), 2.96 (br s, 1H), 2.25 (dd, J = 6.7, 6.7 Hz, 2H), 2.07 (s, 3H), 1.88–1.65 
(m, 2H), 1.65–1.39 (m, 3H), 0.92 (d, J = 7.2 Hz, 6H). 
 
13C NMR (100 MHz, CDCl3, mixture of E- and Z isomers) δ 171.0, 131.6, 130.7, 127.5, 
126.4, 72.3, 72.1, 71.1, 71.0, 65.1, 60.6, 47.5, 43.2, 43.0, 41.1, 36.2, 24.4, 23.4, 22.3, 21.1. 
 
IR (neat) 3378, 2953, 2869, 1738, 1224, 969 cm-1.  
 
LRMS (ESI+) calcd. for C13H24O4Na [M+Na]
+ 267, found 267. 
 
[]25D = –20.02 ° (c = 0.60, CHCl3). 
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(5R,7R,E)-5,7-Dihydroxy-7-phenylhept-2-en-1-yl Acetate (syn-2.3c). 
 
According to general procedure for cross metathesis with syn-2.2c (50 mg, 0.26 mmol, 100 
mol%), the product syn-2.3c was obtained as a brown oil in 80% yield (55.5 mg, 0.21 
mmol, E:Z = 14:1) after flash column chromatography (hexanes/EtOAc = 3:1 to 2:1). 
 
1H NMR (400 MHz, CDCl3) δ 7.40–7.23 (m, 5H), 5.85–5.56 (m, 2H), 4.92 (d, J = 9.5 Hz, 
1H), 4.52 (d, J = 6.1 Hz, 2H), 3.98 (d, J = 7.1 Hz, 1H), 3.48 (br s, 1H), 3.35 (br s, 1H), 2.25 
(dd, J = 6.6, 6.6 Hz, 2H), 2.04 (s, 3H), 1.91–1.70 (m, 2H). 
 
13C NMR (100 MHz, CDCl3, mixture of E- and Z isomers) δ 171.1, 144.4, 131.4, 128.7, 
127.8, 127.6, 125.8, 75.3, 71.7, 65.0, 44.9, 41.0, 21.1. 
 
IR (neat) 3365, 2916, 1735, 1230, 1025, 971 cm-1.  
 
LRMS (ESI+) calcd. for C15H20O4Na [M+Na]
+ 287, found 287. 
 
[]25D = +22.05 ° (c = 1.40, CHCl3). 
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(5S,7S,E)-5,7-Dihydroxyoct-2-en-1-yl Acetate (anti-2.3a). 
 
According to general procedure for cross metathesis with anti-2.2a (100 mg, 0.77 mmol, 
100 mol%), the product anti-2.3a was obtained as a brown oil in 82% yield (128 mg, 0.63 
mmol, E:Z = 5:1) after flash column chromatography (hexanes/EtOAc = 2:1 to 1:1). 
 
1H NMR (400 MHz, CDCl3)  5.82–5.58 (m, 2H), 4.51 (dd,  J = 6.2, 0.9 Hz, 2H), 4.17–
4.05 (m, 1H), 4.01–3.91 (m, 1H), 2.98 (br s, 2H), 2.29–2.21 (m, 2H), 2.04 (s, 3H), 1.67–
1.49 (m, 2H), 1.21 (d,  J = 6.3 Hz, 3H).  
 
13C NMR (100 MHz, CDCl3, mixture of E- and Z isomer)  171.3, 171.1, 132.0, 131.0, 
127.2, 126.2, 68.4, 68.2, 65.3, 65.1, 60.6, 43.9, 43.7, 40.5, 35.7, 23.6, 21.1. 
 
IR (neat) 3382, 2934, 1736, 1230, 1024 cm-1.  
 
HRMS (ESI+) calcd. for C10H18O4Na [M+Na]
+ 225.1097, found 225.1099. 
 
[]25D = +16.67 ° (c = 0.58, CHCl3). 
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(5S,7S,E)-5,7-Dihydroxy-9-methyldec-2-en-1-yl Acetate (anti-2.3b). 
 
According to general procedure for cross metathesis with anti-2.2b (100 mg, 0.58 mmol, 
100 mol%), the product anti-2.3b was obtained as a brown oil in 81% yield (114 mg, 0.47 
mmol, E:Z = 2:1) after flash column chromatography (hexanes/EtOAc = 3:1 to 2:1). 
 
1H NMR (400 MHz, CDCl3)  5.85–5.57 (m, 2H), 4.52 (d,  J = 6.1 Hz, 2H), 4.07–3.93 
(m, 2H), 2.80 (br s, 2H), 2.26 (dd, J = 6.5, 6.5 Hz, 2H), 2.05 (s, 3H), 1.82–1.66 (m, 1H), 
1.66–1.42 (m, 2H), 1.27–1.16 (m, 1H), 0.91 (d,  J = 2.0 Hz, 3H), 0.90 (d,  J = 1.9 Hz, 
3H), 0.92–0.86 (m, 1H).  
 
13C NMR (100 MHz, CDCl3, mixture of E- and Z isomers)  171.3, 171.0, 131.9, 131.0, 
127.3, 126.3, 68.6, 68.4, 67.4, 65.0, 60.6, 46.7, 42.8, 42.6, 40.6, 35.8, 24.7, 23.4, 22.4, 21.1. 
 
IR (neat) 3406, 2953, 1736, 1229, 1024, 969 cm-1.  
 
LRMS (ESI+) calcd. for C13H24O4Na [M+Na]
+ 267, found 267. 
 
[]25D = –18.87 ° (c = 0.53, CHCl3). 
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(5S,7R,E)-5,7-Dihydroxy-7-phenylhept-2-en-1-yl Acetate (anti-2.3c). 
 
According to general procedure for cross metathesis with anti-2.2c (28 mg, 0.15 mmol, 
100 mol%), the product anti-2.3c was obtained as a brown oil in 78% yield (31 mg, 0.12 
mmol, E:Z = 7:1) after flash column chromatography (hexanes/EtOAc = 3:1 to 2:1). 
 
1H NMR (400 MHz, CDCl3) δ 7.42–7.22 (m, 5H), 5.82–5.54 (m, 2H), 5.09–5.01 (m, 1H), 
4.51 (dd, J = 6.0, 0.7 Hz, 2H), 3.98–3.88 (m, 1H), 3.12 (d, J = 4.0 Hz, 1H), 2.65 (d, J = 3.8 
Hz, 1H), 2.27 (dd, J = 6.8, 6.8 Hz, 2H), 2.05 (s, 3H), 1.96–1.81 (m, 2H). 
 
13C NMR (100 MHz, CDCl3, mixture of E- and Z isomers) δ 171.1, 144.5, 131.6, 128.6, 
127.6, 127.5, 125.6, 71.7, 68.2, 65.0, 44.3, 40.5, 21.1. 
 
IR (neat) 3392, 2916, 1734, 1233, 1026, 969 cm-1.  
 
LRMS (ESI+) calcd. for C15H20O4Na [M+Na]
+ 287, found 287. 
 
[]25D = –56.41 ° (c = 0.26, CHCl3). 
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General Procedure for Pd-Catalyzed O-Allylation. 
To a round bottomed flask under an argon atmosphere charged with Pd2(dba)3-CHCl3 and 
DPPBA was added freshly distilled CH2Cl2 (0.006 M to Pd catalyst). The mixture was 
allowed to stir at ambient temperature for 30 minutes, during which time the color of the 
solution changed from purple to orange. The orange solution was transferred via syringe 
to a round-bottomed flask charged with a solution of acetate 2.3 (100 mol%) and Et3N (200 
mol%) in CH2Cl2 (0.013 M). The reaction mixture was allowed to stir at indicated 
temperature for indicated time. The reaction mixture was concentrated in vacuo and the 
residue was subjected to flash column chromatography to furnish the title. 
 
General Procedure for Ir-Catalyzed O-Allylation. 
To a sealed tube under an argon atmosphere charged with [Ir(cod)Cl]2 (3 mol%) and 
(S,S,aS)-L (6 mol%) was added TBD (50 mol%) in THF (0.33 M to Ir catalyst). The 
reaction mixture was allowed to stir at ambient temperature for 10 min, at which point a 
solution of acetate 2.3 (100 mol%) in THF (0.3 M) was added via syringe. The reaction 
mixture was placed in a 90 °C oil bath and was allowed to stir for 20 h. The reaction mixture 
was allowed to cool to ambient temperature, and was concentrated in vacuo. The residue 
was subjected to flash column chromatography to furnish the title and unreacted acetate 
2.3.  
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(2S,4R,6S)-2-Methyl-6-vinyltetrahydro-2H-pyran-4-ol (2,6-cis-2.4a). 
 
According to general procedure for Pd-catalyzed O-allylation with anti-2.3a (40.4 mg, 0.20 
mmol, 100 mol%), Pd2(dba)3-CHCl3 (6.2 mg, 0.006 mmol, 3 mol%), and (S,S)-DPPBA  
(12.4 mg, 0.018 mmol, 9 mol%) at 25 °C for 3 h, the product 2,6-cis-2.4a was obtained as 
a colorless oil in 99% yield (28.2 mg, 0.198 mmol, dr = >20:1) after flash column 
chromatography (hexanes/EtOAc = 3:2 to 2:3). 
 
1H NMR (400 MHz, CDCl3)  5.87 (ddd, J = 17.2, 10.5, 5.8 Hz, 1H), 5.26 (ddd, J = 17.3, 
1.4, 1.4 Hz, 1H), 5.12 (ddd, J = 10.5, 1.4, 1.4 Hz, 1H), 3.88–3.77 (m, 2H), 3.56–3.45 (m, 
1H), 2.02–1.90 (m, 2H), 1.75 (br s, 1H), 1.30–1.12 (m, 2H), 1.25 (d,  J = 6.2 Hz, 3H).  
 
13C NMR (100 MHz, CDCl3)  138.4, 115.5, 76.3, 71.8, 68.1, 42.8, 40.7, 21.9. 
 
IR (neat) 3357, 2973, 2847, 1368, 1308, 1146, 1014, 922 cm-1.  
 
HRMS (ESI+) calcd. for C8H14O2Na [M+Na]
+ 165.0886, found 165.0886. 
 
[]25D = –18.10 ° (c = 1.05, CHCl3). 
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(2S,4S,6S)-2-Methyl-6-vinyltetrahydro-2H-pyran-4-ol (4-epi-2,6-cis-2.4a). 
 
According to general procedure for Pd-catalyzed O-allylation with syn-2.3a (20.2 mg, 0.10 
mmol, 100 mol%), Pd2(dba)3-CHCl3 (3.1 mg, 0.003 mmol, 3 mol%), and (S,S)-DPPBA 
(6.2 mg, 0.009 mmol, 9 mol%) at 50 °C for 18 h, the product 4-epi-2,6-cis-2.4a was 
obtained as a colorless oil in 90% yield (12.8 mg, 0.090 mmol, dr = >20:1) after flash 
column chromatography (hexanes/EtOAc = 3:2). 
 
1H NMR (400 MHz, CDCl3)  5.86 (ddd, J = 17.3, 10.6, 5.9 Hz, 1H), 5.27 (ddd, J = 17.3, 
1.5, 1.5 Hz, 1H), 5.12 (ddd, J = 10.6, 1.3, 1.3 Hz, 1H), 4.35–4.24 (m, 2H), 4.03–3.92 (m, 
1H), 1.75–1.36 (m, 5H), 1.20 (d,  J = 6.2 Hz, 3H).  
 
13C NMR (100 MHz, CDCl3)  139.3, 115.3, 72.5, 67.7, 64.8, 40.2, 38.3, 22.0. 
 
IR (neat) 3357, 2920, 2851, 1632, 1365, 1259, 1018, 965 cm-1.  
 
LRMS (CI+) calcd. for C8H15O2 [M+H]
+ 143, found 143. 
 
[]25D = –11.11 ° (c = 0.09, CHCl3). 
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(2S,4R,6S)-2-Isobutyl-6-vinyltetrahydro-2H-pyran-4-ol (2,6-cis-2.4b). 
 
According to general procedure for Pd-catalyzed O-allylation with anti-2.3b (24.4 mg, 
0.10 mmol, 100 mol%), Pd2(dba)3-CHCl3 (3.1 mg, 0.003 mmol, 3 mol%), and (S,S)-
DPPBA (6.2 mg, 0.009 mmol, 9 mol%) at 50 °C for 20 h, the product 2,6-cis-2.4b was 
obtained as a colorless oil in 84% yield (15.4 mg, 0.084 mmol, dr = >20:1) after flash 
column chromatography (hexanes/EtOAc = 2:1). 
 
1H NMR (400 MHz, CDCl3)  5.91 (ddd, J = 17.3, 10.6, 5.3 Hz, 1H), 5.26 (ddd, J = 17.3, 
1.5, 1.5 Hz, 1H), 5.11 (ddd, J = 10.6, 1.4, 1.4 Hz, 1H), 3.90–3.77 (m, 2H), 3.47–3.37 (m, 
1H), 2.05–1.97 (m, 1H), 1.97–1.89 (m, 1H), 1.88–1.74 (m, 1H), 1.64 (br s, 1H), 1.61–1.51 
(m, 1H), 1.32–1.09 (m, 3H), 0.90 (d, J =2.3 Hz, 3H), 0.89 (d, J = 2.2 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3)  138.6, 115.1, 76.1, 73.9, 68.4, 45.2, 41.5, 41.0, 24.5, 23.2, 
22.6. 
 
IR (neat) 3357, 2954, 1383, 1036 cm-1.  
 
LRMS (CI+) calcd. for C11H21O2 [M+H]
+ 185, found 185. 
 
[]25D = –49.49 ° (c = 0.99, CHCl3). 
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(2S,4S,6S)-2-Isobutyl-6-vinyltetrahydro-2H-pyran-4-ol (4-epi-2,6-cis-2.4b). 
 
According to general procedure for Pd-catalyzed O-allylation with syn-2.3b (24.4 mg, 0.10 
mmol, 100 mol%), Pd2(dba)3-CHCl3 (5.2 mg, 0.005 mmol, 5 mol%), and (S,S)-DPPBA  
(10.4 mg, 0.015 mmol, 15 mol%) at 25 °C for 18 h, the product 4-epi-2,6-cis-2.4b was 
obtained as a colorless oil in 75% yield (13.8 mg, 0.075 mmol, dr = >20:1) after flash 
column chromatography (hexanes/EtOAc = 3:2 to1:1). 
 
1H NMR (400 MHz, CDCl3) δ 5.85 (ddd, J = 17.3, 10.6, 5.3 Hz, 1H), 5.26 (ddd, J = 17.3, 
1.6, 1.6 Hz, 1H), 5.10 (ddd, J = 10.6, 1.5, 1.5 Hz, 1H), 4.33–4.24 (m, 2H), 3.93–3.84 (m, 
1H), 1.90–1.39 (m, 7H), 1.17 (ddd, J = 13.7, 8.1, 4.7 Hz, 1H), 0.92 (d, J = 0.8 Hz, 3H) 0.90 
(d, J = 0.7 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3) δ 139.4, 114.8, 72.2, 69.8, 64.9, 45.5, 39.0, 38.6, 24.5, 23.4, 
22.6. 
 
IR (neat) 3394, 2953, 2869, 1376, 1260, 1095, 1037, 920 cm-1.  
 
LRMS (ESI+) calcd. for C11H20O2Na [M+Na]
+ 207, found 207. 
 
[]25D = –12.82 ° (c = 0.26, CHCl3). 
  
             80 
 
 
 
 
  
             81 
 
(2R,4S,6S)-2-Phenyl-6-vinyltetrahydro-2H-pyran-4-ol (2,6-cis-2.4c). 
 
According to general procedure for Pd-catalyzed O-allylation with anti-2.3c (26.4 mg, 0.10 
mmol, 100 mol%), Pd2(dba)3-CHCl3 (3.1 mg, 0.003 mmol, 3 mol%), and (S,S)-DPPBA 
(6.2 mg, 0.009 mmol, 9 mol%) at 50 °C for 22 h, the product 2,6-cis-2.4c was obtained as 
a colorless oil in 89% yield (18.2 mg, 0.089 mmol, dr = >20:1) after flash column 
chromatography (hexanes/EtOAc = 2:1). 
 
1H NMR (400 MHz, CDCl3)  7.44–7.23 (m, 5H),  5.96 (ddd, J = 17.3, 10.6, 5.4 Hz, 
1H), 5.33 (ddd, J = 17.3, 1.5, 1.5 Hz, 1H), 5.16 (ddd, J = 10.6, 1.4, 1.4 Hz, 1H), 4.44 (dd, 
J = 11.4, 2.0 Hz, 1H), 4.08–3.96 (m, 2H),  2.24–2.17 (m, 1H), 2.15–2.07 (m, 1H), 1.69 
(br, 1H), 1.57–1.33 (m, 2H).  
 
13C NMR (100 MHz, CDCl3)  142.1, 138.3, 128.5, 127.7, 126.1, 115.3, 77.7, 76.6, 68.5, 
43.1, 40.9. 
 
IR (neat) 3358, 2944, 2850, 1059, 698 cm-1.  
 
LRMS (CI+) calcd. for C11H17O2 [M+H]
+ 205, found 205. 
 
[]25D = +52.17 ° (c = 0.46, CHCl3). 
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(2R,4R,6S)-2-Phenyl-6-vinyltetrahydro-2H-pyran-4-ol (4-epi-2,6-cis-2.4c). 
 
According to general procedure for Pd-catalyzed O-allylation with syn-2.3c (26.4 mg, 0.10 
mmol, 100 mol%), Pd2(dba)3-CHCl3 (5.2 mg, 0.005 mmol, 5 mol%), and (S,S)-DPPBA  
(10.4 mg, 0.015 mmol, 15 mol%) at 25 °C for 18 h, the product 2,6-cis-2.4c was obtained 
as a colorless oil in 96% yield (19.6 mg, 0.096 mmol, dr = >20:1) after flash column 
chromatography (hexanes/EtOAc = 3:2 to1:1). 
 
1H NMR (400 MHz, CDCl3) δ 7.51–7.13 (m, 5H), 5.93 (ddd, J = 17.3, 10.6, 5.5 Hz, 1H), 
5.33 (ddd, J = 17.3, 1.6, 1.6 Hz, 1H), 5.13 (ddd, J = 10.6, 1.5, 1.5 Hz, 1H), 4.92 (dd, J = 
11.7, 2.4 Hz, 1H), 4.57–4.45 (m, 1H), 4.40–4.32 (m, 1H), 1.94–1.86 (m, 1H), 1.84–1.62 
(m, 4H). 
 
13C NMR (100 MHz, CDCl3) δ 142.9, 139.1, 128.4, 127.4, 126.1, 115.1, 73.7, 72.8, 64.9, 
40.7, 38.4. 
 
IR (neat) 3400, 2919, 2824, 1453, 1304, 1179, 1023, 920 cm-1.  
 
LRMS (ESI+) calcd. for C13H16O2Na [M+Na]
+ 227, found 227. 
 
[]25D = +38.65 ° (c = 0.12, CHCl3). 
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(2S,4R,6R)-2-Methyl-6-vinyltetrahydro-2H-pyran-4-ol (2,6-trans-2.4a). 
 
According to general procedure for Pd-catalyzed O-allylation with anti-2.3a (40.4 mg, 0.20 
mmol, 100 mol%), Pd2(dba)3-CHCl3 (6.2 mg, 0.006 mmol, 3 mol%), and (R,R)-DPPBA  
(12.4 mg, 0.018 mmol, 9 mol%) at 25 °C for 3 h, the product 2,6-trans-2.4a was obtained 
as a colorless oil in 99% yield (28.1 mg, 0.198 mmol, dr = 1:4, 2,6-cis-2.4a:2,6-trans-
2.4a) after flash column chromatography (hexanes/EtOAc = 3:2 to 2:3). 
 
According to general procedure for Ir-catalyzed O-allylation with anti-2.3a (20.2 mg, 0.10 
mmol, 100 mol%), the product 2,6-trans-2.4a was obtained as a colorless oil in 61% yield 
(8.7 mg, 0.061 mmol, dr = 1:8, 2,6-cis-2.4a:2,6-trans-2.4a) after flash column 
chromatography (hexanes/EtOAc = 3:2 to 2:3). The unreacted anti-2.3a was recovered in 
21% (4.3 mg, 0.021 mmol). Yield based on recovered starting material (BRSM) was 74%. 
 
1H NMR (400 MHz, CDCl3)  5.91 (ddd, J = 17.9, 10.6, 4.1 Hz, 1H), 5.26–5.22 (m, 1H), 
5.22–5.17 (m, 1H), 4.65–4.54 (m, 1H), 3.93 (ddd, J = 15.4, 10.9, 4.5 Hz, 1H), 3.80–3.67 
(m, 1H), 2.12–2.00 (m, 1H), 1.96–1.87 (m, 1H), 1.75–1.53 (m, 2H), 1.27–1.16 (m, 1H), 
1.20 (d,  J = 6.2 Hz, 3H).  
13C NMR (100 MHz, CDCl3)  138.2, 116.6, 73.2, 65.8, 64.5, 43.3, 37.3, 21.9. 
IR (neat) 3356, 2932, 1370, 1122, 1039, 919 cm-1.  
HRMS (ESI+) calcd. for C8H14O2Na [M+Na]
+ 165.0886, found 165.0887. 
[]25D = –64.18 ° (c = 0.67, CHCl3). 
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(2S,4S,6R)-2-Methyl-6-vinyltetrahydro-2H-pyran-4-ol (4-epi-2,6-trans-2.4a). 
 
According to general procedure for Pd-catalyzed O-allylation with anti-2.3a (20.2 mg, 0.10 
mmol, 100 mol%), Pd2(dba)3-CHCl3 (5.2 mg, 0.005 mmol, 5 mol%), and (R,R)-DPPBA  
(10.4 mg, 0.015 mmol, 15 mol%) at 25 °C for 18 h, the product 4-epi-2,6-trans-2.4a was 
obtained as a colorless oil in 90% yield (12.8 mg, 0.090 mmol, dr = 1:2, 4-epi-2,6-cis-
2.4a:4-epi-2,6-trans-2.4a) after flash column chromatography (hexanes/EtOAc = 3:2 to 
2:3). 
According to general procedure for Ir-catalyzed O-allylation with syn-2.3a (20.2 mg, 0.10 
mmol, 100 mol%), the product 4-epi-2,6-trans-2.4a was obtained as a colorless oil in 55% 
yield (7.8 mg, 0.055 mmol, dr = 1:3, 4-epi-2,6-cis-2.4a:4-epi-2,6-trans-2.4a) after flash 
column chromatography (hexanes/EtOAc = 3:2 to 2:3). The unreacted syn-2.3a was 
recovered in 26% (5.2 mg, 0.026 mmol). Yield based on recovered starting material 
(BRSM) was 69%. 
 
1H NMR (400 MHz, CDCl3)  5.91 (ddd, J = 17.4, 10.6, 5.5 Hz, 1H), 5.26 (ddd, J = 17.4, 
1.5, 1.5 Hz, 1H), 5.14 (ddd, J = 10.6, 1.5, 1.5 Hz, 1H), 4.36–4.26 (m, 1H), 4.26–4.18 (m, 
1H), 4.15–4.04 (m, 1H), 2.06–1.97 (m, 1H), 1.80–1.72 (m, 1H), 1.69–1.58 (m, 1H), 1.50 
(br s, 1H), 1.47–1.37 (m, 1H), 1.26 (d,  J = 6.8 Hz, 3H).  
13C NMR (100 MHz, CDCl3) δ 139.2, 115.3, 70.0, 67.2, 64.5, 40.1, 39.4, 19.0. 
IR (neat) 3354, 2928, 1645, 1376, 1186, 1020, 921 cm-1.  
LRMS (CI+) calcd. for C8H15O2 [M+H]
+ 143, found 143. 
[]25D = –38.89 ° (c = 0.18, CHCl3).  
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(2S,4R,6R)-2-Isobutyl-6-vinyltetrahydro-2H-pyran-4-ol (2,6-trans-2.4b). 
 
According to general procedure for Pd-catalyzed O-allylation with anti-2.3b (24.4 mg, 
0.10 mmol, 100 mol%), Pd2(dba)3-CHCl3 (5.2 mg, 0.005 mmol, 5 mol%), and (R,R)-
DPPBA (10.4 mg, 0.015 mmol, 15 mol%) at 25 °C for 20 h, the product 2,6-trans-2.4b 
was obtained as a colorless oil in 73% yield (13.4 mg, 0.073 mmol, dr = 1:4, 2,6-cis-
2.4b:2,6-trans-2.4b) after flash column chromatography (hexanes/EtOAc = 3:2 to1:1). 
 
According to general procedure for Ir-catalyzed O-allylation with anti-2.3b (24.4 mg, 0.10 
mmol, 100 mol%), the product 2,6-trans-2.4b was obtained as a colorless oil in 69% yield 
(12.7 mg, 0.069 mmol, dr = 1:9, 2,6-cis-2.4b:2,6-trans-2.4b) after flash column 
chromatography (hexanes/EtOAc = 3:1 to 1:1). The unreacted anti-2.3b was recovered in 
12% (3.0 mg, 0.012 mmol). Yield based on recovered starting material (BRSM) was 77%. 
 
1H NMR (400 MHz, CDCl3) δ 5.98–5.83 (m, 1H), 5.27–5.24 (m, 1H), 5.22 (ddd, J = 3.8, 
2.2, 1.3 Hz, 1H), 4.61 (ddd, J = 5.9, 3.9, 2.0 Hz, 1H), 4.01–3.88 (m, 1H), 3.72–3.60 (m, 
1H), 2.17–2.05 (m, 1H), 1.96–1.84 (m, 1H), 1.86–1.74 (m, 1H), 1.73–1.62 (m, 1H), 1.54 
(ddd, J = 14.1, 8.8, 5.5 Hz, 2H), 1.24–1.13 (m, 2H), 0.95–0.84 (t, J = 6.4 Hz, 6H). 
13C NMR (100 MHz, CDCl3) δ 138.4, 116.6, 72.9, 67.7, 64.7, 45.5, 42.2, 37.5, 24.4, 23.4, 
22.2. 
IR (neat) 3357, 2925, 2869, 1466, 1367, 1126, 1024, 986 cm-1.  
LRMS (ESI+) calcd. for C11H20O2Na [M+Na]
+ 207, found 207. 
[]25D = –74.07° (c = 0.27, CHCl3).  
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(2S,4S,6R)-2-Isobutyl-6-vinyltetrahydro-2H-pyran-4-ol (4-epi-2,6-trans-2.4b). 
 
According to general procedure for Pd-catalyzed O-allylation with syn-2.3b (24.4 mg, 0.10 
mmol, 100 mol%), Pd2(dba)3-CHCl3 (5.2 mg, 0.005 mmol, 5 mol%), and (R,R)-DPPBA 
(10.4 mg, 0.015 mmol, 15 mol%) at 25 °C for 18 h, the product 4-epi-2,6-trans-2.4b was 
obtained as a colorless oil in 75% yield (14.2 mg, 0.077 mmol, dr = 1:1, 4-epi-2,6-cis-
2.4b:4-epi-2,6-trans-2.4b) after flash column chromatography (hexanes/EtOAc = 3:2 
to1:1). 
According to general procedure for Ir-catalyzed O-allylation with syn-2.3b (40.0 mg, 0.18 
mmol, 100 mol%), the product 4-epi-2,6-trans-2.4b was obtained as a colorless oil in 56% 
yield (18.7 mg, 0.10 mmol, dr = 1:6, 4-epi-2,6-cis-2.4b:4-epi-2,6-trans-2.4b) after flash 
column chromatography (hexanes/EtOAc = 4:1 to 2:1). The unreacted syn-2.3b was 
recovered in 21% (9.2 mg, 0.038 mmol). Yield based on recovered starting material 
(BRSM) was 68%. 
1H NMR (400 MHz, CDCl3) δ 5.95 (ddd, J = 17.3, 10.6, 5.4 Hz, 1H), 5.26 (ddd, J = 17.4, 
1.6, 1.6 Hz, 1H), 5.14 (ddd, J = 10.6, 1.5, 1.5 Hz, 1H), 4.22–4.11 (m, 2H), 4.10–4.03 (m, 
1H), 2.06–1.98 (m, 1H), 1.81–1.58 (m, 4H), 1.50–1.36 (m, 2H), 1.23–1.10 (m, 1H), 0.93 
(d, J = 6.5 Hz, 6H). 
13C NMR (100 MHz, CDCl3) δ 139.3, 115.3, 69.9, 69.5, 64.9, 41.4, 40.1, 38.6, 24.8, 23.4, 
22.3. 
IR (neat) 3361, 2925, 2868, 1366, 1260, 1024, 920 cm-1.  
LRMS (ESI+) calcd. for C11H20O2Na [M+Na]
+ 207, found 207. 
[]25D = –23.09 ° (c = 0.13, CHCl3).  
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(2R,4S,6R)-2-Phenyl-6-vinyltetrahydro-2H-pyran-4-ol (2,6-trans-2.4c). 
 
According to general procedure for Pd-catalyzed O-allylation with anti-2.3c (26.4 mg, 0.10 
mmol, 100 mol%), Pd2(dba)3-CHCl3 (5.2 mg, 0.005 mmol, 5 mol%), and (R,R)-DPPBA 
(10.4 mg, 0.015 mmol, 15 mol%) at 50 °C for 18 h, the product 2,6-trans-2.4c was obtained 
as a colorless oil in 82% yield (28.1 mg, 0.082 mmol, dr = 1:1, 2,6-cis-2.4c:2,6-trans-2.4c) 
after flash column chromatography (hexanes/EtOAc = 2:1). 
 
According to general procedure for Ir-catalyzed O-allylation with anti-2.3c (39.5 mg, 0.15 
mmol, 100 mol%), the product 2,6-trans-2.4c was obtained as a colorless oil in 60% yield 
(18.3 mg, 0.090 mmol, dr = 1:7, 2,6-cis-2.4c:2,6-trans-2.4c) after flash column 
chromatography (toluene/EtOAc = 5:1). The unreacted anti-2.3c was recovered in 26% 
(10.3 mg, 0.039 mmol). Yield based on recovered starting material (BRSM) was 76%. 
 
1H NMR (400 MHz, CDCl3)  7.42–7.24 (m, 5H), 6.00 (ddd, J = 17.6, 11.0, 3.8 Hz, 1H), 
5.37–5.32 (m, 1H), 5.31–5.28 (m, 1H), 4.83–4.77 (m, 1H), 4.66 (dd, J = 11.4, 2.2 Hz, 1H), 
4.17–4.04 (m, 1H), 2.25–2.13 (m, 2H), 1.81 (ddd, J = 12.6, 11.4, 6.0 Hz, 1H), 1.66–1.48 
(m, 2H).  
13C NMR (100 MHz, CDCl3)  142.1, 138.0, 128.6, 127.8, 126.2, 117.1, 73.6, 71.8, 64.9, 
43.3, 37.2. 
IR (neat) 3362, 2943, 1453, 1409, 1055 cm-1.  
LRMS (CI+) calcd. for C13H17O2 [M+H]
+ 205, found 205. 
[]25D = –10.85 ° (c = 0.43, CHCl3).  
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(2R,4R,6R)-2-Phenyl-6-vinyltetrahydro-2H-pyran-4-ol (4-epi-2,6-trans-2.4c). 
 
According to general procedure for Pd-catalyzed O-allylation with syn-2.3c (26.4 mg, 0.10 
mmol, 100 mol%), Pd2(dba)3-CHCl3 (5.2 mg, 0.005 mmol, 5 mol%), and (R,R)-DPPBA 
(10.4 mg, 0.015 mmol, 15 mol%) at 25 °C for 18 h, the product 4-epi-2,6-trans-2.4c was 
obtained as a colorless oil in 95% yield (19.4 mg, 0.095 mmol, dr = 2:1, 4-epi-2,6-cis-
2.4c:4-epi-2,6-trans-2.4c) after flash column chromatography (hexanes/EtOAc = 3:2 to 
1:1). 
According to general procedure for Ir-catalyzed O-allylation with syn-2.3c (26.4 mg, 0.10 
mmol, 100 mol%), the product 4-epi-2,6-trans-2.4c was obtained as a colorless oil in 51% 
yield (10.5 mg, 0.051 mmol, dr = 1:4, 4-epi-2,6-cis-2.4c:4-epi-2,6-trans-2.4c) after flash 
column chromatography (hexanes/EtOAc = 4:1 to 1:1). The unreacted syn-2.3c was 
recovered in 45% (12.0 mg, 0.045 mmol). Yield based on recovered starting material 
(BRSM) was 74%. 
1H NMR (400 MHz, CDCl3) δ 7.50–7.17 (m, 5H), 6.01 (ddd, J = 17.4, 10.6, 5.2 Hz, 1H), 
5.30 (ddd, J = 17.4, 1.6, 1.6 Hz, 1H), 5.25 (dd, J = 4.5, 4.5 Hz, 1H), 5.18 (ddd, J = 10.6, 
1.5, 1.5 Hz, 1H), 4.14–4.07 (m, 1H), 4.07–3.97 (m, 1H), 2.50 (dddd, J = 13.4, 4.0, 4.0, 1.7 
Hz, 1H), 2.07–1.97 (m, 1H), 1.92 (ddd, J = 13.4, 9.5, 5.1 Hz, 1H), 1.62–1.48 (m, 2H). 
13C NMR (100 MHz, CDCl3) δ 140.8, 138.8, 128.8, 127.3, 126.5, 115.5, 72.1, 70.8, 64.8, 
40.0, 37.0. 
IR (neat) 3393, 2923, 2820, 1447, 1363, 1050, 920 cm-1.  
LRMS (ESI+) calcd. for C13H16O2Na [M+Na]
+ 227, found 227. 
[]25D = +33.33 ° (c = 0.06, CHCl3).  
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Chapter 3: Diastereo- and Enantioselective Iridium Catalyzed Coupling 
of Vinyl Aziridines with Alcohols: Site-Selective Modification of 
Unprotected Diols and Synthesis of Substituted Piperidines*  
3.1 INTRODUCTION         
For several years, the Krische group has been interested in redox-triggered iridium 
catalyzed carbonyl addition via transfer hydrogenation, which enables direct primary 
alcohol C-H functionalization.1-3 Emanating from this new pattern of reactivity, the 
enantioselective alcohol C-H allylation,1 crotylation,2 and propargylation3 have been 
recently developed. Additionally, the cyclometalated π-allyliridium catalysts used in such 
alcohol C-H functionalization demonstrate a distinct kinetic preference for primary alcohol 
dehydrogenation,4 facilitating site-selective C-H functionalization of unprotected diols and 
triols with high levels of catalyst-directed diastereoselectivity.5 Taking advantages of these 
methods, the Krische group has provided the most concise routes towards a number of 
representative polyketide natural products.6  
Functionalized piperidines appear frequently as substructures in a number of 
natural alkaloids and pharmaceutical ingredients.7 In fact, the piperidine ring is the third 
most frequently used ring system in small molecule drugs listed in the FDA orange book.8 
Therefore, developing methods to diastereoselectively synthesize piperidine has drawn a 
great deal of attention.9  
3.2 REACTION DEVELOPMENT AND SCOPE 
Here in, we disclose the iridium catalyzed C-C coupling of N-(p-
nitrophenylsulfonyl) protected vinyl aziridine with primary alcohols to furnish products of 
(α-aminomethyl)allylation with excellent levels of anti-diastereo- and enantioselectivity. 
                                                 
* This chapter is based on the published work: 
Wang, G.; Franke, J.; Ngo, C. Q.; Krische, M. J. J. Am. Chem. Soc. 2015, 137, 7915. 
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Further, unprotected diols were employed in this transformation to form the diastereomeric 
products with good isolated yields and high levels of catalyst-directed diastereoselectivity. 
These products were directly converted to the diastereomeric 2,4,5-trisubstituted 
piperidines (Scheme 3.1). 
 
 
Scheme 3.1 Iridium catalyzed coupling of vinyl aziridine with alcohols: site-selective 
modification of unprotected diols and synthesis of substituted piperidines. 
Because of the competing electrophilic of O-allylation of the resulting π-
allyliridium complexes,10 as well as the propensity of vinyl aziridines to participate in metal 
catalyzed ring expansion, the feasibility of engaging vinyl aziridines in metal catalyzed C-
C couplings with primary alcohols was rendered uncertain. Despite these potential 
liabilities, our initial experiments revealed promising results (Table 3.1). From these 
results, (R)-Ir-3-VIb, which incorporates (R)-MeO-BIPHEP provided the most favorable 
results, delivering adduct 3.4a in 85% yield with a 5:1 anti-diastereoselectivity and 96% 
enantiomeric excess (Table 3.1, entry 15). At lower temperature, a slight improvement in 
enantiomeric excess was observed, but the isolated yield decreased significantly (Table 
3.1, entry 16). Conversely, at higher temperature, conversion improved but 
stereoselectivity declined (Table 3.1, entry 17). Whereas decreased loadings of vinyl 
aziridine 3.3a (100 mol%) diminished the isolated yield of adduct 3.4a (Table 3.1, entry 
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18), the use of excessvinyl aziridine 3.3a (100 mol%) provided adduct 3.4a in 96% isolated 
yield with 5:1 anti-diastereoselectivity and 97% enantiomeric excess (Table 3.1, entry 19). 
The use of alternate reaction solvents, such as dioxane or toluene,or omission of potassium 
phosphate led to substantially diminished yields.  
Table 3.1 Selected optimization experiments in the redox-triggered C-C coupling of 
vinyl aziridine 3.3a with benzyl alcohol 3.1a to form p-nitrophenylsulfonyl 
protected amino alcohol 3.4a.a 
 
The scope of the iridium catalyzed (α-aminomethyl)allylation was tested with 
diverse primary alcohols 3.1a-3.1l (100 mol%) and vinyl aziridine 3.3a (300 mol%) under 
the condition of (R)-Ir-3-VIb (5 mol%) and substoichiometric potassium phosphate (5 
mol%) in THF (0.2 M) at 60 oC (Table 3.2). As illustrated in the conversion of 3.1a-3.1f 
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to 3.4a-3.4f, a range of benzylic alcohols participate in C-C coupling, including alcohol 
3.1f, which incorporates a Lewis basic pyridyl-substituent. Cinnamyl alcohol 3.1g, prenyl 
alcohols 3.1h and geraniol 3.1i are transformed to adducts 3.4g-3.4i, illustrating use of 
allylic alcohols as coupling partners. Finally, as demonstrated by the conversion of 
heptanol 3.1j, O-benzyl 1,3-propane diol 3.1k and cyclopropyl methanol 3.1l to adducts 
3.4j-3.4l, respectively, aliphatic alcohols participate in coupling. In each case examined, 
good to excellent yields, good anti-diastereoselectivities and uniformly high 
enantioselectivities were observed. 
Table 3.2 Regio- diastereo- and enantioselective iridium catalyzed (α-
aminomethyl)allylation of alcohols 3.1a-3.1l with vinyl aziridine 3.3a.a 
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Table 3.3 Regio- diastereo- and enantioselective iridium catalyzed (α-
aminomethyl)allylation of aldehydes 3.2a-3.2l with vinyl aziridine 3.3a.a 
 
Related reductive couplings of vinyl aziridine 3.3a with aldehydes 3.4a-3.4l also 
were evaluated (Table 3.3). By using 2-propanol (300 mol%) as terminal reductant, similar 
as alcohols, good to excellent yields, good anti-diastereoselectivities and uniformly high 
enantioselectivities were observed in the coupling reactions. The absolute configuration of 
adducts 3.4a-l was made in analogy to the structural assignment of adducts 3.4b, which 
was determined by single crystal x-ray diffraction analysis. Based on the collective data,11 
a general catalytic mechanism accounting for the reaction of primary alcohols 3.1a-l with 
vinyl aziridines 3.3a to form adducts 3.4a-l is given (Scheme 3.2).  
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Scheme 3.2 General catalytic mechanism for iridium catalyzed (α-
aminomethyl)allylation of alcohols 3.1a-l with vinyl aziridine 3.3a. 
Having demonstrated the feasibility and scope of the coupling of primary alcohols 
3.1a−3.1l, the catalyst-directed diastereo- and site-selective C-C coupling of unprotected 
diols 3.1m-3.1o with vinyl aziridine 3.3a was investigated (Table 3.4). Different from 
aforementioned alcohols, the coupling reactions of unprotected diols with aziridine 3.3a 
required longer reaction time. In addition, the catalysts used in these transformations were 
case dependant. Specifically, in the coupling of diol 3.1m or 3.1o with vinyl aziridines 
3.3a, the iridium catalyst (R)-Ir-3-Vb, which is modified by (R)-Cl,MeO-BIPHEP, gave 
slightly better results than catalyst (R)-Ir-3-VIb, which is modified by (R)-MeO-BIPHEP. 
However, for diol 3.1n, the BINAP modified catalyst (R)-Ir-3-Ib provided the best results. 
In a parallel set of experiments, the unprotected diols 3.1m-3.1o were reacted with the 
respective enantiomeric iridium catalysts. The diastereomeric adducts anti-3.4m, anti-3.4n 
and anti-3.4o also were formed in good yields with similar levels catalyst-directed 
diastereoselectivity.  
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Table 3.4 Catalyst-directed diastereo- and site-selectivity in the iridium catalyzed (α-
aminomethyl)allylation of unprotected 1,3-diols 3.1m-o with vinyl aziridine 
3.3a.a 
  
Table 3.5 Conversion of syn-3.4m-o and anti-3.4m-o to diastereomeric 2,4,5-
trisubstituted piperidines syn-3.5m-o and anti-3.5m-o.a 
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With the diol coupling products syn-3.4m, syn-3.4n and syn-3.4o in hand, 
Mitsunobu reaction conditions12 was applied to convert the coupling products to 2,4,5-
trisubstituted piperidines (Table 3.5). Cyclization proceeded most efficiently using DIAD 
(disisopropyl azodicarboxylate), delivering the 2,4,5-trisubstituted piperidines syn-3.5m, 
syn-3.5n and syn-3.5o as single stereoisomers. Similarly, under Mitsunobu conditions, the 
diol coupling products anti-3.4m, anti-3.4n and anti-3.4o were converted to the 
diastereomeric 2,4,5-trisubstituted piperidines anti-3.5m, anti-3.5n and anti-3.5o. In all 
cases, cyclization proceeded with complete inversion of the carbinol stereocenter in good 
to excellent yield. Finally, as illustrated in the conversion of piperidine anti-3.5o to the free 
secondary amine anti-3.6o, the experiments will be carried out to remove N-(p-
nitrophenylsulfonyl) protecting group13 (Scheme 3.3). 
 
Scheme 3.3 Cleavage of N-(p-nitrophenylsulfonyl) protecting group. 
3.3 CONCLUSION 
The first enantioselective umpoled allylations of aldehydes with vinyl aziridines to 
form products of carbonyl (α-aminomethyl)allylation were developed. These processes 
may be conducted in an equally efficient manner from the alcohol oxidation level or from 
the aldehyde oxidation level, delivering products of C-C bond formation in good to 
excellent yield, good levels of anti-diastereoselectivity and uniformly high levels of 
enantioselectivity. Further, the unprotected chiral diols 3.1m-3.1n could be employed in 
this transformation to provide the diastereomeric products of C-allylation syn-3.4m, syn-
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3.4n and syn-3.4o and anti-3.4m, anti-3.4n, anti-3.4o with good isolated yields and good 
catalyst-directed diastereoselectivity, which enables concise approach to 2,4,5-
trisubstituted piperidines.  
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3.4 EXPERIMENTAL DETAILS 
General Information 
All reactions were run under an atmosphere of argon. Sealed tubes (13x100 mm) 
were purchased from Fischer Scientific (catalog number 14-959-35C) and were flame dried 
followed by cooling in a desiccator. Tetrahydrofuran, toluene, and dioxane were distilled 
from sodium-benzophenone immediately prior to use. Dichloromethane was distilled from 
calcium hydride under a nitrogen atmosphere prior to use. Anhydrous solvents were 
transferred by oven-dried syringes. Analytical thin-layer chromatography (TLC) was 
carried out using 0.25 mm commercial silica gel plates (Dynanmic Absorbents F254). 
Visualization was accomplished with UV light followed by dipping in p-anisaldehyde stain 
solution then heating. Purification of reactions was carried out by flash chromatography 
using Silacycle silica gel (40-63 μm, unless indicated specifically). Potassium phosphate 
was purchased through Acros Organics, flame dried prior to use, and stored in a desiccator. 
Substrates 3.1k, 3.2i and 3.2k were prepared through known procedures..All other alcohols 
and aldehydes were used from commercially available sources, and purified prior to use. 
 
Spectroscopy, Spectrometry, and Data Collection 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. Low-
resolution mass spectra (LRMS) were obtained on a Karatos MS9 and are reported as m/z 
(relative intensity). High-resolution mass spectra (HRMS) were obtained on an Agilent 
Technologies 6530 Accurate Mass Q-TOF LC/MS instrument and are reported as m/z 
(relative intensity). Accurate masses are reported for the molecular ion (M, M+H, or M-
H), or a suitable fragment ion. 1H nuclear magnetic resonance spectra were recorded using 
a 400 MHz spectrometer. Chemical shifts are reported as parts per million (ppm) relative 
to residual CHCl3 δH (7.26 ppm). 13C nuclear magnetic resonance spectra were recorded 
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using a 100 MHz spectrometer for CDCl3 solutions, and chemical shifts are reported as 
parts per million (ppm) relative to residual CDCl3 δC (77.16 ppm). 
 
Synthesis of Vinyl Aziridine 3.3a 
 
 
 
The first step was done follow the reported procedure.14 
To a solution of PhI=NNs (6.4 mmol) in CH3CN 10 ml in a sealed tube at -78 
oC, Cu(acac)2 
(1.3 mmol) was added. Then freshly condensed 1, 3-butadiene (1.8 mL, 19.3 mmol) was 
added into the tube. The resulting mixture was allowed to stir at R.T. for 2 h. The reaction 
mixture was concentrated in vacuo and the crude residue was subjected to flash column 
chromatography (SiO2: hexane/ethyl acetate, 6:1) to furnish the 1-((4-
nitrophenyl)sulfonyl)-2-vinylaziridine 3.3a as an off white solid in 37% yield. Data is 
consistent with that reported in the literature.15 
 
1H NMR (400 MHz, CDCl3) δ 8.40 (d, J = 9.0 Hz, 2H), 8.16 (d, J = 9.0 Hz, 2H), 5.58–
5.43 (m, 2H), 5.33–5.27 (m, 1H), 3.43–3.36 (m, 1H), 2.92 (d, J = 7.1 Hz, 1H), 2.34 (d, J = 
4.6 Hz, 1H). 
 
13C NMR (100 MHz, CDCl3) δ 150.8, 144.2, 132.3, 129.2, 124.5, 121.3, 42.0, 34.9. 
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General Procedure and Spectral Data for Coupling of Vinyl Aziridine and Alcohols 
(3.1a-3.1l) or Aldehydes (3.2a-3.2l) 
 
General Procedure for Coupling of Vinyl Aziridine (3.3a) and Alcohols (3.1a-3.1l)  
A flame-dried pressure tube equipped with a magnetic stir bar was charged with K3PO4 
(1.1 mg, 0.005 mmol, 5 mol%), (R)-Ir-3-VIb (5.0 mg, 0.005 mmol, 5 mol%), alcohol (0.10 
mmol, 100 mol%) and 1-((4-nitrophenyl)sulfonyl)-2-vinylaziridine 3.3a (76.3 mg, 0.30 
mmol, 300 mol%). The reaction vessel was placed under an atmosphere of argon, and THF 
(0.5 mL, 0.2 M) was added by syringe. The reaction vessel was sealed and the reaction 
mixture was allowed to stir at 60 oC for 24 h. The reaction was allowed to reach ambient 
temperature and concentrated in vacuo. The residue was subjected to column 
chromatography to furnish the title compound. 
 
General Procedure for Coupling of Vinyl Aziridine (3.3a) and Aldehydes (3.2a-3.2l) 
A flame-dried pressure tube equipped with a magnetic stir bar was charged with K3PO4 
(1.08 mg, 0.005 mmol, 5 mol%), (R)-Ir-3-VIb (5.0 mg, 0.005 mmol, 5 mol%), aldehyde 
(0.1 mmol, 100 mol%) and 1-((4-nitrophenyl)sulfonyl)-2-vinylaziridine 3.3a (76.3 mg, 0.3 
mmol, 300 mol%). The reaction vessel was placed under an atmosphere of argon, and THF 
(0.5 mL, 0.2 M) and 2-propanol (18.0 mg, 0.3 mmol, 300 mol%) were added by syringe. 
The reaction vessel was sealed and the reaction mixture was allowed to stir at 60 oC for 24 
h. The reaction was allowed to reach ambient temperature and concentrated in vacuo. The 
residue was subjected to column chromatography to furnish the title compound. 
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N-((S)-2-((R)-hydroxy(phenyl)methyl)but-3-en-1-yl)-4-nitrobenzenesulfonamide 
(3.4a) 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with benzyl alcohol (10.8 mg, 0.1 mmol, 100 mol%), the product 3.4a was 
obtained as gel in 96% yields (34.8 mg, 0.096 mmol, anti:syn=5:1) after flash 
chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation level: 
According to general procedure for coupling of vinyl aziridine (3.3a) with benzaldehyde 
(10.6 mg, 0.1 mmol, 100 mol%), the product 3.4a was obtained as gel in 80% yields (29.0 
mg, 0.080 mmol, anti:syn=5:1) after flash chromatography (SiO2: hexane/ethyl acetate, 
5:1-3:1). Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.34 (d, J = 9.0 Hz, 2H), 7.97 (d, J = 9.0 Hz, 2H), 7.35–
7.27 (m, 3H), 7.23–7.17 (m, 2H), 5.58 (ddd, J = 17.2, 10.4, 8.9 Hz, 1H), 5.19 (dd, J = 10.4, 
1.3 Hz, 1H), 5.08–5.00 (m, J = 17.2, 1.3, 0.8 Hz, 2H), 4.72 (dd, J = 5.3, 3.1 Hz, 1H), 3.11 
(ddd, J = 13.2, 7.0, 6.3 Hz, 1H), 2.96 (ddd, J = 12.7, 7.6, 4.8 Hz, 1H), 2.58–2.46 (m, 1H), 
2.20 (d, J = 3.2 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ 150.2, 145.8, 141.2, 134.4, 128.6, 128.4, 128.3, 126.4, 
124.5, 120.7, 75.1, 51.1, 44.3. 
LRMS (ESI) Calcd. for C17H18N2O5SNa [M+Na]
+: 385.1, Found: 385.1.  
FTIR (neat): 2925, 2410, 1540, 1349, 1164, 1092, 855 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 80:20, 1.00 mL/min, 254 nm), ee 
=97% from benzyl alcohol, ee = 95% from benzaldehyde. 
[]20D = +15.60 ° (c 0.30, CHCl3).  
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N-((S)-2-((R)-hydroxy(p-tolyl)methyl)but-3-en-1-yl)-4-nitrobenzenesulfonamide 
(3.4b) 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with 4-methylbenzyl alcohol (12.2 mg, 0.1 mmol, 100 mol%), the product 
3.4b was obtained as white solid in 70% yields (26.4 mg, 0.070 mmol, anti:syn=5:1) after 
flash chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation 
level: According to general procedure for coupling of vinyl aziridine (3.3a) with p-
tolualdehyde (12.0 mg, 0.1 mmol, 100 mol%), the product 3.4b was obtained as white solid 
in 72% yields (27.1 mg, 0.072 mmol, anti:syn=4:1) after flash chromatography (SiO2: 
hexane/ethyl acetate, 5:1-3:1). Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.34 (d, J = 8.8 Hz, 2H), 7.97 (d, J = 8.8 Hz, 2H), 7.11 
(d, J = 8.0 Hz, 2H), 7.07 (d, J = 8.2 Hz, 2H), 5.57 (ddd, J = 17.2, 10.3, 8.9 Hz, 1H), 5.20 
(dd, J = 10.4, 1.3 Hz, 1H), 5.11–5.00 (m, 2H), 4.66 (d, J = 5.4 Hz, 1H), 3.09 (dt, J = 13.0, 
6.6 Hz, 1H), 2.93 (ddd, J = 12.6, 7.5, 4.8 Hz, 1H), 2.56–2.44 (m, 1H), 2.34 (s, 3H), 2.13 
(brs, 1H). 
13C NMR (100 MHz, CDCl3) δ 150.1, 145.9, 138.1, 134. 7, 129.3, 128.4, 126.3, 124.5, 
120.6, 75.1, 50.9, 44.3, 21.3.  
LRMS (ESI) Calcd. for C18H20N2O5SNa [M+Na]
+: 399.1, Found: 399.1.  
FTIR (neat): 3302, 2922, 2411, 1529, 1402, 1348, 1093, 854 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 93:07, 1.00 mL/min, 254 nm), ee 
=94% from 4-methylbenzyl, ee = 96% from p-tolualdehyde. 
[]20D = +7.14 ° (c 0.70, CHCl3). mp:  105-107 oC.  
             114 
 
 
 
  
             115 
 
 
 
 
 
 
 
  
             116 
 
 
 
 
  
             117 
 
N-((S)-2-((R)-(4-bromophenyl)(hydroxy)methyl)but-3-en-1-yl)-4-
nitrobenzenesulfonamide (3.4c) 
 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with 4-bromobenzyl alcohol (18.7 mg, 0.1 mmol, 100 mol%), the product 
3.4c was obtained as gel in 90% yields (39.7 mg, 0.090 mmol, anti:syn=4:1) after flash 
chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation level: 
According to general procedure for coupling of vinyl aziridine (3.3a) with 4-
bromobenzaldehyde (18.5 mg, 0.1 mmol, 100 mol%), the product 3.4c was obtained as gel 
in 86% yields (37.9 mg, 0.086 mmol, anti:syn=4:1) after flash chromatography (SiO2: 
hexane/ethyl acetate, 5:1-3:1). Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.36 (d, J = 9.0 Hz, 2H), 8.00 (d, J = 9.0 Hz, 2H), 7.44 (d, 
J = 8.5 Hz, 2H), 7.11 (d, J = 8.3 Hz, 2H), 5.57 (ddd, J = 17.3, 10.4, 8.9 Hz, 1H), 5.19 (dd, 
J = 10.4, 1.3 Hz, 1H), 5.07–4.94 (m, 2H), 4.80–4.75 (m, 1H), 3.15 (ddd, J = 12.9, 7.4, 6.5 
Hz, 1H), 3.01–2.92 (m, 1H), 2.50 (dt, J = 13.7, 7.0 Hz, 1H), 2.24 (d, J = 3.4 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ 150.2, 145.8, 140.4, 133.7, 131.7, 128.4, 128.02, 124.6, 
121.9, 121.0, 74.1, 51.1, 44.4. 
LRMS (ESI) Calcd. for C17H17BrN2O5SNa [M+Na]
+: 463.0, Found: 463.0.  
FTIR (neat): 3528, 3292, 3103, 2924, 1528, 1347, 1071, 853 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 93:07, 1.00 mL/min, 254 nm), ee 
=96% from 4-bromobenzyl alcohol, ee = 97% from 4-bromobenzaldehyde. 
[]20D = +21.25 ° (c 1.60, CHCl3).  
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N-((S)-2-((R)-benzo[d][1,3]dioxol -5-yl(hydroxy)methyl)but-3-en-1-yl)-4-
nitrobenzensulfonamide (3.4d) 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with piperonyl alcohol (15.2 mg, 0.1 mmol, 100 mol%), the product 3.4d 
was obtained as gel in 73% yields (29.7 mg, 0.073 mmol, anti:syn=4:1) after flash 
chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation level: 
According to general procedure for coupling of vinyl aziridine (3.3a) with piperonal (15.0 
mg, 0.1 mmol, 100 mol%), the product 3.4d was obtained as gel in 87% yields (35.3 mg, 
0.087 mmol, anti:syn=4:1) after flash chromatography (SiO2: hexane/ethyl acetate, 5:1-
3:1). Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.36 (d, J = 8.5 Hz, 2H), 7.98 (d, J = 8.5 Hz, 2H), 6.73 (d, 
J = 7.9 Hz, 1H), 6.67–6.58 (m, 2H), 5.94 (dd, J = 5.2, 1.3 Hz, 2H), 5.56 (dt, J = 17.4, 9.6 
Hz, 1H), 5.22 (d, J = 10.3 Hz, 1H), 5.07 (d, J = 17.2 Hz, 1H), 4.60 (d, J = 3.7 Hz, 1H), 3.04 
(dt, J = 12.8, 6.6 Hz, 1H), 2.92 (ddd, J = 12.5, 7.0, 5.4 Hz, 1H), 2.52–2.41 (m, 1H), 2.20 
(s, 1H). 
13C NMR (100 MHz, CDCl3) δ 150.2, 147.9, 147.5, 145.7, 134.9, 134.6, 128.4, 124.5, 
120.7, 119.9, 108.2, 106.6, 101.3, 75.1, 51.1, 44.2. 
LRMS (ESI) Calcd. for C18H18N2O7SNa [M+Na]
+: 429.1, Found: 429.1.  
FTIR (neat): 3326, 3303, 2923, 1504, 1402, 1349, 1093, 926, 853 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 80:20, 1.00 mL/min, 254 nm), ee 
=96% from piperonyl alcohol, ee = 97% from piperonal. 
[]20D = +3.92 ° (c 0.51, CHCl3).  
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N-((S)-2-((R)-furan-2-yl(hydroxy)methyl)but-3-en-1-yl)-4-nitrobenzenesulfonamide 
(3.4e) 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with furan-2-ylmethanol (9.8 mg, 0.1 mmol, 100 mol%), the product 3.4e 
was obtained as gel in 73% yields (25.7 mg, 0.073 mmol, anti:syn=10:1) after flash 
chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation level: 
According to general procedure for coupling of vinyl aziridine (3.3a) with furan-2-
carbaldehyde (9.6 mg, 0.1 mmol, 100 mol%), the product 3.4d was obtained as gel in 85% 
yields (30.0 mg, 0.085 mmol, anti:syn=9:1) after flash chromatography (SiO2: 
hexane/ethyl acetate, 5:1-3:1). Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 9.0 Hz, 2H), 8.03 (d, J = 9.0 Hz, 2H), 7.33 (dd, 
J = 1.8, 0.8 Hz, 1H), 6.33 (dd, J = 3.3, 1.8 Hz, 1H), 6.23 (dt, J = 3.3, 0.7 Hz, 1H), 5.61 
(ddd, J = 17.2, 10.4, 8.7 Hz, 1H), 5.26–5.20 (m, 1H), 5.18–5.05 (m, 2H), 4.76 (d, J = 4.1 
Hz, 1H), 3.25–3.15 (m, 1H), 3.06–2.96 (m, 1H), 2.72 (dt, J = 13.8, 6.8 Hz, 1H), 2.23 (s, 
1H). 
13C NMR (100 MHz, CDCl3) δ 153.8, 150.0, 145.9, 142.5, 134.2, 128.5, 124.53, 120.6, 
110.5, 107.8, 69.0, 48.7, 44.2. 
HRMS (CI) Calcd. for C15H16N2O6SNa [M+Na]
+: 375.0621, Found: 375.0619.  
FTIR (neat): 3295, 3107, 2925, 1528, 1402, 1348, 1093, 924, 854 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 87:13, 1.00 mL/min, 254 nm), ee 
=97% from furan-2-ylmethanol, ee = 97% from furan-2-carbaldehyde. 
[]20D = +21.00 ° (c 1.00, CHCl3).  
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N-((S)-2-((R)-hydroxy(6-methylpyridin-2-yl)methyl)but-3-en-1-yl)-4-
nitrobenzenesulfonamide (3.4f) 
 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with (6-methylpyridin-2-yl)methanol (12.3 mg, 0.1 mmol, 100 mol%), the 
product 3.4f was obtained as white solid in 78% yields (29.4 mg, 0.078 mmol, 
anti:syn=5:1) after flash chromatography (SiO2: hexane/ethyl acetate, 5:1-2:1). From 
aldehyde oxidation level: According to general procedure for coupling of vinyl aziridine 
(3.3a) with 6-methylpicolinaldehyde (12.1 mg, 0.1 mmol, 100 mol%), the product 3.4f was 
obtained as white solid in 72% yields (27.2 mg, 0.072 mmol, anti:syn=4:1) after flash 
chromatography (SiO2: hexane/ethyl acetate, 5:1-2:1). Spectral data is reported for the 
major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 9.0 Hz, 2H), 8.07 (d, J = 9.0 Hz, 2H), 7.57 (t, 
J = 7.7 Hz, 1H), 7.05 (d, J = 7.6 Hz, 1H), 6.97 (d, J = 7.8 Hz, 1H), 5.68–5.61 (m, 1H), 5.52 
(ddd, J = 17.3, 10.4, 8.8 Hz, 1H), 4.97 (dd, J = 10.4, 1.5 Hz, 2H), 4.88 (ddd, J = 17.3, 1.5, 
0.9 Hz, 1H), 4.82 (d, J = 3.2 Hz, 1H), 3.44–3.32 (m, 1H), 3.18 (ddd, J = 12.6, 6.4, 3.6 Hz, 
1H), 2.68 (dtd, J = 9.3, 6.3, 3.3 Hz, 1H), 2.52 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 157.8, 156.9, 150.1, 146.2, 137.4, 133.3, 128.5, 124.5, 
122.3, 119.8, 117.6, 72.9, 49.9, 45.6, 24.3. 
HRMS (CI) Calcd. for C17H19N3O5SNa [M+Na]
+: 400.0938, Found: 400.0938.  
FTIR (neat): 3295, 3105, 2924, 1596, 1349, 1311, 1162, 1091, 997, 928, 855 cm-1. 
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 96:4, 1.00 mL/min, 254 nm), ee =97% 
from (6-methylpyridin-2-yl)methanol, ee = 96% from 6-methylpicolinaldehyde. 
[]20D = +22.00 ° (c 0.50, CHCl3). mp: 112-115 oC.  
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N-((2S,3S,E)-3-hydroxy-5-phenyl-2-vinylpent-4-en-1-yl)-4-nitrobenzenesulfonamide 
(3.4g) 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with cinnamyl alcohol (13.4 mg, 0.1 mmol, 100 mol%), the product 3.4g 
was obtained as gel in 73% yields (28.4 mg, 0.073 mmol, anti:syn=6:1) after flash 
chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation level: 
According to general procedure for coupling of vinyl aziridine (3.3a) with cinnamaldehyde 
(13.2 mg, 0.1 mmol, 100 mol%), the product 3.4g was obtained as gel in 77% yields (30.0 
mg, 0.077 mmol, anti:syn=5:1) after flash chromatography (SiO2: hexane/ethyl acetate, 
5:1-3:1). Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.30 (d, J = 9.0 Hz, 2H), 8.02 (d, J = 9.0 Hz, 2H), 7.34–
7.22 (m, 5H), 6.53 (dd, J = 15.9, 1.2 Hz, 1H), 6.10 (dd, J = 15.9, 6.7 Hz, 1H), 5.67 (ddd, J 
= 17.3, 10.4, 8.6 Hz, 1H), 5.33–5.11 (m, 3H), 4.43–4.36 (m, 1H), 3.29–3.19 (m, 1H), 3.09 
(m, 1H), 2.56–2.47 (m, 1H), 2.00 (d, J = 3.5 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ 150.1, 145.8, 136.0, 134.2, 132.4, 128.8, 128.4, 128.4, 
128.3, 126.6, 124.5, 120.3, 74.0, 49.2, 44.4. 
LRMS (ESI) Calcd. for C19H20N2O5SNa [M+Na]
+: 411.1, Found: 411.1.  
FTIR (neat): 3325, 3302, 2919, 1529, 1348, 1311, 1163, 1093, 853 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 80:20, 1.00 mL/min, 254 nm), ee 
=95% from connamyl alcohol, ee = 98% from cinnamaldehyde. 
[]20D = -9.00 ° (c 1.00, CHCl3).  
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N-((2S,3S)-3-hydroxy-5-methyl-2-vinylhex-4-en-1-yl)-4-nitrobenzenesulfonamide 
(3.4h) 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with prenol (8.6 mg, 0.1 mmol, 100 mol%), the product 3.4h was obtained 
as gel in 70% yields (23.8 mg, 0.070 mmol, anti:syn=8:1) after flash chromatography 
(SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation level: According to general 
procedure for coupling of vinyl aziridine (3.3a) with prenal (8.4 mg, 0.1 mmol, 100 mol%), 
the product 3.4h was obtained as gel in 96% yields (32.6 mg, 0.096 mmol, anti:syn=7:1) 
after flash chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). Spectral data is reported 
for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.38 (d, J = 9.0 Hz, 2H), 8.05 (d, J = 9.0 Hz, 2H), 5.59 
(ddd, J = 17.2, 10.3, 9.1 Hz, 1H), 5.23 (dd, J = 10.4, 1.6 Hz, 1H), 5.2 –5.08 (m, 3H), 4.42–
4.33 (m, 1H), 3.25 (dt, J = 12.8, 6.6 Hz, 1H), 2.97 (ddd, J = 12.4, 7.6, 4.7 Hz, 1H), 2.30 
(dt, J = 13.7, 6.9 Hz, 1H), 1.72 (d, J = 1.3 Hz, 3H), 1.65 (d, J = 1.3 Hz, 3H), 1.52 (d, J = 
2.8 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ 150.2, 146.1, 138.1, 134.8, 128.5, 124.5, 124.1, 120.3, 
69.6, 49.6, 44.4, 26.1, 18.6. 
LRMS (ESI) Calcd. for C15H20N2O5SNa [M+Na]
+: 363.1, Found: 363.1.  
FTIR (neat): 2922, 2852, 1530, 1349, 1309, 1163,1093, 926, 853 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 93:07, 1.00 mL/min, 254 nm), ee 
=95% from prenol, ee = 99% from prenal. 
[]20D = -43.30 ° (c 0.50, CHCl3).  
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N-((2S,3S,E)-3-hydroxy-5,9-dimethyl-2-vinyldeca-4,8-dien-1-yl)-4-
nitrobenzenesulfonamide (3.4i) 
 
From alcohol oxidation level: According to general procedure (reaction time was 48 h) for 
coupling of vinyl aziridine (3.3a) with greniol (15.4 mg, 0.1 mmol, 100 mol%), the product 
3.4i was obtained as gel in 67% yields (27.3 mg, 0.067 mmol, anti:syn=9:1) after flash 
chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation level: 
According to general procedure for coupling of vinyl aziridine (3.3a) with (E)-citral (15.2 
mg, 0.1 mmol, 100 mol%), the product 3.4i was obtained as gel in 66% yields (27.0 mg, 
0.066 mmol, anti:syn=8:1) after flash chromatography (SiO2: hexane/ethyl acetate, 5:1-
3:1). Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 8.9 Hz, 2H), 8.05 (d, J = 8.8 Hz, 2H), 5.57 
(ddd, J = 17.2, 10.3, 9.1 Hz, 1H), 5.25–5.18 (m, 2H), 5.16–4.98 (m, 3H), 4.41 (dd, J = 9.0, 
4.6 Hz, 1H), 3.25 (dt, J = 12.9, 6.6 Hz, 1H), 2.98 (ddd, J = 12.4, 7.4, 4.8 Hz, 1H), 2.31 (dt, 
J = 13.6, 6.9 Hz, 1H), 2.10–1.95 (m, 4H), 1.70–1.56 (m, 9H), 1.52 (brs, 1H). 
13C NMR (100 MHz, CDCl3) δ 150.2, 146.1, 141.3, 134.8, 132.2, 128.5, 124.5, 123.9, 
123.6, 120.2, 69.7, 49.6, 44.4, 39.8, 26.4, 25.8, 17.9, 17.0. 
LRMS (ESI) Calcd. for C20H28N2O5SNa [M+Na]
+: 431.2, Found: 431.2.  
FTIR (neat): 2967, 2922, 1530, 1437, 1349, 1310, 1164, 1093, 998, 923, 854 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 80:20, 1.00 mL/min, 254 nm), ee 
=94% from greniol, ee = 91% from (E)-citral. 
[]20D = -14.00 ° (c 1.00, CHCl3).  
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N-((2S,3S)-3-hydroxy-2-vinylnonyl)-4-nitrobenzenesulfonamide (3.4j) 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with 1-heptanol (11.6 mg, 0.1 mmol, 100 mol%), the product 3.4j was 
obtained as gel in 96% yields (35.5 mg, 0.096 mmol, anti:syn=6:1) after flash 
chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation level: 
According to general procedure for coupling of vinyl aziridine (3.3a) with heptanal (11.4 
mg, 0.1 mmol, 100 mol%), the product 3.4j was obtained as gel in 90% yields (33.3 mg, 
0.090 mmol, anti:syn=5:1) after flash chromatography (SiO2: hexane/ethyl acetate, 5:1-
3:1). Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 9.0 Hz, 2H), 8.05 (d, J = 9.0 Hz, 2H), 5.65 
(ddd, J = 17.3, 10.4, 9.0 Hz, 1H), 5.22 (dd, J = 10.4, 1.6 Hz, 1H), 5.16 (dd, J = 7.1, 4.5 Hz, 
1H), 5.11 (ddd, J = 17.3, 1.5, 0.8 Hz, 1H), 3.68 (t, J = 6.0 Hz, 1H), 3.25 (ddd, J = 12.6, 7.5, 
6.7 Hz, 1H), 3.04 (ddd, J = 12.5, 7.1, 4.3 Hz, 1H), 2.28 (qd, J = 6.9, 3.0 Hz, 1H), 1.44–
1.15 (m, 11H), 0.87 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 150.2, 146.0, 133.9, 128.4, 124.5, 120.2, 72.6, 48.7, 45.1, 
35.1, 31.9, 29.3, 25.8, 22.7, 14.2. 
HRMS (CI) Calcd. for C17H26N2O5SNa [M+Na]
+: 393.1455, Found: 393.1456.  
FTIR (neat): 3287, 2945, 2925, 1530, 1420, 1347, 1312, 1093, 1006, 935, 855 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 87:13, 1.00 mL/min, 254 nm), ee 
=99% from 1-heptanol, ee = 96% from heptanal. 
 []20D = +2.00 ° (c 1.00, CHCl3).  
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N-((2S,3S)-5-(benzyloxy)-3-hydroxy-2-vinylpentyl)-4-nitrobenzenesulfonamide 
(3.4k) 
 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with 3-(benzyloxy)propan-1-ol (16.6 mg, 0.1 mmol, 100 mol%), the 
product 3.4k was obtained as gel in 87% yields (36.5 mg, 0.087 mmol, anti:syn=8:1) after 
flash chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation 
level: According to general procedure for coupling of vinyl aziridine (3.3a) with 3-
(benzyloxy)propanal (16.4 mg, 0.1 mmol, 100 mol%), the product 3.4k was obtained as 
gel in 85% yields (35.7 mg, 0.085 mmol, anti:syn=7:1) after flash chromatography (SiO2: 
hexane/ethyl acetate, 5:1-3:1). Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.34 (d, J = 9.0 Hz, 2H), 8.03 (d, J = 9.0 Hz, 2H), 7.40–
7.27 (m, 5H), 5.69 (ddd, J = 17.3, 10.4, 8.9 Hz, 1H), 5.56–5.47 (m, 1H), 5.17 (dd, J = 10.4, 
1.5 Hz, 1H), 5.07 (ddd, J = 17.3, 1.5, 0.9 Hz, 1H), 4.50 (s, 2H), 3.96 (d, J = 10.2 Hz, 1H), 
3.72 (dt, J = 8.6, 4.2 Hz, 1H), 3.62 (td, J = 9.7, 3.1 Hz, 1H), 3.47 (brs, 1H), 3.27–3.17 (m, 
1H), 3.08 (ddd, J = 12.4, 6.3, 4.7 Hz, 1H), 2.28 (qd, J = 6.7, 2.9 Hz, 1H), 1.76 (dtd, J = 
14.4, 10.2, 4.2 Hz, 1H), 1.55–1.45 (m, 1H). 
13C NMR (100 MHz, CDCl3) δ 150.1, 146.1, 137.5, 134.4, 128.7, 128.4, 128.2, 127.9, 
124.5, 119.5, 73.7, 73.7, 69.9, 48.6, 45.2, 33.6, 29.8. 
LRMS (ESI) Calcd. for C20H24N2O6SNa [M+Na]
+: 443.1, Found: 443.1.  
FTIR (neat): 3297, 2923, 2861, 1738, 1529, 1348, 1162, 1091, 1006, 926, 854 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 87:13, 1.00 mL/min, 254 nm), ee 
=98% from 3-(benzyloxy)propan-1-ol, ee = 95% from 3-(benzyloxy)propanal. 
[]20D = +8.76 ° (c 1.15, CHCl3).  
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N-((S)-2-((S)-cyclopropyl(hydroxy)methyl)but-3-en-1-yl)-4-nitrobenzenesulfonamide 
(3.4l) 
 
From alcohol oxidation level: According to general procedure for coupling of vinyl 
aziridine (3.3a) with cyclopropylmethanol (7.2 mg, 0.1 mmol, 100 mol%), the product 3.4l 
was obtained as gel in 64% yields (20.8 mg, 0.064 mmol, anti:syn=4:1) after flash 
chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). From aldehyde oxidation level: 
According to general procedure for coupling of vinyl aziridine (3.3a) with 
cyclopropanecarbaldehyde (7.0 mg, 0.1 mmol, 100 mol%), the product 3.4l was obtained 
as gel in 63% yields (20.5 mg, 0.063 mmol, anti:syn=4:1) after flash chromatography 
(SiO2: hexane/ethyl acetate, 5:1-3:1). Spectral data is reported for the major isomer. 
1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 8.8 Hz, 2H), 8.05 (d, J = 8.8 Hz, 2H), 5.76 
(ddd, J = 17.3, 10.3, 9.2 Hz, 1H), 5.26–5.10 (m, 3H), 3.32 (ddd, J = 12.5, 7.5, 6.4 Hz, 1H), 
3.05 (ddd, J = 12.3, 7.2, 4.2 Hz, 1H), 2.87 (dd, J = 9.1, 3.2 Hz, 1H), 2.44 (ddd, J = 12.9, 
8.3, 5.1 Hz, 1H), 1.66 (brs, 1H), 0.98–0.86 (m, 1H), 0.62–0.47 (m, 2H), 0.28 (dt, J = 8.6, 
3.6 Hz, 1H), 0.18 (dt, J = 10.5, 2.9 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ 150.2, 146.1, 134.5, 128.5, 124.5, 120.0, 78.4, 49.2, 45.2, 
15.7, 3.2, 3.1. 
HRMS (CI) Calcd. for C14H18N2O5SNa [M+Na]
+: 349.0829, Found: 349.0830.  
FTIR (neat): 3288, 3106, 2923, 1607, 1527, 1402, 1348, 1161, 920, 854 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 87:13, 1.00 mL/min, 254 nm), ee 
=95% from cyclopropylmethanol, ee = 98% from cyclopropanecarbaldehyde. 
[]20D = +4.00 ° (c 1.00, CHCl3).  
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General Procedure and Spectral Data for Coupling of Vinyl Aziridine and Diols 
(3.2m-3.2o) 
 
A flame-dried pressure tube equipped with a magnetic stir bar was charged with K3PO4 
(1.1 mg, 0.005 mmol, 5 mol%), Ir-catalyst (0.005 mmol, 5 mol%), diol (0.10 mmol, 100 
mol%) and 1-((4-nitrophenyl)sulfonyl)-2-vinylaziridine 3.3a (76.3 mg, 0.30 mmol, 300 
mol%). The reaction vessel was placed under an atmosphere of argon, and THF (0.5 mL, 
0.2 M) was added by syringe. The reaction vessel was sealed and the reaction mixture was 
allowed to stir at 80 oC for 48 h. The reaction was allowed to reach ambient temperature 
and concentrated in vacuo. The residue was subjected to column chromatography to furnish 
the title compound. 
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N-((2S,3S,5S)-3,5-dihydroxy-2-vinylhexyl)-4-nitrobenzenesulfonamide (syn-3.4m) 
 
 
According to general procedure for coupling of vinyl aziridine (3.3a) with (S)-butane-1,3-
diol (9.0 mg, 0.1 mmol, 100 mol%), in the presence of (R)-Ir-3-Vb (5.31 mg, 0.005 mmol, 
5 mol%), the product syn-3.4m was obtained as gel in 60% yields (20.7 mg, 0.060 mmol, 
dr=6:1) after flash chromatography (SiO2: hexane/ethyl acetate, 4:1-1:1). Spectral data is 
reported for the major isomer. 
 
1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 9.0 Hz, 2H), 8.05 (d, J = 9.0 Hz, 2H), 5.69 
(ddd, J = 17.3, 10.4, 8.8 Hz, 1H), 5.59 (s, 1H), 5.18 (dd, J = 10.4, 1.5 Hz, 1H), 5.09 (ddd, 
J = 17.3, 1.5, 0.9 Hz, 1H), 4.05 (ddt, J = 9.6, 5.5, 3.1 Hz, 2H), 3.95 (s, 1H), 3.28–3.17 (m, 
1H), 3.07 (ddd, J = 12.5, 6.1, 4.6 Hz, 1H), 2.35–2.24 (m, 1H), 2.21 (s, 1H), 1.53–1.36 (m, 
2H), 1.21 (d, J = 6.2 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3) δ 150.1, 146.1, 134.3, 128.5, 124.5, 119.5, 73.6, 69.8, 48.8, 
44.9, 41.5, 24.9. 
 
LRMS (ESI) Calcd. for C14H20N2O6SNa [M+Na]
+: 367.1, Found: 367.1.  
 
FTIR (neat): 3295, 2961, 2924, 2852, 2323, 1530, 1349, 1163, 928, 854 cm-1.  
 
[]20D = -8.64 ° (c 0.27, EtOAc).  
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N-((2R,3R,5S)-3,5-dihydroxy-2-vinylhexyl)-4-nitrobenzenesulfonamide (anti-3.4m) 
 
 
According to general procedure for coupling of vinyl aziridine (3.3a) with (S)-butane-1,3-
diol (9.0 mg, 0.1 mmol, 100 mol%), in the presence of (S)-Ir-3-Vb (5.31 mg, 0.005 mmol, 
5 mol%), the product anti-3.4m was obtained as yellow solid in 62% yields (21.3 mg, 0.062 
mmol, dr=5:1) after flash chromatography (SiO2: hexane/ethyl acetate, 4:1-1:1). Spectral 
data is reported for the major isomer. 
 
1H NMR (400 MHz, CDCl3) δ 8.38 (d, J = 9.0 Hz, 2H), 8.05 (d, J = 9.0 Hz, 2H), 5.71 
(ddd, J = 17.3, 10.4, 9.0 Hz, 1H), 5.53 (dd, J = 7.8, 3.9 Hz, 1H), 5.20 (dd, J = 10.4, 1.6 Hz, 
1H), 5.10 (ddd, J = 17.3, 1.6, 0.8 Hz, 1H), 4.23–4.11 (m, 2H), 3.39 (s, 1H), 3.29 (dt, J = 
12.4, 7.8 Hz, 1H), 2.98 (ddd, J = 12.3, 6.1, 3.9 Hz, 1H), 2.24 (td, J = 8.7, 2.9 Hz, 1H), 2.03 
(s, 1H), 1.69 (ddd, J = 14.0, 10.6, 3.2 Hz, 1H), 1.34 (ddd, J = 14.5, 7.6, 2.2 Hz, 1H), 1.25 
(d, J = 6.3 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 150.3, 145.8, 134.3, 128.4, 124.6, 119.8, 67.9, 65.9, 49.3, 
44.9, 42.2, 23.6.  
 
LRMS (ESI) Calcd. for C14H20N2O6SNa [M+Na]
+: 367.1, Found: 367.1.  
 
FTIR (neat): 3346, 3241, 2919, 1529, 1105, 1310, 1091, 1061, 937, 847 cm-1.  
 
[]20D = -1.33 ° (c 0.25, EtOAc). mp:  105-112 oC.  
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N-((2S,3S,5S)-3,5-dihydroxy-7-methyl-2-vinyloctyl)-4-nitrobenzenesulfonamide 
(syn-3.4n) 
 
 
According to general procedure for coupling of vinyl aziridine (3.3a) with (S)-5-
methylhexane-1,3-diol (13.2 mg, 0.1 mmol, 100 mol%), in the presence of (R)-Ir-3-Ib 
(5.17 mg, 0.005 mmol, 5 mol%), the product syn-3.4n was obtained as gel in 67% yields 
(25.8 mg, 0.067 mmol, dr=7:1) after flash chromatography (SiO2: 
dichloromethane/methanol, 100:1-80:1). Spectral data is reported for the major isomer. 
 
1H NMR (400 MHz, CDCl3) δ 8.36 (d, J = 9.0 Hz, 2H), 8.05 (d, J = 9.0 Hz, 2H), 5.69 
(ddd, J = 17.3, 10.4, 8.8 Hz, 1H), 5.63–5.58 (m, 1H), 5.17 (dd, J = 10.4, 1.3 Hz, 1H), 5.08 
(ddd, J = 17.3, 1.6, 0.9 Hz, 1H), 4.03 (dd, J = 10.6, 4.3 Hz, 2H), 3.92 (s, 1H), 3.27–3.18 
(m, 1H), 3.07 (ddd, J = 12.5, 6.1, 4.7 Hz, 1H), 2.28 (td, J = 8.9, 2.7 Hz, 1H), 2.12 (s, 1H), 
1.74–1.64 (m, 1H), 1.45–1.34 (m, 3H), 1.28–1.17 (m, 1H), 0.90 (dd, J = 6.6, 1.2 Hz, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 150.2, 146.2, 134.4, 128.5, 124.5, 119.5, 73.7, 71.8, 48.7, 
47.9, 45.1, 40.3, 24.4, 23.3, 22.2. 
 
LRMS (ESI) Calcd. for C17H26N2O6SNa [M+Na]
+: 409.1, Found: 409.1.  
 
FTIR (neat): 2955, 2925, 2869, 2322, 2282, 1531, 1012, 929, 855 cm-1.  
 
[]20D = -5.20 ° (c 0.24, EtOAc).  
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N-((2R,3R,5S)-3,5-dihydroxy-7-methyl-2-vinyloctyl)-4-nitrobenzenesulfonamide 
(anti-3.4n) 
 
According to general procedure for coupling of vinyl aziridine (3.3a) with (S)-5-
methylhexane-1,3-diol (13.2 mg, 0.1 mmol, 100 mol%), in the presence of (S)-Ir-3-Ib (5.17 
mg, 0.005 mmol, 5 mol%), the product anti-3.4n was obtained as yellow solid in 68% 
yields (26.2 mg, 0.068 mmol, dr=4:1) after flash chromatography (SiO2: 
dichloromethane/methanol, 100:1-80:1). Spectral data is reported for the major isomer. 
 
1H NMR (400 MHz, CDCl3) δ 8.38 (d, J = 9.0 Hz, 2H), 8.05 (d, J = 9.0 Hz, 2H), 5.78–
5.62 (m, 2H), 5.19 (dd, J = 10.4, 1.6 Hz, 1H), 5.13–5.05 (m, 1H), 4.25 (d, J = 10.2 Hz, 1H), 
4.01 (s, 1H), 3.70 (s, 1H), 3.36–3.26 (m, 1H), 2.93 (ddd, J = 12.1, 5.7, 3.6 Hz, 1H), 2.23 
(qd, J = 8.4, 2.6 Hz, 1H), 2.07 (s, 1H), 1.81–1.62 (m, 2H), 1.47 (ddd, J = 14.4, 9.0, 5.6 Hz, 
1H), 1.36–1.19 (m, 2H), 0.92 (dd, J = 6.5, 5.5 Hz, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 150.3, 145.8, 134.4, 128.4, 124.6, 119.7, 77.4, 67.8, 49.4, 
46.6, 44.9, 41.2, 24.8, 23.4, 22.2. 
 
LRMS (ESI) Calcd. for C17H26N2O6SNa [M+Na]
+: 409.1, Found: 409.1.  
 
FTIR (neat): 2951, 2924, 2869, 2359, 2223, 1606, 1464, 1310, 925, 855 cm-1.  
 
[]20D = -16.00 ° (c 0.25, EtOAc). mp: 136-138 oC.  
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N-((2S,3S,5R)-3,5-dihydroxy-5-(6-methylpyridin-2-yl)-2-vinylpentyl)-4-
nitrobenzene-sulfonamide (syn-3.4o) 
 
According to general procedure for coupling of vinyl aziridine (3.3a) with (R)-1-(6-
methylpyridin-2-yl)propane-1,3-diol (16.7 mg, 0.1 mmol, 100 mol%), in the presence of 
(R)-Ir-3-Vb (5.31 mg, 0.005 mmol, 5 mol%), the product syn-3.4o was obtained as gel in 
65% yields (27.4 mg, 0.065 mmol, dr=4:1) after flash chromatography (SiO2: 
dichloromethane/methanol, 100:1-80:1). Spectral data is reported for the major isomer. 
 
1H NMR (400 MHz, CDCl3) δ 8.34 (d, J = 8.8 Hz, 2H), 8.05 (d, J = 8.8 Hz, 2H), 7.59 (t, 
J = 7.7 Hz, 1H), 7.09 (d, J = 7.7 Hz, 1H), 6.98 (d, J = 7.6 Hz, 1H), 5.77 (t, J = 5.4 Hz, 1H), 
5.75–5.67 (m, 1H), 5.26 (brs, 1H), 5.17–5.02 (m, 2H), 4.88 (dd, J = 10.5, 2.7 Hz, 1H), 
4.27–4.19 (m, 1H), 3.28–3.19 (m, 1H), 3.18–3.08 (m, 1H), 2.55 (s, 3H), 2.37 (td, J = 8.9, 
2.9 Hz, 1H), 1.73 (ddd, J = 14.2, 2.9, 1.7 Hz, 1H), 1.64 (s, 1H), 1.50 (dt, J = 14.3, 10.5 Hz, 
1H). 
13C NMR (100 MHz, CDCl3) δ 159.3, 157.2, 150.0, 146.2, 137.6, 134.5, 128.5, 124.4, 
122.5, 119.3, 116.9, 73.3, 72.9, 48.4, 45.2, 41.6, 24.3. 
 
LRMS (ESI) Calcd. for C19H23N3O6SNa [M+Na]
+: 444.1, Found: 444.1.  
 
FTIR (neat): 3368, 2927, 1597, 1577, 1558, 1530, 1460, 1310, 1011, 854 cm-1. 
  
[]20D = +2.61 ° (c 0.64, CHCl3).  
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N-((2R,3R,5R)-3,5-dihydroxy-5-(6-methylpyridin-2-yl)-2-vinylpentyl)-4-
nitrobenzene-sulfonamide (anti-3.4o) 
 
According to general procedure for coupling of vinyl aziridine (3.3a) with (R)-1-(6-
methylpyridin-2-yl)propane-1,3-diol (16.7 mg, 0.1 mmol, 100 mol%), in the presence of 
(S)-Ir-3-Vb (5.31 mg, 0.005 mmol, 5 mol%), the product anti-3.4o was obtained as gel in 
62% yields (26.1 mg, 0.062 mmol, dr=4:1) after flash chromatography (SiO2: 
dichloromethane/methanol, 100:1-80:1). Spectral data is reported for the major isomer. 
 
1H NMR (400 MHz, CD3COCD3) δ 8.31 (d, J = 9.0 Hz, 2H), 8.01 (d, J = 9.0 Hz, 2H), 
7.52 (t, J = 7.7 Hz, 1H), 7.14 (d, J = 7.8 Hz, 1H), 6.98 (d, J = 7.6 Hz, 1H), 6.68 (s, 1H), 
5.60 (ddd, J = 17.3, 10.4, 9.1 Hz, 1H), 4.97–4.85 (m, 2H), 4.76–4.66 (m, 1H), 4.56 (d, J = 
5.3 Hz, 1H), 4.32 (brs, 1H), 3.94 (d, J = 10.0 Hz, 1H), 3.12 (dt, J = 12.5, 6.1 Hz, 1H), 2.99–
2.88 (m, 1H), 2.33 (s, 3H), 2.14 (td, J = 9.5, 2.5 Hz, 1H), 1.70 (ddd, J = 14.1, 10.2, 3.8 Hz, 
1H), 1.41 (ddd, J = 14.1, 8.4, 2.3 Hz, 1H). 
13C NMR (100 MHz, CD3COCD3) δ 164.8, 158.1, 151.4, 148.3, 138.5, 137.2, 129.8, 
125.7, 122.7, 119.2, 118.3, 72.0, 69.3, 51.6, 46.4, 45.1, 24.8. 
 
LRMS (ESI) Calcd. for C19H23N3O6SNa [M+Na]
+: 444.1, Found: 444.1.  
 
FTIR (neat): 3376, 3286, 2920, 2359, 1529, 1348, 1162, 924, 854 cm-1.  
 
[]20D = -61.91 ° (c 0.14, CHCl3). mp: 156-158 oC.  
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General Procedure and Spectral Data for Mitsunobu Reaction to Form Piperidines 
(3.5m-3.5o) 
 
A flame-dried flask equipped with a magnetic stir bar was charged 3.4m, 3.4n or 3.4o (0.05 
mmol, 100 mol%) in 0.5 mL dichloromethane (0.1 M). Triphenylphosphine (19.7 mg, 
0.075 mmol, 150 mol%) and DIAD (disisopropyl azodicarboxylate, 15.2 mg, 0.075 mmol, 
150 mol%) were added at 0 oC. The flask was capped and the reaction mixture was allowed 
to stir at r.t. for 16 h. The reaction mixture was concentrated in vacuo. The residue was 
subjected to column chromatography to furnish the title compound. 
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(2R,4S,5S)-2-methyl-1-((4-nitrophenyl)sulfonyl)-5-vinylpiperidin-4-ol (syn-3.5m) 
 
According to general procedure with syn-3.4m (17.2 mg, 0.05 mmol, 100 mol%), 
triphenylphosphine (19.7 mg, 0.075 mmol, 150 mol%) and DIAD (15.2 mg, 0.075 mmol, 
150 mol%), the product syn-3.5m was obtained as gel in 80% yields (13.1 mg, 0.040 mmol) 
after flash chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). 
 
1H NMR (400 MHz, CDCl3) δ 8.36 (d, J = 9.0 Hz, 2H), 7.99 (d, J = 9.1 Hz, 2H), 5.71 
(ddd, J = 17.3, 10.4, 8.0 Hz, 1H), 5.26 (dt, J = 17.3, 1.3 Hz, 1H), 5.23–5.18 (m, 1H), 3.81 
(dd, J = 12.8, 3.6 Hz, 1H), 3.77–3.69 (m, 2H), 3.18 (dd, J = 12.8, 5.9 Hz, 1H), 2.42–2.31 
(m, 1H), 2.03 (ddd, J = 14.0, 4.8, 4.0 Hz, 1H), 1.74 (d, J = 2.9 Hz, 1H), 1.65–1.54 (m, 1H), 
1.27 (d, J = 6.9 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3) δ 150.0, 146.7, 135.8, 128.4, 124.5, 118.8, 69.8, 50.9, 46.9, 
44.3, 37.0, 19.6. 
 
LRMS (ESI) Calcd. for C14H18N2O5SNa [M+Na]
+: 349.1, Found: 349.1.  
 
FTIR (neat): 2924, 2856, 1605, 1529, 1453, 1348, 1217, 1151, 1013, 919, 855 cm-1.  
 
[]20D = -1.07 ° (c 0.94, CHCl3).  
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(2R,4R,5R)-2-methyl-1-((4-nitrophenyl)sulfonyl)-5-vinylpiperidin-4-ol (anti-3.5m) 
 
According to general procedure with anti-3.4m (17.2 mg, 0.05 mmol, 100 mol%), 
triphenylphosphine (19.7 mg, 0.075 mmol, 150 mol%) and DIAD (15.2 mg, 0.075 mmol, 
150 mol%), the product anti-3.5m was obtained as white solid in 85% yields (13.9 mg, 
0.043 mmol) after flash chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). 
 
1H NMR (400 MHz, CDCl3) δ 8.36 (d, J = 9.0 Hz, 2H), 8.01 (d, J = 9.0 Hz, 2H), 5.59 
(ddd, J = 17.0, 10.5, 8.5 Hz, 1H), 5.33–5.24 (m, 2H), 4.48–4.39 (m, 1H), 3.84 (ddd, J = 
13.8, 4.8, 1.2 Hz, 1H), 3.70–3.61 (m, 1H), 2.91 (dd, J = 13.9, 11.9 Hz, 1H), 2.04–1.93 (m, 
1H), 1.89 (ddd, J = 13.0, 4.4, 1.9 Hz, 1H), 1.81 (d, J = 3.0 Hz, 1H), 1.57–1.47 (m, 1H), 
1.14 (d, J = 7.0 Hz, 3H). 
 
13C NMR (100 MHz, CDCl3) δ 150.1, 147.0, 135.2, 128.2, 124.6, 120.5, 66.9, 49.8, 43.3, 
37.9, 17.1. 
 
mp:  118-120 oC. 
 
LRMS (ESI) Calcd. for C14H18N2O5SNa [M+Na]
+: 349.1, Found: 349.1.  
 
FTIR (neat): 2922, 2855, 2323, 1605, 1528, 1348, 1160, 1025, 920, 854 cm-1.  
 
[]20D = -43.34 ° (c 0.70, CHCl3).  
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(2R,4S,5S)-2-isobutyl-1-((4-nitrophenyl)sulfonyl)-5-vinylpiperidin-4-ol (syn-3.5n) 
 
According to general procedure with syn-3.4n (19.3 mg, 0.05 mmol, 100 mol%), 
triphenylphosphine (19.7 mg, 0.075 mmol, 150 mol%) and DIAD (15.2 mg, 0.075 mmol, 
150 mol%), the product syn-3.5n was obtained as gel in 86% yields (15.8 mg, 0.043 mmol) 
after flash chromatography (SiO2: hexane/ethyl acetate, 5:1-3:1). 
 
1H NMR (400 MHz, CDCl3) δ 8.35 (d, J = 8.8 Hz, 2H), 8.00 (d, J = 8.8 Hz, 2H), 5.78–
5.65 (m, 1H), 5.25–5.09 (m, 2H), 3.98–3.88 (m, 1H), 3.83 (s, 1H), 3.69 (dt, J = 13.3, 3.1 
Hz, 1H), 3.48 (dd, J = 13.3, 3.2 Hz, 1H), 2.37 (d, J = 3.6 Hz, 1H), 2.01–1.86 (m, 2H), 1.75–
1.65 (m, 2H), 1.50 (dt, J = 11.8, 6.1 Hz, 1H), 1.16 (ddd, J = 13.5, 5.3, 2.6 Hz, 1H), 0.82 
(td, J = 6.6, 3.0 Hz, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 149.9, 147.5, 136.3, 128.4, 124.3, 118.1, 69.4, 52.4, 46.2, 
42.5, 41.2, 31.4, 25.4, 23.5, 21.7. 
 
LRMS (ESI) Calcd. for C17H24N2O5SNa [M+Na]
+: 391.1, Found: 391.1.  
 
FTIR (neat): 3540, 2956, 1605, 1528, 1347, 1305, 1150, 959, 854 cm-1.  
 
[]20D = -6.33 ° (c 1.00, CHCl3).  
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(2R,4R,5R)-2-isobutyl-1-((4-nitrophenyl)sulfonyl)-5-vinylpiperidin-4-ol (anti-3.5n) 
 
According to general procedure with anti-3.4n (19.3 mg, 0.05 mmol, 100 mol%), 
triphenylphosphine (19.7 mg, 0.075 mmol, 150 mol%) and DIAD (15.2 mg, 0.075 mmol, 
150 mol%), the product anti-3.5n was obtained as gel in 62% yields (11.4 mg, 0.031 mmol) 
after flash chromatography (SiO2: dichloromethane/methanol, 120:1-90:1). 
 
1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 9.0 Hz, 2H), 8.03 (d, J = 9.0 Hz, 2H), 5.55 
(ddd, J = 17.1, 10.4, 8.5 Hz, 1H), 5.32–5.26 (m, 1H), 5.22 (ddd, J = 17.1, 1.4, 0.8 Hz, 1H), 
4.30 (dd, J = 13.6, 7.0 Hz, 1H), 3.83 (ddd, J = 14.6, 4.8, 1.1 Hz, 1H), 3.67–3.55 (m, 1H), 
2.92 (dd, J = 14.6, 12.0 Hz, 1H), 1.90 (ddd, J = 13.1, 4.4, 1.8 Hz, 1H), 1.88–1.78 (m, 1H), 
1.74 (d, J = 3.0 Hz, 1H), 1.62–1.51 (m, 1H), 1.47–1.24 (m, 3H), 0.91 (dd, J = 6.6, 4.7 Hz, 
6H). 
 
13C NMR (100 MHz, CDCl3) δ 150.1, 147.2, 135.2, 128.3, 124.6, 120.4, 67.1, 52.5, 49.3, 
43.7, 40.1, 35.7, 25.1, 22.7, 22.5. 
 
LRMS (ESI) Calcd. for C17H24N2O5SNa [M+Na]
+: 391.1, Found: 391.1.  
 
FTIR (neat): 3102, 2955, 2869, 2359, 1529, 1349, 1162, 989, 854 cm-1.  
 
[]20D = -17.86 ° (c 0.56, CHCl3).  
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(2S,4S,5S)-2-(6-methylpyridin-2-yl)-1-((4-nitrophenyl)sulfonyl)-5-vinylpiperidin-4-ol 
(syn-3.5o) 
 
According to general procedure with syn-3.4o (21.0 mg, 0.05 mmol, 100 mol%), 
triphenylphosphine (19.7 mg, 0.075 mmol, 150 mol%) and DIAD (15.2 mg, 0.075 mmol, 
150 mol%), the product syn-3.5o was obtained as gel in 70% yields (14.1 mg, 0.035 mmol) 
after flash chromatography (SiO2: hexane/ethyl acetate, 5:1-2:1). 
 
1H NMR (400 MHz, CDCl3) δ 8.10 (d, J = 9.0 Hz, 2H), 7.63 (d, J = 9.0 Hz, 2H), 7.55 (t, 
J = 7.7 Hz, 1H), 7.21 (d, J = 7.6 Hz, 1H), 7.07–7.01 (m, 1H), 5.84 (ddd, J = 17.6, 10.6, 7.3 
Hz, 1H), 5.32–5.24 (m, 2H), 5.13 (dt, J = 10.6, 1.3 Hz, 1H), 3.89–3.82 (m, 1H), 3.77 (dd, 
J = 12.8, 2.9 Hz, 1H), 3.69 (dd, J = 12.8, 2.3 Hz, 1H), 2.66–2.58 (m, 1H), 2.44 (ddd, J = 
14.9, 7.9, 3.9 Hz, 1H), 2.37 (s, 3H), 2.03–1.93 (m, 1H). 
 
13C NMR (100 MHz, CDCl3) δ 157.7, 157.1, 149.6, 145.6, 138.3, 136.3, 128.3, 123.7, 
123.2, 121.8, 117.6, 66.8, 56.8, 45.1, 41.6, 30.2, 23.8. 
 
LRMS (ESI) Calcd. for C19H21N3O5SNa [M+Na]
+: 426.1, Found: 426.1.  
 
FTIR (neat): 2925, 2859, 1596, 1523, 1214, 1175, 1042, 908, 854 cm-1.  
 
[]20D = -16.80 ° (c 1.00, CHCl3).  
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(2S,4R,5R)-2-(6-methylpyridin-2-yl)-1-((4-nitrophenyl)sulfonyl)-5-vinylpiperidin-4-
ol (anti-3.5o) 
 
According to general procedure with anti-3.4o (21.0 mg, 0.05 mmol, 100 mol%), 
triphenylphosphine (39.4 mg, 0.15 mmol, 300 mol%, two portions) and DIAD (30.4 mg, 
0.15 mmol, 300 mol%, two portions), the product anti-3.5o was obtained as gel in 65% 
yields (13.1 mg, 0.033 mmol) after flash chromatography (SiO2: hexane/ethyl acetate, 5:1-
2:1). 
 
1H NMR (400 MHz, CDCl3) δ 8.19 (d, J = 8.9 Hz, 2H), 7.82 (d, J = 8.9 Hz, 2H), 7.51 (t, 
J = 7.7 Hz, 1H), 7.09 (d, J = 7.7 Hz, 1H), 6.93 (d, J = 7.5 Hz, 1H), 5.55 (ddd, J = 17.5, 
10.0, 8.6 Hz, 1H), 5.38 (d, J = 6.0 Hz, 1H), 5.31–5.24 (m, 2H), 3.93 (ddd, J = 12.9, 4.9, 
1.1 Hz, 1H), 3.72–3.63 (m, 1H), 3.50–3.41 (m, 1H), 2.59 (ddd, J = 13.0, 4.3, 2.1 Hz, 1H), 
2.20 (s, 3H), 2.18–2.10 (m, 1H), 1.85–1.73 (m, 2H). 
 
13C NMR (100 MHz, CDCl3) δ 157.7, 157.6, 149.8, 146.1, 137.2, 135.6, 128.3, 124.0, 
121.9, 120.2, 118.8, 66.7, 57.9, 49.4, 46.3, 36.6, 24.4. 
 
LRMS (ESI) Calcd. for C19H21N3O5SNa [M+Na]
+: 426.1, Found: 426.1.  
 
FTIR (neat): 2923, 2856, 1590, 1529, 1456, 1349, 1165, 1042, 992, 855 cm-1.  
 
[]20D = -76.00 ° (c 1.00, CHCl3).  
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Deprotection of syn-5n to Form free Piperidine (syn-3.6n) 
(2R,4S,5S)-2-isobutyl-5-vinylpiperidin-4-ol (syn-3.6n) 
 
A flame-dried pressure tube equipped with a magnetic stir bar was charged syn-3.5n (18.4 
mg, 0.05 mmol, 100 mol%) and K2CO3 (41.5 mg, 0.3 mmol, 600 mol%). The reaction tube 
was placed under an atmosphere of argon, PhSH (22 mg, 0.2 mmol, 400 mol%) and MeCN 
(0.5 mL, 0.1 M) was added by syringe. The tube was capped and the reaction mixture was 
allowed to stir at 50 oC for 24 h. The reaction mixture was concentrated in vacuo. The 
product syn-3.6n was obtained as white solid in 85% yields (7.8 mg, 0.043 mmol) after 
flash chromatography (SiO2: dichloromethane/methanol, 20:1-10:1). 
1H NMR (400 MHz, CD3OD) δ 5.82–5.70 (m, 1H), 5.26–5.22 (m, 1H), 5.20 (d, J = 0.5 
Hz, 1H), 3.58–3.50 (m, 1H), 3.21 (dd, J = 12.9, 4.5 Hz, 1H), 3.17–3.10 (m, 1H), 2.84 (t, J 
= 12.6 Hz, 1H), 2.25 (ddd, J = 7.8, 6.1, 3.3 Hz, 1H), 2.19 (ddd, J = 13.6, 4.5, 2.8 Hz, 1H), 
1.75 (dp, J = 19.9, 6.6 Hz, 1H), 1.54–1.39 (m, 2H), 1.38–1.25 (m, 1H), 0.96 (dd, J = 8.0, 
6.6 Hz, 6H). 
13C NMR (100 MHz, CD3OD) δ 136.9, 118.9, 70.6, 55.2, 48.3, 47.9, 44.2, 39.4, 25.4, 
23.12, 22.4. 
mp: 218-220 oC. 
LRMS (ESI) Calcd. for C11H21NONa [M+Na]
+: 206.2, Found: 206.2.  
FTIR (neat): 3399, 2956, 2924, 2851, 2359, 1443, 1260, 1024, 996, 801 cm-1.  
[]20D = -11.19 ° (c 0.58, MeOH).  
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X-ray Experimental for complex 3.4b–CHCl3:   
Crystals grew as colorless plates by slow evaporation from chloroform. The data 
crystal was cut from a larger crystal and had approximate dimensions; 0.22 x 0.15 x 0.03 
mm. The data were collected on an Agilent Technologies SuperNova Dual Source 
diffractometer using a -focus Cu K radiation source (=1.5418Å) with collimating 
mirror monochromators. A total of 1665 frames of data were collected using-scans with a 
scan range of 1 and a counting time of 7.5 seconds per frame with a detector offset of +/- 
40.5 and 20 seconds per frame with a detector offset of +/- 111. The data were collected 
at 100 K using an Oxford Cryostream low temperature device. Details of crystal data, data 
collection and structure refinement are listed in Table 1. Data collection, unit cell 
refinement and data reduction were performed using Agilent Technologies CrysAlisPro V 
1.171.37.31. The structure was solved by direct methods using SIR97 and refined by full-
matrix least-squares on F2 with anisotropic displacement parameters for the non-H atoms 
using SHELXL-2013. Structure analysis was aided by use of the programs PLATON98 
and WinGX. The hydrogen atoms on carbon were calculated in ideal positions with 
isotropic displacement parameters set to 1.2xUeq of the attached atom (1.5xUeq for methyl 
hydrogen atoms). The hydrogen atoms bound to N2 and O5 were observed in a ∆F map 
and refined with isotropic displacement parameters. 
A molecule of chloroform was disordered by rotation about one of the Cl to C 
bonds. The disorder was modeled by assigning the variable x to the site occupancy of one 
component of the disorder. The variable (1-x) was assigned to the site occupancy of the 
alternate component. The variable x was refined while restraining the geometry of the two 
components to be equivalent. A common isotropic displacement parameter was refined 
while refining x. In this way, the site occupancy for the major component of the disorder 
refined to 70(2)%. The chlorine atoms involved in the disorder were refined with 
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anisotropic displacement parameters that were restrained to be approximately isotropic in 
the final refinement model. 
The absolute configuration was determined by the method of Flack. The Flack x 
parameter refined to 0.01(2). This assignment was corroborated by use of the Hooft y-
parameter. The Hooft y-parameter refined to 0.011(7).     
The function, w(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[((Fo))2+ 
(0.0606*P)2 + (0.4875*P)] and P = (|Fo|2 + 2|Fc|2)/3. Rw(F2) refined to 0.104, with R(F) 
equal to 0.0388 and a goodness of fit, S, = 1.03. Definitions used for calculating R(F), 
Rw(F2) and the goodness of fit, S, are given below. The data were checked for secondary 
extinction effects but no correction was necessary. Neutral atom scattering factors and 
values used to calculate the linear absorption coefficient are from the International Tables 
for X-ray Crystallography (1992). All figures were generated using SHELXTL/PC. Tables 
of positional and thermal parameters, bond lengths and angles, torsion angles and figures 
are found elsewhere.  
             187 
 
Table 3.6  Crystal data and structure refinement for 3.4b-CHCl3. 
Empirical formula  C19 H21 Cl3 N2 O5 S 
Formula weight  495.79 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  monoclinic 
Space group  P 21 
Unit cell dimensions a = 5.34030(10) Å  
 b = 12.4724(2) Å  
 c = 17.1880(3) Å  
Volume 1144.40(3) Å3 
Z 2 
Density (calculated) 1.439 Mg/m3 
Absorption coefficient 4.767 mm-1 
F(000) 512 
Crystal size 0.220 x 0.150 x 0.027 mm 
Theta range for data collection 2.572 to 76.118°. 
Index ranges -6<=h<=6, -15<=k<=15, -21<=l<=21 
Reflections collected 11741 
Independent reflections 4566 [R(int) = 0.0313] 
Completeness to theta = 67.684° 99.8 %  
Absorption correction Gaussian 
Max. and min. transmission 0.939 and 0.696 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4566 / 55 / 299 
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Table 3.6 (cont’d) 
Goodness-of-fit on F2 1.023 
Final R indices [I>2sigma(I)] R1 = 0.0388, wR2 = 0.1025 
R indices (all data) R1 = 0.0400, wR2 = 0.1040 
Absolute structure parameter 0.01(2) 
Extinction coefficient n/a 
Largest diff. peak and hole            0.504 and -0.389 e.Å-3 
 
Table 3.7   Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for 3.4b-CHCl3. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 x y z U(eq) 
 
C1 8313(6) 6272(3) 7124(2) 21(1) 
C2 7783(7) 5680(3) 7778(2) 34(1) 
C3 6000(9) 6064(4) 8286(2) 42(1) 
C4 4859(7) 7024(3) 8122(2) 34(1) 
C5 5368(8) 7623(3) 7475(2) 36(1) 
C6 7114(7) 7238(3) 6962(2) 30(1) 
C7 7236(6) 4184(3) 6024(2) 20(1) 
C8 6671(5) 3450(2) 5324(2) 18(1) 
C9 5714(6) 4099(3) 4639(2) 22(1) 
C10 6971(7) 4266(3) 4000(2) 29(1) 
C11 4742(6) 2597(3) 5547(2)  19(1)  
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Table 3.7 (cont’d) 
 
C12 5454(6) 1982(3) 6282(2) 21(1) 
C13 7548(6) 1318(3) 6319(2) 25(1) 
C14 8128(6) 756(3) 7005(2) 31(1) 
C15 6680(7) 849(3) 7658(2) 33(1) 
C16 4616(7) 1524(3) 7618(2) 33(1) 
C17 4025(6) 2094(3) 6939(2) 26(1) 
C18 7292(10) 229(4) 8397(3) 48(1) 
N1 2943(8) 7416(4) 8654(2) 50(1) 
N2 8775(5) 5104(2) 5782(2) 20(1) 
O1 2457(9) 6877(4) 9214(3) 76(1) 
O2 1914(9) 8257(4) 8513(3) 81(1) 
O3 11914(4) 4960(2) 6857(2) 29(1) 
O4 11564(5) 6616(2) 6057(2) 29(1) 
O5 4264(5) 1877(2) 4908(1) 24(1) 
S1 10409(1) 5727(1) 6446(1) 20(1) 
C19 10387(10) 3370(5) 9579(3) 56(1) 
Cl1 9115(3) 2957(1) 8682(1) 59(1) 
Cl2 11142(5) 4673(2) 9564(1) 74(1) 
Cl3 13102(4) 2537(2) 9794(1) 68(1) 
Cl2A 8880(10) 4797(4) 9843(3) 63(1) 
Cl3A 13597(11) 3787(8) 9673(5) 107(3) 
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Table 3.8 Bond lengths [Å] and angles [°] for 3.4b-CHCl3. 
C1-C2  1.381(5)  
C1-C6  1.389(5) 
C1-S1  1.773(3) 
C2-C3  1.393(6) 
C2-H2  0.95 
C3-C4  1.369(6) 
C3-H3  0.95 
C4-C5  1.374(6) 
C4-N1  1.475(5) 
C5-C6  1.386(5) 
C5-H5  0.95 
C6-H6  0.95 
C7-N2  1.478(4) 
C7-C8  1.535(4) 
C7-H7A  0.99 
C7-H7B  0.99 
C8-C9  1.507(4) 
C8-C11  1.536(4) 
C8-H8  1.00 
C9-C10  1.320(5) 
C9-H9  0.95 
C10-H10A  0.95 
C10-H10B  0.95 
C11-O5  1.437(4) 
C11-C12  1.518(4) 
C11-H11  1.00 
C12-C17  1.387(5) 
C12-C13  1.392(5) 
C13-C14  1.398(5) 
C13-H13  0.95 
C14-C15  1.384(5) 
C14-H14  0.95 
C15-C16  1.387(6) 
C15-C18  1.516(5) 
C16-C17  1.395(5) 
C16-H16  0.95 
C17-H17  0.95 
C18-H18A  0.98 
C18-H18B  0.98 
C18-H18C  0.98 
N1-O1  1.207(6) 
N1-O2  1.205(6) 
N2-S1  1.616(3) 
N2-H2N  0.96(5) 
O3-S1  1.424(3) 
O4-S1  1.442(2) 
O5-H5O  0.72(4) 
C19-Cl2  1.675(6)  
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Table 3.8 (cont’d) 
C19-Cl1  1.744(5) 
C19-Cl3A  1.795(8) 
C19-Cl3  1.813(6) 
C19-Cl2A  2.011(8) 
C19-H19A  0.96 
C19-H19B  0.96 
C2-C1-C6 121.5(3) 
C2-C1-S1 118.5(3) 
C6-C1-S1 119.8(3) 
C1-C2-C3 119.0(4) 
C1-C2-H2 120.5 
C3-C2-H2 120.5 
C4-C3-C2 118.7(4) 
C4-C3-H3 120.7 
C2-C3-H3 120.7 
C3-C4-C5 123.1(4) 
C3-C4-N1 118.4(4) 
C5-C4-N1 118.5(4) 
C4-C5-C6 118.5(4) 
C4-C5-H5 120.8 
C6-C5-H5 120.8 
C5-C6-C1 119.2(4) 
C5-C6-H6 120.4 
 
 
C1-C6-H6      120.4 
N2-C7-C8      109.9(2) 
N2-C7-H7A      109.7 
C8-C7-H7A      109.7 
N2-C7-H7B      109.7 
C8-C7-H7B      109.7 
H7A-C7-H7B      108.2 
C9-C8-C7      110.3(2) 
C9-C8-C11        110.6(2) 
C7-C8-C11      109.7(2) 
C9-C8-H8      108.7 
C7-C8-H8      108.7 
C11-C8-H8      108.7 
C10-C9-C8      124.5(3) 
C10-C9-H9      117.8 
C8-C9-H9      117.8 
C9-C10-H10A     120.0 
C9-C10-H10B      120.0 
H10A-C10-H10B   120.0 
O5-C11-C12      110.9(3) 
O5-C11-C8      110.4(2) 
C12-C11-C8      113.7(2) 
O5-C11-H11      107.1  
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Table 3.8 (cont’d) 
C12-C11-H11      107.1 
C8-C11-H11      107.2 
C17-C12-C13      118.8(3) 
C17-C12-C11      119.7(3) 
C13-C12-C11       121.4(3) 
C12-C13-C14       119.7(3) 
C12-C13-H13       120.1 
C14-C13-H13       120.1 
C15-C14-C13       121.7(3) 
C15-C14-H14       119.2 
C13-C14-H14       119.2 
C14-C15-C16       118.1(3) 
C14-C15-C18       121.6(4) 
C16-C15-C18       120.3(4) 
C15-C16-C17       120.8(3) 
C15-C16-H16       119.6 
C17-C16-H16       119.6 
C12-C17-C16       120.8(3) 
C12-C17-H17       119.6 
C16-C17-H17       119.6 
C15-C18-H18A 109.5 
C15-C18-H18B 109.5 
H18A-C18-H18B 109.5 
C15-C18-H18C 109. 5 
 
H18A-C18-H18C 109.5 
H18B-C18-H18C 109.5 
O1-N1-O2       122.5(4) 
O1-N1-C4       118.5(5) 
O2-N1-C4       119.0(5) 
C7-N2-S1       117.9(2) 
C7-N2-H2N       114(3) 
S1-N2-H2N       111(3) 
C11-O5-H5O       113(3) 
O3-S1-O4       120.22(16) 
O3-S1-N2       108.25(15) 
O4-S1-N2       105.79(14) 
O3-S1-C1       106.85(16) 
O4-S1-C1       107.19(15) 
N2-S1-C1       108.05(14) 
Cl2-C19-Cl1       111.2(3) 
Cl1-C19-Cl3A      120.9(4) 
Cl2-C19-Cl3       111.5(3) 
Cl1-C19-Cl3       107.5(3) 
Cl1-C19-Cl2A      108.2(3) 
Cl3A-C19-Cl2A 96.3(4) 
Cl2-C19-H19A 108.8 
Cl1-C19-H19A 108.9 
Cl3-C19-H19A 108.8  
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Table 3.8 (cont’d) 
Cl1-C19-H19B 110.2 
Cl3A-C19-H19B 110.1 
Cl2A-C19-H19B 110.1
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Table 3.9 Anisotropic displacement parameters (Å2x103) for 3.4b-CHCl3. The 
anisotropic displacement factor exponent takes the form: -22[h2a*2U11+...+2 
h k a* b* U12]. 
 
 
 U11 U22  U33 U23 U13 U12 
 
C1 19(1)  21(2) 24(1)  -5(1) -3(1)  -4(1) 
C2 44(2)  25(2) 33(2)  2(2) 10(1)  4(2) 
C3 56(3)  35(2) 37(2)  -1(2) 18(2)  0(2) 
C4 29(2)  37(2) 37(2)  -16(2) 6(2)  -5(2) 
C5 40(2)  32(2) 36(2)  -9(2) -5(2)  13(2) 
C6 36(2)  28(2) 27(2)  -3(1) -2(1)  7(1) 
C7 22(1)  16(1) 24(1)  -2(1) 2(1)  -3(1) 
C8 15(1)  14(1) 24(1)  -2(1) 0(1)  0(1) 
C9 22(1)  13(1) 30(2)  -2(1) -3(1)  -1(1) 
C10 36(2)  22(2) 30(2)  2(1) 1(1)  4(1) 
C11 18(1)  17(2) 23(1)  -3(1) -1(1)  -1(1) 
C12 18(1)  18(2) 26(1)  -1(1) -3(1)  -4(1) 
C13 20(2)  23(2) 33(2)  -1(1) 1(1)  -1(1) 
C14 27(2)  23(2) 42(2)  3(2) -8(1)  4(2) 
C15 40(2)  28(2) 31(2)  4(1) -8(1)  -4(2) 
C16 37(2)  35(2) 28(2)  1(1) 4(1)  1(2) 
C17 22(2)  26(2) 29(2)  -1(1) 1(1)  3(1) 
C18 61(3)  42(2) 38(2)  12(2) -14(2)  3(2)  
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Table 3.9 (cont’d) 
N1 43(2)  55(3) 54(2)  -27(2) 12(2)  -3(2) 
N2 20(1)  15(1) 24(1)  -1(1) -1(1)  -2(1) 
O1 93(3)  56(2) 83(3)  -17(2) 59(3)  -13(2) 
O2 81(3)  93(4) 70(3)  -16(2) 21(2)  48(3) 
O3 17(1)  33(1) 37(1)  -2(1) -4(1)  6(1) 
O4 28(1)  25(1) 35(1)  -2(1) 4(1)  -12(1) 
O5 27(1)  20(1) 24(1)  -5(1) 2(1)  -7(1) 
S1 15(1)  19(1) 26(1)  -2(1) -1(1)  -2(1) 
C19 51(3)  77(4) 41(2)  16(2) 0(2)  -14(3) 
Cl1 68(1)  46(1) 64(1)  2(1) -11(1)  -5(1) 
Cl2 121(2)  54(1) 46(1)  -6(1) -17(1)  -25(1) 
Cl3 49(1)  104(2) 50(1)  15(1) -4(1)  6(1) 
Cl2A 76(3)  57(3) 55(2)  -5(2) -22(2)  2(2) 
Cl3A 51(3)  148(7) 122(5)  46(5) 14(3)  14(3) 
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Table 3.10 Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 
103) for 3.4b-CHCl3. 
 
 x  y  z  U(eq) 
  
H2 8622 5022 7881 40 
H3 5585 5667 8736 51 
H5 4541 8287 7380 43 
H6 7487 7630 6506 36 
H7A 5647 4447 6239 24 
H7B 8144 3775 6437 24 
H8 8253 3082 5178 21 
H9 4095 4409 4670 26 
H10A 8596 3967 3950 35 
H10B 6252 4684 3590 35 
H11 3138 2980 5646 23 
H13 8579 1246 5881 30 
H14 9552 300 7024 37 
H16 3592 1599 8058 40 
H17 2626 2565 6927 31 
H18A 6922 -532 8313 72 
H18B 6278 503 8820 72 
H18C 9073 316 8535 72 
H19A 9172 3255 9972 68 
H19B   10020 2853 9974 68  
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Table 3.10 (cont’d) 
H5O 5350(80) 1780(30) 4680(20) 13(10) 
H2N 7880(80) 5600(40) 5450(30) 35(11) 
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Table 3.11 Torsion angles [°] for 3.4b-CHCl3. 
C6-C1-C2-C3 0.1(6) 
S1-C1-C2-C3 -175.3(3) 
C1-C2-C3-C4 -0.9(6) 
C2-C3-C4-C5 0.8(7) 
C2-C3-C4-N1 179.0(4) 
C3-C4-C5-C6 0.1(6) 
N1-C4-C5-C6 -178.1(3) 
C4-C5-C6-C1 -0.9(6) 
C2-C1-C6-C5 0.8(5) 
S1-C1-C6-C5 176.2(3) 
N2-C7-C8-C9 -49.2(3) 
N2-C7-C8-C11 -171.2(2) 
C7-C8-C9-C10 110.3(4) 
C11-C8-C9-C10 -128.2(4) 
C9-C8-C11-O5 60.4(3) 
C7-C8-C11-O5 -177.7(2) 
C9-C8-C11-C12 -174.2(3) 
C7-C8-C11-C12 -52.3(3) 
O5-C11-C12-C17 -121.1(3) 
C8-C11-C12-C17 113.8(3) 
O5-C11-C12-C13 60.1(4) 
C8-C11-C12-C13 -65.0(4) 
C17-C12-C13-C14 1.8(5) 
C11-C12-C13-C14 -179.4(3) 
C12-C13-C14-C15 -0.6(5) 
C13-C14-C15-C16 -0.2(6) 
C13-C14-C15-C18 179.2(4) 
C14-C15-C16-C17 -0.2(6) 
C18-C15-C16-C17 -179.6(4) 
C13-C12-C17-C16 -2.3(5) 
C11-C12-C17-C16 178.9(3) 
C15-C16-C17-C12 1.5(6) 
C3-C4-N1-O1 0.1(6) 
C5-C4-N1-O1 178.4(4) 
C3-C4-N1-O2 -179.5(5) 
C5-C4-N1-O2 -1.2(6) 
C8-C7-N2-S1 -158.2(2) 
C7-N2-S1-O3 53.7(3) 
C7-N2-S1-O4 -176.2(2) 
C7-N2-S1-C1 -61.7(3) 
C2-C1-S1-O3 -22.8(3) 
C6-C1-S1-O3 161.7(3) 
C2-C1-S1-O4 -152.9(3) 
C6-C1-S1-O4 31.6(3) 
C2-C1-S1-N2 93.5(3) 
C6-C1-S1-N2 -82.0(3)
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Table 3.12 Hydrogen bonds for 3.4b-CHCl3. 
 
  D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
  
O5-H5O...O4#1 0.72(4) 2.12(4) 2.832(4) 175(4) 
 N2-H2N...O5#2 0.96(5) 2.04(5) 2.971(3) 161(4) 
 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,y-1/2,-z+1    #2 -x+1,y+1/2,-z+1     
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Figure 3.1 View of 3.4b-CHCl3 showing the atom labeling scheme. Displacement 
ellipsoids are scaled to the 50% probability level. 
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X-ray Experimental for complex anti-3.5m: 
 
Table 3.13 Crystal data and structure refinement for anti-3.5m. 
Empirical formula  C14 H18 N2 O5 S 
Formula weight  326.36 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  monoclinic 
Space group  P 21 
Unit cell dimensions a = 8.10640(10) Å  
 b = 7.84280(10) Å  
 c = 12.2165(2) Å  
Volume 763.258(19) Å3 
Z 2 
Density (calculated) 1.420 Mg/m3 
Absorption coefficient 2.124 mm-1 
F(000) 344 
Crystal size 0.370 x 0.080 x 0.040 mm 
Theta range for data collection 3.682 to 76.003°. 
Index ranges -9<=h<=10, -9<=k<=9, -15<=l<=15 
Reflections collected 8408 
Independent reflections 3059 [R(int) = 0.0189] 
Completeness to theta = 67.684° 100.0 %  
Absorption correction Semi-empirical from equivalents  
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Table 3.13 (cont’d) 
Max. and min. transmission 1.00 and 0.805 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3059 / 1 / 205 
Goodness-of-fit on F2 1.053 
Final R indices [I>2sigma(I)] R1 = 0.0214, wR2 = 0.0559 
R indices (all data) R1 = 0.0215, wR2 = 0.0561 
Absolute structure parameter 0.013(14) 
Extinction coefficient n/a 
Largest diff. peak and hole            0.167 and -0.258 e.Å-3 
  
             203 
 
Table 3.14 Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for anti-3.5m. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 x y z U(eq) 
 
C1 7232(2) 5833(2) 9067(2) 19(1) 
C2 6023(2) 7278(2) 9214(2) 20(1) 
C3 5305(2) 8197(2) 8131(2) 21(1) 
C4 6696(2) 8893(2) 7563(2) 18(1) 
C5 7893(2) 7429(2) 7418(1) 18(1) 
C6 6368(3) 4279(3) 8460(2) 26(1) 
C7 6001(3) 9636(3) 6436(2) 25(1) 
C8 6433(3) 11110(3) 6056(2) 31(1) 
C9 10888(2) 4472(2) 7916(2) 16(1) 
C10 10603(2) 2798(2) 8215(1) 17(1) 
C11 10845(2) 1477(2) 7517(2) 17(1) 
C12 11388(2) 1868(3) 6534(2) 17(1) 
C13 11685(2) 3523(3) 6223(2) 19(1) 
C14 11423(2) 4849(2) 6924(2) 18(1) 
N1 8526(2) 6606(2) 8498(1) 17(1) 
N2 11654(2) 460(2) 5791(1) 20(1) 
O1 4302(2) 9610(2) 8342(1) 29(1) 
O2 10791(2) 5461(2) 9931(1) 21(1) 
O3 11431(2) 7578(2) 8556(1) 21(1) 
O4 11279(2) -993(2) 6038(1) 28(1)  
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Table 3.14 (cont’d) 
O5 12236(2) 791(2) 4960(1) 28(1) 
S1 10485(1) 6132(1) 8819(1) 15(1) 
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Table 3.15 Bond lengths [Å] and angles [°] for anti-3.5m. 
C1-N1    1.490(2) 
C1-C6    1.528(3) 
C1-C2    1.530(2) 
C1-H1    1.00 
C2-C3    1.524(3) 
C2-H2A   0.99 
C2-H2B    0.99 
C3-O1    1.426(2) 
C3-C4    1.530(3) 
C3-H3    1.00 
C4-C7    1.504(2) 
C4-C5    1.535(2) 
C4-H4    1.00 
C5-N1  1.473(2) 
C5-H5A   0.99 
C5-H5B   0.99 
C6-H6A   0.98 
C6-H6B   0.98 
C6-H6C   0.98 
C7-C8    1.318(3) 
C7-H7    0.95 
C8-H8A   0.95 
C8-H8B   0.95 
C9-C14   1.393(2) 
C9-C10   1.394(2) 
C9-S1    1.7749(18) 
C10-C11  1.379(3) 
C10-H10  0.95 
C11-C12  1.388(2) 
C11-H11  0.95 
C12-C13  1.386(3) 
C12-N2  1.470(2) 
C13-C14  1.388(3) 
C13-H13  0.95 
C14-H14  0.95 
N1-S1       1.6075(15) 
N2-O5     1.224(2) 
N2-O4  1.232(2) 
O1-H1O    0.84(3) 
O2-S1    1.4353(13) 
      O3-S1    1.4384(14) 
N1-C1-C6 113.39(15) 
N1-C1-C2 105.98(14) 
C6-C1-C2 113.67(16) 
N1-C1-H1 107.8 
C6-C1-H1 107.8 
C2-C1-H1 107.8 
C3-C2-C1 113.46(15)  
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Table 3.15 (cont’d) 
      C3-C2-H2A 108.9 
C1-C2-H2A 108.9 
C3-C2-H2B 108.9 
C1-C2-H2B 108.9 
H2A-C2-H2B 107.7 
O1-C3-C2 110.49(16) 
O1-C3-C4 107.29(15) 
C2-C3-C4 111.57(15) 
O1-C3-H3 109.1 
C2-C3-H3 109.1 
C4-C3-H3 109.1 
C7-C4-C3 111.77(15) 
C7-C4-C5 108.76(15) 
C3-C4-C5 108.68(15) 
C7-C4-H4 109.2 
C3-C4-H4 109.2 
C5-C4-H4 109.2  
N1-C5-C4 110.30(14) 
N1-C5-H5A 109.6 
C4-C5-H5A 109.6 
N1-C5-H5B 109.6 
C4-C5-H5B 109.6 
H5A-C5-H5B 108.1 
C1-C6-H6A 109.5 
 
C1-C6-H6B 109.5 
H6A-C6-H6B 109.5 
C1-C6-H6C 109.5 
H6A-C6-H6C 109.5 
H6B-C6-H6C 109.5 
C8-C7-C4 125.71(19) 
C8-C7-H7 117.1 
C4-C7-H7 117.1 
C7-C8-H8A 120.0 
C7-C8-H8B 120.0 
H8A-C8-H8B 120.0 
C14-C9-C10 121.41(17) 
C14-C9-S1 120.55(14) 
C10-C9-S1 118.02(14) 
C11-C10-C9 119.78(16) 
C11-C10-H10 120.1 
C9-C10-H10 120.1 
C10-C11-C12 118.25(16) 
C10-C11-H11 120.9 
C12-C11-H11 120.9 
C13-C12-C11 122.89(17) 
C13-C12-N2 118.77(17) 
C11-C12-N2 118.34(16) 
C12-C13-C14 118.59(17)  
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Table 3.15 (cont’d) 
C12-C13-H13 120.7 
C14-C13-H13 120.7 
C13-C14-C9 119.08(17) 
C13-C14-H14 120.5 
C9-C14-H14 120.5 
C5-N1-C1 115.96(14) 
C5-N1-S1 118.93(12) 
C1-N1-S1 122.78(12) 
O5-N2-O4 123.41(17) 
 
O5-N2-C12 118.40(16) 
O4-N2-C12 118.19(16) 
C3-O1-H1O 104(2) 
O2-S1-O3 119.67(8) 
O2-S1-N1 107.78(8) 
O3-S1-N1 107.87(8) 
O2-S1-C9 107.42(8) 
O3-S1-C9 105.81(8) 
      N1-S1-C9  107.78(8) 
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Table 3.16 Anisotropic displacement parameters (Å2x103) for anti-3.5m. The anisotropic 
displacement factor exponent takes the form: -22[h2a*2U11+...+2 h k a* b* U12]. 
U11 U22  U33 U23 U13 U12 
C1 18(1)  19(1) 21(1)  2(1) 8(1)  0(1) 
C2 16(1)  21(1) 26(1)  -2(1) 10(1)  -1(1) 
C3 14(1)  17(1) 31(1)  -2(1) 5(1)  2(1) 
C4 16(1)  16(1) 20(1)  -1(1) 2(1)  2(1) 
C5 18(1)  18(1) 18(1)  0(1) 4(1)  2(1) 
C6 25(1)  18(1) 36(1)  0(1) 9(1)  -2(1) 
C7 23(1)  24(1) 25(1)  0(1) -2(1)  5(1) 
C8 35(1)  28(1) 29(1)  7(1) 0(1)  7(1) 
C9 13(1)  17(1) 20(1)  1(1) 3(1)  3(1) 
C10 16(1)  19(1) 18(1)  3(1) 6(1)  2(1) 
C11 17(1)  14(1) 21(1)  3(1) 4(1)  1(1) 
C12 16(1)  17(1) 18(1)  1(1) 2(1)  3(1) 
C13 20(1)  20(1) 18(1)  4(1) 6(1)  2(1) 
C14 19(1)  15(1) 21(1)  4(1) 6(1)  2(1) 
N1 15(1)  18(1) 18(1)  2(1) 6(1)  2(1) 
N2 22(1)  20(1) 18(1)  0(1) 3(1)  4(1) 
O1 17(1)  21(1) 50(1)  -2(1) 13(1)  4(1) 
O2 22(1)  22(1) 18(1)  -1(1) 2(1)  5(1) 
O3 17(1)  17(1) 30(1)  -3(1) 7(1)  -1(1) 
O4 41(1)  17(1) 28(1)  -2(1) 10(1)  -1(1) 
O5 41(1)  27(1) 20(1)  0(1) 13(1)  5(1) 
S1 14(1)  14(1) 18(1)  -1(1) 4(1)  2(1)
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Table 3.17 Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 103) for 
anti-3.5m. 
 x  y  z  U(eq) 
 
H1 7803 5458 9825 23 
H2A 5085 6803 9535 24 
H2B 6620 8115 9752 24 
H3 4595 7384 7616 25 
H4 7332 9795 8044 21 
H5A 7295 6578 6890 22 
H5B 8848 7877 7104 22 
H6A 5473 3887 8840 39 
H6B 7191 3364 8461 39 
H6C 5885 4589 7690 39 
H7 5179 8985 5958 30 
H8A 7251 11803 6506 38 
H8B 5928 11480 5331 38 
H10 10244 2568 8898 21 
H11 10644 329 7704 21 
H13 12059 3745 5544 23 
H14 11607 5997 6729 22 
H1O               3440(40) 9160(40) 8510(30) 53(9) 
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Table 3.18 Torsion angles [°] for anti-3.5m. 
O1-C3-C4-C7  -64.93(19) 
C2-C3-C4-C7  173.92(15) 
O1-C3-C4-C5  175.03(15) 
C2-C3-C4-C5  53.88(19) 
C7-C4-C5-N1  -176.83(14) 
C3-C4-C5-N1  -54.94(18) 
C3-C4-C7-C8  133.9(2) 
C5-C4-C7-C8  -106.1(2) 
C14-C9-C10-C11 -0.4(3) 
S1-C9-C10-C11 177.74(13) 
C9-C10-C11-C12 0.7(3) 
C10-C11-C12-C13 -0.5(3) 
C10-C11-C12-N2 179.74(15) 
C11-C12-C13-C14 -0.1(3) 
N2-C12-C13-C14 179.63(16) 
C12-C13-C14-C9 0.5(3) 
C10-C9-C14-C13 -0.3(3) 
S1-C9-C14-C13 -178.32(14) 
C4-C5-N1-C1  60.42(19) 
C4-C5-N1-S1  -136.40(13) 
C6-C1-N1-C5  67.8(2) 
C2-C1-N1-C5  -57.54(18) 
C6-C1-N1-S1  -94.63(17) 
C2-C1-N1-S1  140.00(13) 
C13-C12-N2-O5 4.9(2) 
C11-C12-N2-O5 -175.34(16) 
C13-C12-N2-O4 -175.18(17) 
C11-C12-N2-O4 4.6(2) 
C5-N1-S1-O2  176.14(13) 
C1-N1-S1-O2  -21.90(16) 
C5-N1-S1-O3  45.63(15) 
C1-N1-S1-O3  -152.41(13) 
C5-N1-S1-C9  -68.20(15) 
C1-N1-S1-C9       93.77(15) 
C14-C9-S1-O2 -151.51(14) 
C10-C9-S1-O2 30.38(16) 
C14-C9-S1-O3 -22.60(16) 
C10-C9-S1-O3 159.29(14) 
C14-C9-S1-N1 92.59(15) 
C10-C9-S1-N1 -85.52(15)
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Table 3.19 Hydrogen bonds for anti-3.5m [Å and °]. 
 
 D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
 
 O1-H1O...O3#1 0.84(3) 2.06(4) 2.872(2) 163(3) 
 
Symmetry transformations used to generate equivalent atoms:  
#1 x-1,y,z
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Figure 3.2 View of anti-3.5m showing the atom labeling scheme. Displacement 
ellipsoids are scaled to the 50% probability level. 
 
 
 
 
 
             213 
 
Chapter 4: Total Synthesis of (+)-SCH 351448: Efficiency via 
Chemoselectivity and Redox-Economy Powered by Metal Catalysis* 
4.1 INTRODUCTION 
Chemoselectivity (site-selectivity),1 the ability to discriminate between like or 
unlike functional groups, and redox-economy2 have the greatest potential to impact step-
economy, which may be considered the primary indicator of strategic efficiency3 among 
the many issues of selectivity that impact chemical synthesis. In the syntheses of complex 
molecules, using protecting groups and discrete oxidation level adjustments, which could 
be precluded by chemoselective and redox-economic methods, may account for over half 
the total steps.4-6 Taking advantages of these strategies, the Krische group has developed a 
lexicon of catalytic methods7 for the direct stereo- and site-selective conversion of lower 
alcohols to higher alcohols, as well as related carbonyl reductive couplings mediated by 2-
propanol.7 These methods bypass discrete alcohol-to-carbonyl redox reactions and use of 
premetalated C-nucleophiles and have been shown to streamline the synthesis of diverse 
polyketide natural products.7d  
The type I polyketide (+)-SCH 351448,8,9 an ionophoric macrodiolide bearing 14 
stereogenic centers, is an ideal vehicle to demonstrate the impact of redox-economy and 
chemoselectivity on synthetic efficiency, as eight elegant prior syntheses are available to 
serve as benchmarks (Figure 4.1).10-12  
Previously, 22-32 steps (LLS) were required to construct (+)-SCH 351448.10-12 
Through the use of exclusive chemoselectivity (site-selective modification of one 
functional group in the presence of multiple like/unlike functional groups), inclusive 
chemoselectivity (concomitant modification of multiple like/unlike functional groups) and 
                                                 
* Adapted with the permission from (Wang, G.; Krische, M. J. J. Am. Chem. Soc. 2016, 138, 8088.). 
Copyright (2016) American Chemical Society. 
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redox-economic methods, (+)-SCH 351448, is now prepared in only 14 steps (LLS). An 
analysis of reaction type for past and present syntheses suggest the accumulation of 
chemoselective and redox-economic processes manifest in the present route as an increased 
proportion of skeletal construction events, an outcome that is better aligned with the ideals 
of synthetic efficiency.13 
 
 
Figure 4.1 The type I polyketide (+)-SCH 351448, depiction of the sodium ion binding 
motif adapted from single crystal X-ray diffraction data and summary of 
synthetic work.a  
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(+)-SCH 351448, a secondary metabolite of Micromonospora sp. bacteria, was 
identified in connection with a bioassay-guided fractionation aimed at the identification of 
cholesterol reducing agents.8 Specifically, (+)-SCH 351448 is a selective activator of low 
density lipoprotein receptor (LDL-R) promoter (IC50 = 25 μM). As increased expression of 
LDL-R decreases blood serum cholesterol levels,14 (+)-SCH 351448, the first small 
molecule activator of the LDL-R promoter, has garnered interest from synthetic chemists 
as a potential starting point for the design of therapeutic agents for the treatment of 
hypercholesterolemia.10-12 
4.2 RETROSYNTHETIC ANALYSIS 
The following retrosynthetic analysis of (+)-SCH 351448 was envisioned (Scheme 
4.1). The symmetric macrodiolide is assembled from Fragments A and B via esterification 
and cross-metathesis/RCM reactions.15 For the synthesis of Fragment A, 4 consecutive 
metal catalyzed reactions are employed: cross-metathesis to form alcohol 4.2,15,18 tandem 
nucleophilic16a,b and electrophilic17 allylations to convert alcohol 4.2 to pyran 4.418 and the 
Suzuki cross-coupling of pyran 4.4 with aryl triflate 4.5.19 Fragment B is prepared in 8 
steps from 5-hexen-1-ol 4.1. Key transformations include Kiyooka’s variant of the 
enantioselective Mukaiyama aldol reaction (applied to aldehyde 4.6)20 followed by Fuwa’s 
cascading cross-metathesis-oxa-Michael cyclization21,22 to form pyran 4.8, with upon 
sequential asymmetric transfer hydrogenative allylation16a,b and crotylation16c,d deliver to 
Fragment B. The proposed synthesis of (+)-SCH 351448 depends on the implementation 
of several chemoselective and redox-economic transformations. For example, the C-H 
allylation of alcohol 4.2 avoids discrete alcohol-to-carbonyl redox reactions and requires 
chemoselective ionization of allylic carboxylate groups. The hydroboration of pyran 4.4 
requires discrimination between allylic vs homoallylic terminal olefin moieties. The two-
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step conversion of aldehyde 4.6 to pyran 4.8 occurs in the absence of redox reactions, 
whereas the final step of the synthesis, the concomitant hydrogenation and hydrogenolysis 
of six functional groups (two olefins, two benzyl ethers, two benzyl esters), represents a 
redox event that embodies a high degree of inclusive chemoselectivity. Although the 
endgames differ, it should be noted that Fragments A and B appears as intermediates in 
total syntheses by Lee (4 vs 16 steps)10a,b and Panek (8 vs 18 steps),10h respectively. 
 
 
Scheme 4.1 Retrosynthetic analysis of (+)-SCH 351448. 
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4.3 SYNTHESIS OF FRAGMENT A. 
The synthesis of Fragment A is achieved using 4 consecutive metal catalyzed 
transformations (Scheme 4.2). Cross-metathesis of 5-hexen-1-ol 4.1 with cis-1,4-
diacetoxy-2-butene18 using the second generation Grubbs catalyst15,23 delivers the allylic 
acetate 4.2 in 87% yield as a 7:1 mixture of alkene E:Z stereoisomers. Transfer 
hydrogenative C-allylation of allylic acetate 4.2 using allyl acetate as the allyl donor 
provides the homoallylic alcohol 4.3 in 62% yield and 96% enantiomeric excess. Here, 
chemoselective activation of allylic acetates is achieved by virtue of the fact that the 
stability of late transition metal-olefin π-complex decreases with increasing degree of 
olefin substitution.24 Tsuji-Trost cyclization17 converts the homoallylic alcohol 4.3 to the 
2,6-cis-disubstituted pyran 4.4 with good levels of diastereoselectivity, as determined by 
1H NMR analysis.18 The Suzuki cross-coupling of pyran 4.4 with aryl triflate 4.5 requires 
chemoselective hydroboration of allylic vs homoallylic ethers. Due to the negative 
inductive effect of the pyran oxygen, the alkene moiety of the homoallylic ether undergoes 
selective hydroboration with 9-BBN, enabling formation of Fragment A in 55% yield, 
along with a 21% yield of recovered pyran 4.4. Thus, Fragment A, previously made in 16 
steps (LLS),10a,b is now made in four steps (LLS).  
4.4 SYNTHESIS OF FRAGMENT B. 
The synthesis of Fragment B begins with Moffatt-Swern oxidation of 5-pentenol 
4.1 (Scheme 4.3).25 The resulting aldehyde 4.6 is subjected to Kiyooka’s variant of the 
enantioselective Mukaiyama aldol reaction20 to furnish the neopentyl alcohol 4.7 in 70% 
yield and 93% ee. In alignment with Fuwa’s observations,21,22 cross-metathesis of 
unsaturated alcohol 4.7 with crotonaldehyde in the presence of substoichiometric quantities 
of (S)-camphorsulfonic acid using the second-generation Hoveyda-Grubbs catalyst occurs 
with spontaneous oxa-Michael cyclization to furnish the 2,6-disubstituted pyran 4.8 as a 
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single diastereomer, as determined by 1H NMR analysis. Exposure of aldehyde 4.8 to 
conditions for allylation via 2-propanol mediated for transfer hydrogenation enabled 
formation of homoallylic alcohol 4.9, which upon benzylation and ozonolysis delivered 
aldehyde 4.10. Transfer hydrogenative crotylation of 4.10 provided the homoallylic 
alcohol 4.11 with good levels of anti-diastereoselectivity (12:1 dr) accompanied by 
complete levels of stereocontrol at the newly formed carbinol stereocenter. Conversion to 
the TBS ether completes the synthesis of Fragment B in a total of eight steps (LLS). 
Previously, Fragment B was prepared in 18 steps (LLS).10h 
 
 
Scheme 4.2 Synthesis of Fragment A using four consecutive metal catalyzed 
transformations.a   
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Scheme 4.3 Synthesis of Fragment B.a 
4.5 UNION OF FRAGMENTS A AND B AND TOTAL SYNTHESIS OF (+)-SCH 351448. 
The assembly of Fragments A and B to form (+)-SCH 351448 is accomplished in 
a step-wise manner through successive esterification and cross-metathesis reactions 
(Scheme 4.4). Initial attempts at the cross-metathesis of Fragments A and B using 
conditions reported by Panek suffered from competing isomerization.10h,26 Using the 
second generation Hoveyda-Grubbs catalyst in combination with 1,4-benzoquinone,27 the 
desired product of cross-metathesis 4.12 could be formed in 53% yield. Exposure of 
compound 4.12 to the secondary alcohol 4.11 in the presence of sodium 
hexamethyldisilazide (NaHMDS) provided the product of transesterification 4.13 in 80% 
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yield. This transformation was very sensitive to moisture and optimal results required use 
of reactants dried through repeated evaporation from benzene. Removal of the TBS 
protecting group followed by a second transesterification provided compound 4.14 in 85% 
yield. Ring-closing metathesis followed by concomitant hydrogenation and hydrogenolysis 
of the two olefins, two benzyl ethers and two benzylic esters (inclusive chemoselectivity) 
provides (+)-SCH 351448 in 14 steps (LLS).28 
 
Scheme 4.4 Union of Fragments A and B and total synthesis of (+)-SCH 351448.a  
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4.6 CONCLUSION 
In summary, as the macrodiolide ionophore (+)-SCH 351448, a type I polyketide 
bearing 14 stereogenic centers, is prepared in 14 steps (LLS). In eight prior syntheses, 
22−32 steps (LLS) were required. An analysis of reaction type across each route suggests 
enhanced efficiency may be attributed to the use of multiple chemoselective and redox-
economic2 functional group interconversions, a conclusion that adds clarity vis-à-vis 
strategy selection amid an ever-expanding and evolving lexicon of synthetic methods. 
Future studies will focus on the discovery, development, and application of catalytic 
methods for protecting-group-free skeletal assembly that merge redox and C−C bond 
construction events.2  
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4.7 EXPERIMENTAL DETAILS 
Summaries of Previous Syntheses: 
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General Information 
All reactions were carried out in oven- or flame-dried flasks, under an inert atmosphere of argon or 
nitrogen if anhydrous conditions were required. Anhydrous solvents were transferred by oven-dried 
syringes and needles. Reagents obtained from Acros, Sigma-Aldrich, Alfa Aesar, Fisher Scientific, 
Takasago, Oakwood, or Strem Fine Chemicals suppliers were used directly as supplied or following 
purification according to procedures described by Amarego and Chai.29 Tetrahydrofuran, 
dichloromethane, diethyl ether, and toluene were distilled prior to use. Thin layer chromatography 
(TLC) was performed on Dynamic Adsorbents F254 0.25 mm precoated silica gel plates. 
Compounds were visualised under UV light and by staining with potassium permanganate, or para-
anisaldehyde solution. Flash column chromatography was performed using silica gel (40–63 μm, 
Silicycle) and using head pressure by means of a positive pressure from an air line, according to 
Still.30 Infra-red spectra were recorded on a Thermo Nicolet 380 spectrometer. High-resolution 
mass spectra were recorded on an Agilent Technologies 6530 Accurate Mass Q-Tof LC/MS 
instrument for electrospray ionisation (ESI) or a Micromass Autospec Ultima instrument for 
chemical ionization (CI) and are reported as a ratio of mass to charge (m/z) in Daltons. Specific 
optical rotations were recorded on an Atago AP-300 automatic polarimeter at the sodium line 
(589.3 nm) in CHCl3. Solution concentrations are given in the units of 10-2 g mL-1. 1H NMR spectra 
were recorded on an Agilent MR (400 MHz), Varian DirectDrive (400 MHz) spectrometer in 
CDCl3 or CD2Cl2 at ambient temperature. Chemical shifts are quoted to two decimal places in parts 
per million (ppm) with splittings recorded as singlet (s), doublet (d), triplet (t), quartet (q), quintet 
(quin) and multiplet (m). Coupling constants, J, are quoted to one decimal place in Hz. 13C NMR 
spectra were recorded on an Agilent MR (100 MHz), Varian DirectDrive (100 MHz spectrometer 
in CDCl3 or CD2Cl2 with broadband decoupling. Chemical shifts are quoted to one decimal place 
in parts per million (ppm). All NMR chemical shifts were referenced to residual solvent peaks 
(CDCl3, δH 7.26 ppm, δC 77.0 ppm; CD2Cl2 δH 5.32 ppm, δC 53.8 ppm).  
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Experimental Procedure and Characterization of Intermediates: 
(E)-7-hydroxyhept-2-en-1-yl acetate (4.2) 
 
To a sealed tube under an argon atmosphere charged with hex-5-en-1-ol (4.1) (400.6 mg, 
4.00 mmol, 100 mol%) and cis-1,4-diacetoxy-2-butene (688.7 mg, 16.00 mmol, 400 mol%) 
was added freshly distilled CH2Cl2 (22 mL, 0.18 M). The Grubbs’ second generation 
catalyst [Cl2(PCy3)(IMes)Ru=CHPh] (101.9 mg, 0.12 mmol, 3 mol%) was added in one 
portion. The septum was quickly replaced with a screw cap, and the reaction mixture was 
allowed to stir in an oil bath at 50 oC for 20 h. The reaction mixture was allowed to cool 
ambient temperature, was concentrated in vacuo. The residue was subjected to flash 
column chromatography (SiO2: hexane/ethyl acetate, 4:1 to 2:1) to furnish the title product 
4.2 in 87% yield (600 mg, 3.48 mmol, E:Z=7:1). Spectral data is reported for the major 
isomer. 
1H NMR (400 MHz, CDCl3) δ 5.82–5.71 (m, 1H), 5.58 (dtt, J = 15.6, 6.5, 1.4 Hz, 1H), 
4.51 (dd, J = 6.5, 1.1 Hz, 2H), 3.65 (t, J = 6.4 Hz, 2H), 2.14–2.07 (m, 2H), 2.06 (s, 3H), 
1.64–1.53 (m, 2H), 1.52–1.44 (m, 2H), 1.40 (br s, 1H). 
 
13C NMR (100 MHz, CDCl3) δ 171.0, 136.2, 124.3, 65.3, 62.8, 32.3, 32.1, 25.1, 21.1. 
 
HRMS (ESI) Calcd. for C9H16O3Na [M+Na]
+: 195.0992, Found: 195.0996.  
 
FTIR (neat): 3381, 2934, 1736, 1364, 1227, 1023, 969 cm-1.  
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(R,E)-7-hydroxydeca-2, 9-dien-1-yl acetate (4.3) 
 
 
 
To a sealed tube under an argon atmosphere charged with alcohol 4.2 (390.0 mg, 2.27 
mmol, 100 mol%), [Ir(cod)Cl]2 (38.3 mg, 0.057mmol, 2.5 mol%), (S)-BINAP (71.0 mg, 
0.114 mmol, 5.0 mol%), Cs2CO3 (148.0 mg, 0.45 mmol, 20 mol%) and 4-CN-3-NO2-
BzOH (39.3 mg, 0.23 mmol, 10 mol%) was added freshly distilled THF (11.4 mL, 0.2 M) 
and allyl acetate (454.5 mg, 4.54 mmol, 200 mol%). The septum was quickly replaced with 
a screw cap and the reaction mixture was allowed to stir in an oil bath at 100 °C for 72 h. 
The reaction mixture was allowed to cool to ambient temperature, and was concentrated in 
vacuo. The residue was subjected to flash column chromatography (SiO2: hexane/ethyl 
acetate, 8:1 to 4:1) to furnish the title product 4.3 in 62% yield (298.8 mg, 1.41 mmol, 96% 
ee), catalyst was recovered using DCM/ether, 4:1. 
1H NMR (400 MHz, CDCl3) δ 5.90–5.73 (m, 2H), 5.58 (dtt, J = 15.4, 6.6, 1.4 Hz, 1H), 
5.23–5.09 (m, 2H), 4.51 (dt, J = 6.5, 1.0 Hz, 2H), 3.72–3.61 (m, 1H), 2.31 (dddt, J = 13.7, 
6.2, 4.2, 1.3 Hz, 1H), 2.19–2.07 (m, 3H), 2.06 (s, 3H), 1.71 (br s, 1H), 1.63–1.53 (m, 1H), 
1.53–1.43 (m, 3H). 
13C NMR (100 MHz, CDCl3) δ 171.0, 136.3, 134.9, 124.3, 118.4, 70.6, 65.4, 42.1, 36.3, 
32.3, 25.1, 21.2. 
HRMS (ESI) Calcd. for C12H20O3Na [M+Na]
+: 235.1305, Found: 235.1309.  
FTIR (neat): 3420, 2933, 1738, 1437, 1363, 1231, 1024, 969, 913 cm-1.  
HPLC: (Chiralcel AD-H column, hexanes:i-PrOH = 87:13, 1.00 mL/min, 254 nm), ee 
=96% (Alcohol 3 was protected with benzyl group). 
[]20D = +10.00 ° (c 1.0, CHCl3).  
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(2R,6S)-2-allyl-6-vinyltetrahydro-2H-pyran (4.4) 
 
To a sealed tube under an argon atmosphere charged with Pd(PPh3)4 (208.0 mg, 0.18 mmol, 
18 mol%) and toluene (8.30 mL) was added Et3N (202.4 mg, 2.0 mmol, 200 mol%). 
Alcohol 4.3 in toluene (4.2 mL) was added to the reaction mixture. The reaction mixture 
was allowed to stir for at 30 °C for 48 h. The reaction mixture was directly subjected to 
flash column chromatography (SiO2: hexane/ethyl acetate, 100:0 to 25:1) to furnish the 
title product 4.4 in 65% yield (98.9 mg, 0.65 mmol, 6:1 dr).  
 
1H NMR (400 MHz, CDCl3) δ 5.94–5.79 (m, 2H), 5.24 (dt, J = 17.3, 1.7 Hz, 1H), 5.13–
4.99 (m, 3H), 3.83 (dddd, J = 10.7, 5.3, 2.6, 1.5 Hz, 1H), 3.40 (dtd, J = 11.2, 6.3, 2.0 Hz, 
1H), 2.37 (dtt, J = 14.3, 6.5, 1.5 Hz, 1H), 2.20 (dddt, J = 14.0, 7.6, 6.4, 1.2 Hz, 1H), 1.92–
1.80 (m, 1H), 1.70–1.57 (m, 2H), 1.52 (tt, J = 13.0, 3.9 Hz, 1H), 1.37–1.14 (m, 2H). 
 
13C NMR (100 MHz, CDCl3) δ 139.7, 135.2, 116.6, 114.5, 78.4, 77.4, 41.2, 31.5, 30.9, 
23.6. 
 
HRMS (CI) Calcd. for C10H17O [M+H]
+: 153.1279, Found: 153.1278.  
 
FTIR (neat): 3075, 2935, 2844, 1642, 1434, 1200, 1083, 1046, 994, 914, 696 cm-1.  
 
[]20D = -4.70 ° (c 1.0, CHCl3).  
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2,2-dimethyl-5-(3-((2S,6S)-6-vinyltetrahydro-2H-pyran-2-yl)propyl)-4H-
benzo[d][1,3]dioxin-4-one (Fragment A) 
 
 
 
A flask was charged with diene 4.4 (343.0 mg, 2.25 mmol, 100 mol%) and 2.25 mL (1 M) 
fresh distilled THF. The flask was cooled to 0 °C for 5 min. 9-BBN (5.86 mL, 2.93 mmol, 
130 mol%) was added dropwise over 1h. The reaction mixture was stirred at 0 °C for 0.5 
h, and then gradually warmed to ambient temperature. After 4 h, KF (784.0 mg, 13.5 mmol, 
600 mol%), 2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-5-yl trifluoromethanesulfonate 
(5)31 (1100.0 mg, 3.375 mmol, 150 mol%), PdCl2(dppf) (82.7 mg, 0.11 mmol, 5 mol%) 
and H2O (486.0 mg, 27.0 mmol, 1200 mol%) in 9.0 mL DMF was added to the reaction 
mixture. The resulting solution was stirred at ambient temperature for 16 h. EtOAc and 
H2O (25 mL : 25 mL) were added to the reaction mixture. The organic layer was washed 
with 25 mL H2O three times. Dried with Na2SO4, and concentrated under vacuo. The 
residue was subjected to flash column chromatography (SiO2: hexane/ethyl acetate, 50:1 
to 25:1) to furnish the title product Fragment A in 55% yield (409.0 mg, 1.24 mmol) with 
21% diene 4.4 (72.0 mg, 0.47 mmol) recovered. 
 
1H NMR (400 MHz, CDCl3) δ 7.39 (dd, J = 8.2, 7.6 Hz, 1H), 6.94 (dd, J = 7.7, 1.2 Hz, 
1H), 6.79 (dd, J = 8.2, 1.2 Hz, 1H), 5.85 (ddd, J = 17.4, 10.6, 5.4 Hz, 1H), 5.22 (dt, J = 
17.4, 1.7 Hz, 1H), 5.06 (dt, J = 10.6, 1.6 Hz, 1H), 3.84–3.76 (m, 1H), 3.41–3.33 (m, 1H), 
3.17–3.03 (m, 2H), 1.92–1.80 (m, 1H), 1.79–1.45 (m, 13H), 1.34–1.13 (m, 2H). 
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13C NMR (100 MHz, CDCl3) δ 160.4, 157.3, 148.3, 139.9, 135.2, 125.4, 115.3, 114.4, 
112.2, 105.1, 78.4, 77.8, 36.5, 34.4, 31.6, 31.4, 27.2, 25.8, 25.8, 23.7. 
 
HRMS (ESI) Calcd. for C20H26O4Na [M+Na]
+: 353.1723, Found: 353.1729.  
 
FTIR (neat): 2992, 2932, 2858, 1736, 1695, 1605, 1582, 1476, 1389, 1378, 1313, 1269, 
1208, 1074, 1043, 923, 808, 777, 698 cm-1. 
 
[]20D = -12.67 ° (c 0.5, CHCl3). 
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Benzyl (R)-3-hydroxy-2,2-dimethyloct-7-enoate (4.7) 
 
 
BH3·THF (1.0 M in THF, 11.0 mL, 11.0 mmol) was added dropwise to N-tosyl-L-valine
31 
(1 step, 2984.3 mg, 11.0 mmol, 100 mol%) in DCM (0.1 M, 110.0 mL) at room temperature 
over 30 min. Then a solution of 5-hexenal32 (1 step, 1080.0 mg, 11.0 mmol, 100 mol%) in 
DCM (11.0 mL) and ((1-(benzyloxy)-2-methylprop-1-en-1-yl)oxy)trimethylsilane33 (1 
step, 3055.0 mg, 12.2 mmol, 110 mol%) were added to the resulting solution at -78 °C. 
After stirring for 4 h, the reaction was quenched at -78 °C by addition of a pH 7.0 buffer 
solution (115 mL). The resulting mixture was extracted with DCM (3 X 77.0 mL), and the 
combined organic extracts were washed with brine (150 mL) and concentrated under 
reduced pressure. The residue was subjected to flash column chromatography (SiO2: 
hexane/ethyl acetate, 20:1 to 10:1) to furnish the title product 4.7 in 70% yield (2128.0 mg, 
7.7 mmol, 93% ee). 
 
1H NMR (400 MHz, CDCl3) δ 7.42–7.28 (m, 5H), 5.78 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 
5.14 (s, 2H), 5.03–4.91 (m, 2H), 3.63 (ddd, J = 10.4, 6.9, 1.8 Hz, 1H), 2.37–2.34 (m, 1H), 
2.04 (dtt, J = 13.3, 6.8, 1.4 Hz, 2H), 1.73–1.64 (m, 1H), 1.47–1.34 (m, 2H), 1.31–1.22 (m, 
1H), 1.20 (d, J = 2.4 Hz, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 177.4, 138.6, 135.9, 128.6, 128.2, 127.9, 114.6, 76.5, 66.3, 
47.3, 33.5, 31.1, 25.9, 22.2, 20.4. 
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HRMS (ESI) Calcd. for C17H24O3Na [M+Na]
+: 299.1618, Found: 299.1619.  
 
FTIR (neat): 3504, 2976, 2937, 1720, 1455, 1390, 1263, 1213, 1133, 1078, 1029, 993, 
969, 911, 750, 697 cm-1.  
 
HPLC: (Chiralcel OD-H column, hexanes:i-PrOH = 95:5, 1.00 mL/min, 254 nm), ee 
=93%. 
 
[]20D = +11.11 ° (c 0.9, CHCl3). 
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Benzyl 2-methyl-2-((2R,6S)-6-(2-oxoethyl)tetrahydro-2H-pyran-2-yl)propanoate 
(4.8) 
 
 
 
 
A flame dried flask was charged Hoveyda-Grubbs’ 2nd catalyst (551.4 mg, 0.88 mmol, 10 
mol%) and (S)-camphorsulfonic acid (204.3 mg, 0.88 mmol, 10 mol%). The flask was 
sealed with a septum and purged with Ar, then freshly distilled CH2Cl2 (0.2 M, 44 mL) 
was added. Alcohol 4.7 (2432 mg, 8.8 mmol, 100 mol%) and crotonaldehyde (2467 mg, 
35.2 mmol, 400 mol%) were added. The resulting mixture was stirred at 35 °C for 10 h. 
The crude mixture was cooled down to ambient temperature, concentrated under vacuo. 
The residue was subjected to flash column chromatography (SiO2: hexane/ethyl acetate, 
20:1 to 10:1) to furnish the title product 4.8 in 85% yield (2277.0 mg, 7.48 mmol, >20:1 
dr). 
 
1H NMR (400 MHz, CDCl3) δ 9.65 (dd, J = 2.7, 2.0 Hz, 1H), 7.40–7.26 (m, 5H), 5.13 (d, 
J = 12.6 Hz, 1H), 5.07 (d, J = 12.6 Hz, 1H), 3.84–3.76 (m, 1H), 3.60 (dd, J = 11.4, 1.9 Hz, 
1H), 2.48–2.31 (m, 2H), 1.92–1.83 (m, 1H), 1.60–1.43 (m, 3H), 1.32–1.19 (m, 2H), 1.18 
(s, 3H), 1.13 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 201.7, 176.4, 136.4, 128.4, 128.0, 127.9, 82.4, 73.6, 66.1, 
49.7, 46.6, 31.2, 24.7, 23.3, 21.2, 20.0. 
 
HRMS (ESI) Calcd. for C18H24O4Na [M+Na]
+: 327.1567, Found: 327.1576.  
 
FTIR (neat): 2940, 2860,1727, 1497, 1455, 1391, 1265, 1134, 1085, 1048, 976, 749, 697 
cm-1.  
 
[]20D = -3.30° (c 1.0, CHCl3).  
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Benzyl 2-((2R,6S)-6-((R)-2-hydroxypent-4-en-1-yl)tetrahydro-2H-pyran-2-yl)-2-
methylpropanoate (4.9) 
 
To a sealed tube under an argon atmosphere charged with aldehyde 4.8 (304.4 mg, 1.00 
mmol, 100 mol%), [Ir(cod)Cl]2 (16.8 mg, 0.025 mmol, 2.5 mol%), (R)-BINAP (31.1 mg, 
0.05 mmol, 5.0 mol%), 2-PrOH (180.3 mg, 3.00 mmol, 300 mol%), Cs2CO3 (65.1 mg, 0.20 
mmol, 20 mol%) and 4-Cl-3-NO2-BzOH (20.16 mg, 0.10 mmol, 10 mol%) was added 
freshly distilled THF (5.0 mL, 0.2 M) and allyl acetate (200.2 mg, 2.00 mmol, 200 mol%). 
The reaction mixture was allowed to stir under microwave condition at 100 °C for 6 h. The 
reaction mixture was allowed to cool to ambient temperature, and was concentrated in 
vacuo. The residue was subjected to flash column chromatography (SiO2: hexane/ethyl 
acetate, 15:1 to 8:1) to furnish the title product 4.9 in 82% yield (284.1 mg, 0.82 
mmol, >20:1 dr). 
 
1H NMR (400 MHz, CDCl3) δ 7.38–7.28 (m, 5H), 5.83 (ddt, J = 17.2, 10.2, 7.1 Hz, 1H), 
5.21–5.02 (m, 4H), 3.82–3.74 (m, 1H), 3.61 (dd, J = 11.3, 1.8 Hz, 1H), 3.58–3.51 (m, 2H), 
2.30–2.21 (m, 1H), 2.19–2.11 (m, 1H), 1.89–1.79 (m, 1H), 1.60–1.43 (m, 5H), 1.33–1.21 
(m, 2H), 1.20 (s, 3H), 1.15 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 176.4, 136.2, 135.2, 128.4, 128.1, 128.0, 116.9, 82.7, 79.8, 
71.3, 66.4, 46.6, 42.1, 41.9, 31.9, 24.8, 23.2, 21.5, 20.1. 
HRMS (ESI) Calcd. for C21H30O4Na [M+Na]
+: 369.2036, Found: 369.2043.  
FTIR (neat): 2936, 2860, 1730, 1639, 1455, 1392, 1262, 1140, 1084, 1045, 914, 750, 697 
cm-1.  
[]20D = +2.00° (c 1.0, CHCl3).  
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Benzyl 2-((2R,6S)-6-((R)-2-(benzyloxy)pent-4-en-1-yl)tetrahydro-2H-pyran-2-yl)-2-
methylpropanoate 
 
 
 
A flame dried flask was charged with alcohol 4.9 (2222.2 mg, 6.41 mmol, 100 mol%) in 
THF (74.0 mL) and DMF (18.5 mL) at 0 °C. BnBr (1645.3 mg, 9.62 mmol, 150 mol%) 
was added to the solution followed by NaHMDS (1.0 M in THF, 10.3 mL, 10.3 mmol, 160 
mol%) at 0 °C. The reaction mixture was warmed to room temperature. After 12 h, the 
reaction was quenched with 1 N HCl solution (100 mL), and the aqueous layer was 
extracted with ether (3 X 100 mL). The combined organic extracts were washed with brine 
(200 mL), dried over Na2SO4, filtered and was concentrated in vacuo. The residue was 
subjected to flash column chromatography (SiO2: hexane/ethyl acetate, 60:1 to 30:1) to 
furnish the title product in 90% yield (2518.7 mg, 5.77 mmol). 
1H NMR (400 MHz, CDCl3) δ 7.37–7.24 (m, 10H), 5.85 (ddt, J = 17.2, 10.2, 7.0 Hz, 1H), 
5.13–5.02 (m, 4H), 4.47 (dd, J = 11.7 Hz, 2H), 3.62–3.56 (m, 1H), 3.53 (dd, J = 11.3, 1.8 
Hz, 1H), 3.45–3.38 (m, 1H), 2.41–2.32 (m, 1H), 2.31–2.22 (m, 1H), 1.88–1.77 (m, 2H), 
1.58–1.50 (m, 1H), 1.49–1.39 (m, 3H), 1.30–1.21 (m, 2H), 1.20 (s, 3H), 1.13 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 176.7, 138.9, 136.4, 135.1, 128.4, 128.2, 127.9, 127.7, 
127.7, 127.4, 116.8, 82.2, 75.4, 74.9, 70.7, 66.0, 46.8, 40.2, 38.0, 31.7, 25.2, 23.6, 21.2, 
20.5. 
HRMS (ESI) Calcd. for C28H36O4Na [M+Na]
+: 459.2506, Found: 459.2511.  
FTIR (neat): 2931, 2858, 2322, 1731, 1640, 1454, 1264, 1134, 1088, 1047, 911, 796, 
735, 696, 669 cm-1.  
[]20D = -20.00° (c 0.4, CHCl3).  
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Benzyl 2-((2R,6S)-6-((S)-2-(benzyloxy)-4-oxobutyl)tetrahydro-2H-pyran-2-yl)-2-
methylpropanoate (4.10) 
 
 
 
 
A flask was charged with alkene (2310.0 mg, 5.29 mmol, 100 mol%) and freshly distilled 
DCM (88.2 mL, 0.06 M) was added at -78 °C. Ozone was bubbled through the solution for 
about 15 min at -78 °C. Argon was bubbled through the solution to remove the ozone, then 
PPh3 (4170.3 mg, 15.9 mmol, 300 mol%) was added to the solution. The reaction mixture 
was gradually warmed to room temperature and stirred overnight. The solution was 
concentrated in vacuo and the residue was subjected to flash column chromatography 
(SiO2: hexane/ethyl acetate, 20:1 to 10:1) to furnish the title product 4.10 in 83% yield 
(1925.6 mg, 4.39 mmol). 
1H NMR (400 MHz, CDCl3) δ 9.69 (t, J = 2.2 Hz, 1H), 7.36–7.26 (m, 10H), 5.12 (d, J = 
12.7 Hz, 1H), 5.07 (d, J = 12.6 Hz, 1H), 4.51 (d, J = 11.6 Hz, 1H), 4.43 (d, J = 11.6 Hz, 
1H), 4.12–4.03 (m, 1H), 3.55 (dd, J = 11.4, 1.8 Hz, 1H), 3.45–3.38 (m, 1H), 2.62–2.56 (m, 
2H), 1.95–1.81 (m, 2H), 1.65–1.56 (m, 1H), 1.51–1.42 (m, 3H), 1.32–1.20 (m, 2H), 1.19 
(s, 3H), 1.13 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 201.9, 176.6, 138.3, 136.3, 128.5, 128.4, 127.9, 127.7, 
127.7, 127.6, 82.2, 74.4, 71.6, 70.9, 66.0, 48.0, 46.7, 39.9, 31.8, 25.0, 23.5, 21.5, 20.2. 
HRMS (ESI) Calcd. for C27H34O5Na [M+Na]
+: 461.2298, Found: 461.2294.  
FTIR(neat): 2941, 2860, 1727, 1455, 1391, 1265, 1163, 1138, 1087, 1050, 735, 697 cm-1.  
[]20D = +8.33° (c 1.0, CHCl3).  
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Benzyl 2-((2R,6S)-6-((2R,4R,5S)-2-(benzyloxy)-4-hydroxy-5-methylhept-6-en-1-
yl)tetra-hydro-2H-pyran-2-yl)-2-methylpropanoate (4.11) 
 
To a sealed tube under an argon atmosphere charged with aldehyde 4.10 (200.0 mg, 0.46 
mmol, 100 mol%), (S)-Ir-SEGPHOS (23.5 mg, 0.023 mmol, 5.0 mol%), 2-PrOH (55.3 mg, 
0.92 mmol, 200 mol%), K2CO3 (31.8 mg, 0.23 mmol, 50 mol%) and H2O (41.4 mg, 2.30 
mmol, 500 mol%) was added freshly distilled THF (0.23 mL, 2.0 M) and α-Me-AllyOAc 
(105.0 mg, 0.92 mmol, 200 mol%). The septum was quickly replaced with a screw cap and 
the reaction mixture was allowed to stir in an oil bath at 60 °C for 48 h. The reaction 
mixture was allowed to cool to ambient temperature, and was concentrated in vacuo. The 
residue was subjected to flash column chromatography (SiO2: hexane/ethyl acetate, 30:1 
to 20:1) to furnish the title product 4.11 in 65% yield (148.0 mg, 0.30 mmol, 12:1 dr). 
 
1H NMR (400 MHz, CDCl3) δ 7.35–7.26 (m, 10H), 5.87–5.76 (m, 1H), 5.16–5.00 (m, 4H), 
4.54–4.40 (dd, J = 12.0, 11.6 Hz 2H), 3.89–3.81 (m, 1H), 3.76–3.69 (m, 1H), 3.51 (dd, J = 
11.3, 1.8 Hz, 1H), 3.38–3.29 (m, 1H), 2.73 (d, J = 3.6 Hz, 1H), 2.23–2.10 (m, 1H), 1.97–
1.78 (m, 2H), 1.73–1.39 (m, 6H), 1.32–1.10 (m, 8H), 1.02 (d, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 176.8, 140.8, 138.6, 136.5, 128.6, 128.5, 128.1, 128.0, 
127.8, 127.7, 115.3, 82.3, 75.1, 74.2, 71.5, 71.2, 66.2, 46.9, 44.2, 39.9, 37.2, 32.1, 25.2, 
23.8, 21.4, 20.5, 16.2. 
HRMS (ESI) Calcd. for C31H42O5Na [M+Na]
+: 517.2924, Found: 517.2926.  
FTIR (neat): 2937, 2858, 2322, 1731, 1496, 1454, 1391, 1265, 1196, 1137, 1087, 1049, 
913, 805, 734, 697 cm-1.  
[]20D = +8.80° (c 2.5, CHCl3).  
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Benzyl 2-((2R,6S)-6-((2S,4R,5S)-2-(benzyloxy)-4-((tert-butyldimethylsilyl)oxy)-5-
methylhept -6-en-1-yl)tetrahydro-2H-pyran-2-yl)-2-methylpropanoate 
 
 
 
2,6-Lutidine (91.8 mg, 0.856 mmol, 400 mol%) and TBSOTf (113.1mg, 0.428 mmol, 200 
mol%) were added to a solution of alcohol 4.11 (106.0 mg, 0.214 mmol, 100 mol%) in 
DCM (3.6 mL, 0.06 M) at 0 °C. After stirring for 3 h, the reaction mixture was diluted with 
DCM (4 mL) and washed with sat. NH4Cl solution (10 mL). The aqueous layer was 
extracted with DCM (3 X 10 mL). The combined organic layer was washed with brine (30 
mL), dried over Na2SO4, filtered and concentrated in vacuo. The residue was subjected to 
flash column chromatography (SiO2: hexane/ethyl acetate, 20:1) to furnish the title product 
Fragment B in 90% yield (117.3 mg, 0.193 mmol). 
 
1H NMR (400 MHz, CDCl3) δ 7.37–7.24 (m, 10H), 5.86–5.74 (m, 1H), 5.14 (d, J = 12.6 
Hz, 1H), 5.09 (d, J = 12.6 Hz, 1H), 5.05–4.98 (m, 2H), 4.48 (d, J = 11.7 Hz, 1H), 4.39 (d, 
J = 11.7 Hz, 1H), 3.91–3.85 (m, 1H), 3.71–3.63 (m, 1H), 3.51–3.45 (m, 1H), 3.40 (m, 1H), 
2.39–2.30 (m, 1H), 1.90–1.76 (m, 2H), 1.71–1.61 (m, 1H), 1.55–1.35 (m, 5H), 1.31–1.10 
(m, 8H), 1.00 (d, J = 6.8 Hz, 3H), 0.89 (s, 9H), 0.03 (d, J = 6.6 Hz, 6H). 
13C NMR (100 MHz, CDCl3) δ 176.5, 140.6, 139.2, 136.4, 128.4, 128.2, 127.9, 127.7, 
127.4, 127.2, 114.6, 82.0, 75.1, 73.2, 72.4, 69.7, 66.0, 46.8, 43.4, 41.0, 38.7, 31.6, 26.0, 
25.6, 23.7, 22.2, 20.2, 18.1, 14.1, -4.3, -4.4. 
HRMS (ESI) Calcd. for C37H56O5SiNa [M+Na]
+: 631.3804, Found: 631.3808.  
FTIR (neat): 2930, 2856, 1735, 1471, 1455, 1373, 1316, 1257, 1135, 1088, 1048, 1005, 
914, 834, 774, 733, 696 cm-1.  
[]20D = +8.67° (c 1.0, CHCl3).  
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Benzyl 2-((2S,6S)-6-((2S,4R,5S,E)-2-(benzyloxy)-4-((tert-butyldimethylsilyl)oxy)-7-
((2S,6S)-6-(3-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-5-yl)propyl)tetrahydro-
2H-pyran-2-yl)-5-methylhept-6-en-1-yl)tetrahydro-2H-pyran-2-yl)-2-
methylpropanoate (4.12) 
 
A flame dried flask under an argon atmosphere was charged with fragment A (57.0 mg, 
0.172 mmol, 150 mol%), fragment B (70.0 mg, 0.115 mmol, 100 mol%), 1,4-benzoquinone 
(1.2 mg, 0.0115 mmol, 10 mol%) and second generation Hoveyda-Grubbs catalyst (7.2 
mg, 0.0115 mmol, 10 mol%). C6H5Cl (2.90 mL, 0.04 M) was added and the resulting 
solution was heated at 85 °C for 16 h. The reaction mixture was allowed to cool to ambient 
temperature, and was concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2: hexane/acetone, 30:1) to furnish the title product 4.12 in 53% yield 
(55.5 mg, 0.061 mmol, >20:1 E:Z). 
 
1H NMR (400 MHz, CDCl3) δ 7.37–7.21 (m, 11H), 6.87 (dd, J = 7.7, 1.1 Hz, 1H), 6.77 
(dd, J = 8.2, 1.2 Hz, 1H), 5.60 (dd, J = 15.6, 6.5 Hz, 1H), 5.49 (dd, J = 15.7, 6.0 Hz, 1H), 
5.16–5.06 (m, 2H), 4.49–4.36 (m, 2H), 3.90–3.83 (m, 1H), 3.80–3.73 (m, 1H), 3.69–3.61 
(m, 1H), 3.46 (d, J = 10.2 Hz, 1H), 3.42–3.29 (m, 2H), 3.13–2.98 (m, 2H), 2.38–2.29 (m, 
1H), 1.89–1.74 (m, 3H), 1.68 (s, 6H), 1.65–1.53 (m, 6H), 1.53–1.34 (m, 7H), 1.32–1.08 
(m, 10H), 0.97 (d, J = 6.7 Hz, 3H), 0.87 (s, 9H), 0.01 (s, 6H). 
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13C NMR (100 MHz, CDCl3) δ 176.5, 160.2, 157.1, 148.1, 139.2, 136.4, 135.0, 132.8, 
131.9, 128.4, 128.2, 127.9, 127.7, 127.5, 127.4, 127.2, 125.2, 115.1, 112.0, 104.9, 82.0, 
78.4, 77.6, 75.1, 73.2, 72.4, 69.6, 65.9, 46.8, 41.9, 41.1, 38.4, 36.4, 34.3, 31.9, 31.5, 31.2, 
29.7, 27.0, 26.0, 25.7, 25.6, 23.6, 22.2, 20.2, 18.1, 13.9, -4.3, -4.4. 
 
HRMS (ESI) Calcd. for C55H78O9SiNa [M+Na]
+: 933.5307, Found: 933.5309.  
 
FTIR (neat): 2932, 2850, 1737, 1606, 1582, 1478, 1468, 1453, 1388, 1378, 1305, 1271, 
1208, 1111, 1072, 1044, 967, 927, 807, 749, 689 cm-1.  
 
[]20D = -10.00° (c 0.2, CHCl3).  
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(3S,4R,6S)-6-(benzyloxy)-7-((2S,6R)-6-(1-(benzyloxy)-2-methyl-1-oxopropan-2-
yl)tetrahydro -2H-pyran-2-yl)-3-methylhept-1-en-4-yl 2-(3-((2S,6S)-6-((3S,4R,6S,E)-
6-(benzyloxy)-7-((2S, 6S)-6-(1-(benzyloxy)-2-methyl-1-oxopropan-2-yl)tetrahydro-
2H-pyran-2-yl)-4-((tert-butyldi-methylsilyl)oxy)-3-methylhept-1-en-1-yl)tetrahydro-
2H-pyran-2-yl)propyl)-6-hydroxybenz-oate (4.13) 
 
A flame dried flask under an argon atmosphere was charged with alcohol 4.11 (37.1 mg, 
0.0751 mmol, 120 mol%) in THF (1.25 mL, 0.05 M) at 0 °C. NaHMDS (0.313 mL, 0.313 
mmol, 500 mol%) was added dropwise at 0 °C. After stirring for 30 min, the alkene 4.12 
(57.0 mg, 0.0625 mmol, 100 mol%) in dry THF (0.6 mL) was added dropwise. The reaction 
was warmed to room temperature and stirred for 1 h and then quenched with sat. NH4Cl 
solution (5.0 mL). The resulting mixture was extracted with ether (3 X 5.0 mL). The 
combined organic extracts were washed with brine (15.0 mL), dried over Na2SO4 and 
concentrated in vacuo. The residue was subjected to flash column chromatography (SiO2: 
hexane/ethyl acetate, 30:1 to 15:1) to furnish the title product 4.13 in 80% yield (67.4 mg, 
0.05 mmol). 
 
1H NMR (400 MHz, CDCl3) δ 11.19 (s, 1H), 7.35–7.21 (m, 21H), 6.80 (d, J = 8.3 Hz, 
1H), 6.64 (d, J = 7.6 Hz, 1H), 5.87–5.76 (m, 1H), 5.65–5.57 (m, 2H), 5.55–5.45 (m, 1H), 
5.13–5.02 (m, 6H), 4.49–4.28 (m, 4H), 3.91–3.84 (m, 1H), 3.76 (dd, J = 10.9, 6.0 Hz, 1H), 
3.69–3.63 (m, 1H), 3.60–3.53 (m, 1H), 3.51–3.22 (m, 5H), 2.95–2.78 (m, 2H), 2.58–2.49 
(m, 1H), 2.39–2.30 (m, 1H), 1.90–1.74 (m, 7H), 1.70–1.52 (m, 7H), 1.52–1.30 (m, 11H), 
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1.23 (s, 6H), 1.16 (d, J = 1.4 Hz, 6H), 1.06 (m, 9H), 1.01–0.95 (m, 2H), 0.88 (s, 9H), 0.01 
(s, 6H). 
 
13C NMR (100 MHz, CDCl3) δ 176.5, 176.3, 170.9, 162.4, 145.4, 139.2, 139.1, 138.5, 
136.4, 136.3, 133.8, 132.9, 131.8, 128.4, 128.3, 128.2, 128.1, 127.9, 127.9, 127.7, 127.5, 
127.5, 127.2, 122.1, 116.3, 115.6, 112.5, 82.0, 81.9, 78.6, 77.7, 76.0, 75.1, 74.5, 73.2, 72.9, 
72.4, 71.2, 69.7, 66.0, 46.8, 46.6, 42.1, 41.9, 41.2, 40.6, 38.4, 37.6, 36.8, 36.1, 32.0, 31.8, 
31.6, 31.3, 29.7, 28.0, 26.0, 25.6, 25.5, 23.6, 23.6, 22.3, 21.9, 20.2, 20.0, 18.1, 16.2, 13.8, 
-4.3, -4.4. 
 
HRMS (ESI) Calcd. for C83H114O13SiNa [M+Na]
+: 1369.7921, Found: 1369.7918.  
 
FTIR (neat): 2934, 2856, 1730, 1610, 1549, 1453, 1371, 1251, 1214, 1087, 1048, 1028, 
896, 827, 752, 697 cm-1.  
[]20D = +12.70° (c 0.5, CHCl3).  
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(3S,4R,6S)-6-(benzyloxy)-7-((2S,6R)-6-(1-(benzyloxy)-2-methyl-1-oxopropan-2-
yl)tetrahydr-o-2H-pyran-2-yl)-3-methylhept-1-en-4-yl 2-(3-((2S,6S)-6-((3S,4R,6R,E)-
6-(benzyloxy)-7-((2S, 6S)-6-(1-(benzyloxy)-2-methyl-1-oxopropan-2-yl)tetrahydro-
2H-pyran-2-yl)-4-hydroxy-3-methylhept-1-en-1-yl)tetrahydro-2H-pyran-2-
yl)propyl)-6-hydroxybenzoate 
 
 
 
To a solution of alkene 4.13 (30 mg, 0.022 mmol, 100 mol%) in THF (0.6 mL, 0.037 M) 
was added HF/Py (0.016 mL, 22.0 mmol, 100000 mol%), and the mixture was stirred at 
room temperature for 16 h. The reaction was quenched by addition of a sat. NaHCO3 (10 
mL), and extracted with ether (3 X 10 mL). The combined organic mixture was dried with 
Na2SO4 and and concentrated in vacuo. The residue was subjected to flash column 
chromatography (SiO2: hexane/ethyl acetate, 10:1 to 5:1) to furnish the title product in 90% 
yield (24.7 mg, 0.020 mmol). 
 
1H NMR (400 MHz, CDCl3) δ 11.16 (s, 1H), 7.36–7.20 (m, 21H), 6.79 (dd, J = 8.3, 1.2 
Hz, 1H), 6.66 (dd, J = 7.6, 1.2 Hz, 1H), 5.89–5.76 (m, 1H), 5.70–5.58 (m, 2H), 5.57–5.49 
(m, 1H), 5.14–5.03 (m, 6H), 4.52–4.29 (m, 4H), 3.88–3.75 (m, 2H), 3.74–3.65 (m, 1H), 
3.61–3.53 (m, 1H), 3.52–3.46 (m, 1H), 3.43–3.25 (m, 4H), 2.95–2.81 (m, 2H), 2.70 (s, 1H), 
2.58–2.49 (m, 1H), 2.22–2.12 (m, 1H), 1.95–1.74 (m, 7H), 1.73–1.50 (m, 10H), 1.50–1.35 
(m, 7H), 1.30–1.17 (m, 6H), 1.17–1.11 (m, 6H), 1.11–1.02 (m, 9H), 1.00 (d, J = 6.8 Hz, 
3H). 
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13C NMR (100 MHz, CDCl3) δ 176.6, 176.3, 170.9, 162.3, 145.4, 139.1, 138.6, 138.5, 
136.4, 136.3, 133.8, 132.6, 132.5, 128.4, 128.4, 128.3, 128.3, 128.1, 127.9, 127.9, 127.8, 
127.7, 127.7, 127.5, 127.5, 122.1, 116.3, 115.6, 112.5, 82.2, 81.9, 78.2, 77.8, 76.0, 75.0, 
74.5, 74.1, 72.9, 71.6, 71.2, 71.0, 66.0, 65.9, 46.7, 46.6, 42.6, 42.1, 40.6, 39.9, 37.6, 37.1, 
36.7, 36.1, 32.0, 31.9, 31.8, 31.3, 28.0, 25.5, 25.1, 23.6, 23.6, 21.9, 21.2, 20.5, 20.0, 16.2, 
15.9. 
 
HRMS (ESI) Calcd. for C77H100O13Na [M+Na]
+: 1255.7056, Found: 1255.7037.  
 
FTIR (neat): 2931, 2856, 1731, 1652, 1454, 1373, 1311, 1263, 1213, 1163, 1139, 1086, 
1048, 1028, 1017, 734, 697 cm-1.  
 
[]20D = +6.00° (c 1.0, CHCl3).  
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(3S,4R,6S)-6-(benzyloxy)-7-((2S,6R)-6-(1-(benzyloxy)-2-methyl-1-oxopropan-2-
yl)tetra-hydro-2H-pyran-2-yl)-3-methylhept-1-en-4-yl 2-(3-((2S,6S)-6-((3S,4R,6S,E)-
6-(benzyloxy)-7-((2S,6S)-6-(1-(benzyloxy)-2-methyl-1-oxopropan-2-yl)tetrahydro-
2H-pyran-2-yl)-4-((2-hydroxy-6-(3-((2S,6S)-6-vinyltetrahydro-2H-pyran-2-
yl)propyl)benzoyl)oxy)-3-methylhept-1-en-1-yl)tetra-hydro-2H-pyran-2-yl)propyl)-
6-hydroxybenzoate (4.14) 
 
 
 
A flame dried flask was charged with alcohol (70.0 mg, 0.0567 mmol, 100 mol%) in THF 
(1.13 mL, 0.05 M) at 0 °C. NaHMDS (0.284 mL, 0.284 mmol, 500 mol%) was added 
dropwise at 0 °C. After stirring for 30 min, fragment A (74.9 mg, 0.227 mmol, 400 mol%) 
in dry THF (0.6 mL) was added dropwise. The reaction was warmed to room temperature 
and stirred for 1 h and then quenched with sat. NH4Cl solution (5.0 mL). The resulting 
mixture was extracted with ether (3 X 5.0 mL). The combined organic extracts were 
washed with brine (15.0 mL), dried over Na2SO4 and concentrated in vacuo and subjected 
to flash column chromatography (SiO2: hexane/ethyl acetate, 20:1 to 6:1) to furnish the 
title product 4.14 in 85% yield (72.6 mg, 0.048 mmol). 
 
1H NMR (400 MHz, CDCl3) δ 11.16 (s, 1H), δ 11.14 (s, 1H), 7.36–7.19 (m, 22H), 6.82–
6.77 (m, 2H), 6.69–6.63 (m, 2H), 5.90–5.75 (m, 2H), 5.67–5.52 (m, 4H), 5.24–5.00 (m, 
8H), 4.48–4.40 (m, 2H), 4.34–4.25 (m, 2H), 3.82–3.69 (m, 2H), 3.61–3.53 (m, 2H), 3.44–
3.21 (m, 6H), 2.97–2.79 (m, 4H), 2.60–2.48 (m, 2H), 1.89–1.73 (m, 11H), 1.66–1.32 (m, 
21H), 1.30–1.00 (m, 26H). 
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13C NMR (100 MHz, CDCl3) δ 176.3, 176.3, 170.9, 170.8, 162.4, 162.3, 145.4, 145.4, 
139.7, 139.1, 138.5, 138.5, 136.3, 133.8, 133.7, 133.3, 130.9, 128.4, 128.3, 128.3, 128.1, 
128.0, 127.9, 127.7, 127.5, 127.5, 122.2, 122.1, 116.3, 115.6, 114.3, 112.6, 81.9, 81.9, 78.3, 
77.6, 76.1, 76.0, 74.6, 74.5, 72.9, 71.2, 65.9, 46.6, 42.1, 40.8, 40.7, 40.6, 37.6, 36.7, 36.2, 
36.1, 32.0, 32.0, 31.5, 31.4, 31.4, 31.3, 29.7, 28.0, 25.5, 23.6, 23.6, 23.5, 21.9, 20.1, 16.2, 
15.9. 
 
HRMS (ESI) Calcd. for C94H120O16Na [M+Na]
+: 1527.8469, Found: 1527.8443.  
 
FTIR (neat): 2936, 2860, 1731, 1652, 1605, 1449, 1366, 1310, 1250, 1214, 1164, 1088, 
1048, 918, 816, 738, 697 cm-1.  
 
[]20D = +14.70° (c 1.0, CHCl3).  
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(3S,4R,6S)-6-(benzyloxy)-7-((2S,6S)-6-(1-(benzyloxy)-2-methyl-1-oxopropan-2-
yl)tetra-hydro-2H-pyran-2-yl)-3-methylhept-1-en-4-yl 2-hydroxy-6-(3-((2S,6S)-6-
vinyltetra-hydro-2H-pyran-2-yl)propyl)benzoate dimer 
 
 
 
Diene 4.14 (30.0 mg, 0.02 mmol, 100 mol%) and Grubbs’ second generation catalyst (1.70 
mg, 0.002 mmol, 10 mol%) were dissolved in dry DCM (6.70 mL, 0.003 M) and the 
solution was heated at 40 °C. After stirring for 10 h, the reaction was concentrated in vacuo 
and subjected to flash column chromatography (SiO2: hexane/ethyl acetate, 20:1 to 6:1) to 
furnish the title product in 68% yield (20.1 mg, 0.0136 mmol). 
 
1H NMR (400 MHz, CDCl3) δ 11.60 (s, 2H), 7.35–7.18 (m, 22H), 6.79 (d, J = 8.3 Hz, 
2H), 6.61 (d, J = 7.6 Hz, 2H), 5.66–5.52 (m, 6H), 5.03 (s, 4H), 4.43 (dd, J = 11.0, 4.9 Hz, 
2H), 4.30 (dd, J = 11.4, 5.1 Hz, 2H), 3.63 (d, J = 11.2 Hz, 1H), 3.56 (s, 2H), 3.43–3.28 (m, 
4H), 3.27–3.18 (m, 1H), 2.95–2.83 (m, 1H), 2.82–2.71 (m, 1H), 2.56–2.45 (m, 2H), 1.92–
1.71 (m, 10H), 1.66–1.38 (m, 20H), 1.38–0.95 (m, 30H), 0.92–0.79 (m, 2H). 
 
13C NMR (100 MHz, CDCl3) δ 176.3, 171.5, 163.0, 145.9, 138.5, 136.3, 134.0, 133.3, 
130.1, 128.4, 128.3, 128.1, 127.9, 127.7, 127.5, 122.3, 115.6, 81.9, 78.2, 76.2, 74.7, 72.9, 
71.2, 66.0, 46.7, 41.6, 40.9, 38.7, 37.3, 37.2, 32.0, 31.7, 31.2, 29.7, 29.1, 25.6, 23.7, 22.1, 
19.8, 17.7. 
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HRMS (ESI) Calcd. for C92H116O16Na [M+Na]
+: 1499.8156, Found: 1499.8121.  
 
FTIR (neat): 2918, 2603, 2359, 2205, 2158, 2106, 2091, 2052, 2037, 1733, 1714, 1698, 
1651, 1574, 1537, 1454, 1253, 837 cm-1.  
 
[]20D = +28.70° (c 0.5, CHCl3).  
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(+)-SCH 351448 
 
 
To a flask charged with diene (10.0 mg, 0.0067 mmol, 100 mol%) and Pd/C (10% w/w, 
1.4 mg, 20 mol%), was added EtOAc (1 mL) and MeOH (3 mL). The reaction mixture was 
stirred under 1 atm H2 (balloon) for 8 h. The solution was filtered and the filtrate was 
concentrated. The residue was diluted with 5 mL of hexane, and then washed with 2 mL 
of a 4 N HCl solution saturated with NaCl. The aqueous layer was extracted with 5 mL 
hexane. The combined organic solution was dried over Na2SO4 and concentrated in vacuo 
to afford crude (+)-SCH 351448 in 65% (5.0 mg) as a white solid. 
 
1H NMR (400 MHz, CDCl3) δ 7.25 (t, J = 7.9 Hz, 2H), 6.81 (d, J = 8.3 Hz, 2H), 6.72 (d, 
J = 7.5 Hz, 2H), 5.67–5.59 (m, 2H), 3.77–3.69 (m, 2H), 3.64–3.54 (m, 2H), 3.50 (d, J = 
11.3 Hz, 2H), 3.19–3.06 (m, 6H), 2.60–2.48 (m, 2H), 2.10–2.00 (m, 2H), 1.90–1.80 (m, 
4H), 1.80–1.72 (m, 2H), 1.73–1.62 (m, 6H), 1.63–1.55 (m, 4H), 1.56–1.37 (m, 22H), 1.36–
1.18 (m, 10H), 1.12 (s, 6H), 1.09 (s, 6H), 1.01 (d, J = 6.7 Hz, 6H). 
 
13C NMR (151 MHz, CD2Cl2) δ 178.7, 171.1, 160.2, 145.1, 133.5, 122.4, 115.9, 115.5, 
83.3, 79.2, 78.3, 78.1, 77.7, 67.5, 46.5, 43.7, 37.9, 37.5, 36.9, 36.6, 35.2, 32.9, 32.5, 32.0, 
30.1, 29.5, 25.2, 24.3, 23.5, 23.2, 19.3, 15.1. 
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HRMS (ESI) Calcd. for C64H95O16Na [M+Na]
+: 1143.6591, Found: 1143.6574.  
 
FTIR (neat): 3446, 2922, 2856, 1990, 1707, 1655, 1575, 1449, 1375, 1292, 1253, 1212, 
1087, 1045 cm-1.  
 
[]20D = +27.60° (c 0.3, CHCl3).  
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Natural sample of (+)-SCH 35144834 
 
 
 
 
Synthetic sample of (+)-SCH 351448 
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13C NMR comparison to the natural sample35 of (+)-SCH 351448  
Carbon 
# 
13C (Hegde) 
13C 
(Krische) 
1 178.7 178.7 
2 46.4 46.5 
3 83.2 83.3 
4 37.8 37.9 
5 23.5 23.5 
6 32.8 32.9 
7 79.1 79.2 
8 43.6 43.7 
9 67.5 67.5 
10 37.4 37.5 
11 77.6 77.7 
12 36.9 36.9 
13 29.5 29.5 
14 25.2 25.2 
15 78.1 78.1 
16 32.5 32.5 
17 24.2 24.3 
18 31.9 32.0 
19 78.2 78.3 
20 35.1 35.2 
21 30.0 30.1 
22 36.6 36.6 
23 145.0 145.1 
24 122.3 122.4 
25 133.4 133.5 
26 115.8 115.9 
27 160.1 160.2 
28 115.5 115.5 
29 171.0 171.1 
1-Me 19.3 19.3 
1-Me 23.1 23.2 
12-Me 15.0 15.1 
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Chapter 5: Regioselective Hydrohydroxyalkylation of Styrene with 
Primary Alcohols or Aldehydes via Ruthenium Catalyzed C-C Bond 
Forming Transfer Hydrogenation* 
5.1 INTRODUCTION 
The use of premetalated C-nucleophiles in carbonyl addition has opened immense 
volume of chemical space and is now a longstanding cornerstone of chemical synthesis 
since the work of Butlerov and Grignard.1,2 As an alternative to classic carbonyl addition, 
the catalytic reductive coupling of π-unsaturated reactants with carbonyl compounds 
potentially avoids stoichiometric organometallic reagents and the issue of safety, 
selectivity and waste that attend their use (Figure 5.1).3,5c As exemplified by 
hydroformylation,4 the prototypical catalytic reductive coupling, byproduct-free 
transformations are preferred for large volume chemical manufacture. Additionally, the 
identification of terminal reductants that are less costly than the coupling partners 
themselves is important. Hence, reductive couplings in which alcohols serve dually as 
hydrogen donors and carbonyl precursor are especially attractive.5  
 
 
Figure 5.1 The catalytic reductive coupling of π-unsaturated reactants with carbonyl 
compounds. 
                                                 
* This chapter is based on the published work: 
Xiao, H.; Wang, G.; Krische, M. J. Angew. Chem., Int. Ed. 2016, 55, 16119. 
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Styrene ranks among the most abundant π-unsaturated feedstocks (>25 x 106 
tons/2010),6 yet very few catalytic reductive coupling of styrene with carbonyl compounds 
have developed (Scheme 5.1). Following an initial report by Miura,7a the present author 
developed a rhodium catalyzed reductive coupling of styrene with carboxylic anhydrides 
mediated by elemental hydrogen.7b Recently, Buchwald reported an enantioselective 
copper-catalyzed variant of this transformation mediated by silane.7c These processes 
display branch-regioselectivity. In contrast, Ye reports a 2-propanol mediated reductive 
Prins reaction of vinyl arenes with aldehydes to form linear adducts.7d As anticipated based 
on the mechanism, this process is most efficient for olefins capable of stabilizing a cationic 
intermediate and only one example of styrene was described. 
 
 
Scheme 5.1 Metal catalyzed reductive coupling of styrene with carbonyl compounds.  
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5.2 REACTION DEVELOPMENT AND SCOPE 
Here, we describe an intermolecular ruthenium catalyzed reductive coupling of 
unactivated aldehydes with styrene wherein primary alcohols serve dually as reductant and 
carbonyl precursor. Notably, using the precatalyst HClRu(CO)(PCy3)2 in combination with 
substoichiometric quantities of AgOTf or HBF4, benzylic or aliphatic alcohols are 
converted to branched or linear adducts, respectively (Scheme 5.2). 
 
 
Scheme 5.2 Ruthenium catalyzed reductive coupling of styrene with carbonyl 
compounds. 
Our initial studies were inspired by Yi’s observation that the addition of HBF4•OEt2 
to the ruthenium-hydride complex HClRu(CO)(PCy3)2 dramatically enhances catalytic 
activity in alkene hydrogenation8a and hydrovinylation.8b As corroborated by mechanistic 
studies, HBF4 serves to open a coordination site at ruthenium by protonating a 
tricyclohexylphosphine ligand.8a As demonstrated in our laboratory,5,9,10 closely related 
ruthenium(II) carbonyl complexes catalyze the coupling of primary alcohols with diverse 
olefin pronucleophiles, including 1,3-dienes9 and 1,3-enynes.10 Despite longstanding 
effort, the use of styrene and α-olefins as pronucleophiles in C-C bond forming transfer 
hydrogenation remained an elusive challenge. Hence, a series of experiments were 
conducted to assess whether the use of HBF4•OEt2 might unlock reactions of this type 
(Scheme 5.3, a). Exposure of heptanol 5.1a to styrene 5.2a in the presence of commercially 
available HClRu(CO)(PPh3)3 did not lead to products of C-C coupling in the absence or 
presence of HBF4•OEt2. The related catalyst, HClRu(CO)(PCy3)2 was ineffective by itself, 
             280 
 
however, in the presence of HBF4•OEt2 the linear product of C-C bond formation 5.3a was 
formed in 73% yield as a single regioisomer. Other Brønsted acids were assayed, but were 
uniformly less effective. 
 
 
Scheme 5.3 Selected optimization experiments for the ruthenium catalyzed C-C 
coupling of 1-heptanol 5.1a and bicenzyl alcohol 5.1g with styrene 5.2a.a 
Although the stoichiometric reaction of HBF4•OEt2 with HClRu(CO)(PCy3)2 was 
demonstrated by Yi to result in protonation of PCy3,
5a a control experiment was performed 
to rule out intervention of cationic ruthenium(II) complexes that potentially arise upon 
protonation of a hydride ligand.9e,f Specifically, the coupling of 5.1a and 5.2a was 
attempted using HClRu(CO)(PCy3)2 in the presence of AgOTf. Here, the linear 
regioisomer 5.3a was not formed, yet a small quantity of the corresponding branched 
             281 
 
regioisomer was detected. These data suggest cationic complexes do not catalyze reactions 
that form linear regioisomers and support the feasibility of optimizing a catalytic pathway 
to branched adducts. While aliphatic alcohols were recalcitrant partners for branch-
selective coupling, the coupling of benzylic alcohol 5.1g with styrene 5.2a to form the 
branched adduct 5.3g was amenable to optimization (Scheme 5.3, b). 
Table 5.1 Ruthenium catalyzed C-C coupling of aliphatic alcohols 5.1a-5.1f with 
styrene 5.2a to form secondary alcohols 5.3a-5.3f.a 
 
The scope of this regiodivergent transfer hydrogenative coupling of aliphatic and 
benzylic alcohols was briefly surveyed (Tables 5.1 and 5.2). The reaction of styrene 5.2a 
with aliphatic alcohols 5.1a-5.1f provided adducts 5.3a-5.3f in good yield with complete 
levels of linear regioselectivity (Table 5.1). Even alcohols with branching at the β-position, 
such as cyclohexyl methanol 5.1e, participate in C-C coupling although higher 
temperatures (120 oC) are required. The coupling of benzylic alcohols 5.1g-5.1l delivered 
adducts 5.3g-5.3l in good to excellent yields with complete branched regioselectivity 
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(Table 5.2). Here, electron deficient benzylic alcohols were more efficient partners for 
coupling. Beyond the redox-neutral couplings from the alcohol oxidation level, 2-propanol 
mediated reductive coupling of styrene 5.2a with alkyl- and aryl-substituted aldehydes also 
is possible, as illustrated by the conversion of heptanal (dehydro-5.1a) to the linear 
secondary alcohol 3a (Scheme 5.4, a) and the conversion of benzyl alcohol 5.1g to the 
branched adduct 5.3g (Scheme 5.4, b). 
Table 5.2 Ruthenium catalyzed C-C coupling of benzylic alcohols 5.1g-5.1l with 
styrene 5.2a to form secondary alcohols 5.3g-5.3l.a 
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Scheme 5.4 Ruthenium catalyzed C-C coupling of dehydro-5.1a and dehydro-5.1g 
with styrene 5.2a. 
5.3 MECHANISM AND DISCUSSION 
To gain insight into the catalytic mechanism, in particular the origins of linear vs. 
branched regioselectivity, a series of deuterium labelling experiments were performed 
(Scheme 5.5). Exposure of deuterio-5.1a, which is deuterated at the carbinol position (97% 
2H), to styrene 5.2a under standard conditions results in the formation of deuterio-5.3a 
(Scheme 5.5, a). Complete retention of deuterium at the carbinol methane (96% 2H) is 
accompanied by complete transfer of deuterium to the benzylic methylene (>98% 2H). 
These data are consistent with a catalytic mechanism involving carbonyl-styrene oxidative 
coupling to form an oxaruthenacycle, which upon transfer hydrogenolysis mediated by 
deuterio-5.1a delivers deuterio-5.3a. Here, formation of a benzylic carbon-ruthenium bond 
defines the regioselectivity of oxaruthenacycle formation and, hence, the linear 
regioselectivity of C-C coupling. Although the primary alcohol reactant deuterio-5.1a 
dehydrogenates upon oxaruthenacycle transfer hydrogenolysis, the secondary alcohol 
product deuterio-5.3a appears kinetically unreactive toward dehydrogenation, presumably 
due to steric effects. A related deuterium labeling experiment in which alcohol 5.1a is 
reacted with d8-styrene 5.2a provides a result consistent with this mechanistic 
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interpretation (Scheme 5.5, b). Exposure of deuterio-5.1h, to styrene 5.2a under standard 
conditions for the coupling of benzylic alcohols provides deuterio-5.3h (Scheme 5.5, c). 
Significant loss of deuterium is observed at the carbinol methine (61% 2H) and transfer of 
deuterium to the methyl hydrogen is incomplete (11% 2H). Such loss of deuterium is 
consistent with a mechanism involving rapid, reversible hydrogen transfer between 
deuterio-5.1h and styrene 5.2a to form aldehyde-benzylruthenium pairs in advance of turn-
over limiting carbonyl addition. Here, hydrometalation to form a benzylic carbon-
ruthenium bond defines the branched regioselectivity of C-C coupling. The related 
deuterium labeling experiment wherein the non-deuterated alcohol 5.1h is reacted with d8-
styrene 5.2a corroborates reversible transfer of hydrogen between alcohol 5.1h and d8-
styrene 5.2a (Scheme 5.5, d). 
5.4 CONCLUSION 
In summary, we report the first examples of metal catalyzed carbonyl-styrene C-C 
coupling. These processes can be conducted in redox-neutral manner from the alcohol 
oxidation level of the reactant via hydrogen auto-transfer. Alternatively, reductive coupling 
from the aldehyde oxidation level is possible using 2-propanol as an exogenous terminal 
reductant. Remarkably, the ruthenium precatalyst HClRu(CO)(PCy3)2 delivers branched or 
linear adducts from benzylic or aliphatic alcohols when modified by AgOTf or HBF4, 
respectively.  
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Scheme 5.5 General catalytic pathways accounting for linear vs branched 
regioselectivity as corroborated by deuterium labelling studies.a 
 
5.5 EXPERIMENTAL DETAILS 
General Information: 
The ruthenium catalyst RuHCl(CO)(PCy3)2 was prepared according to the literature.
11 All 
reactions were run under an atmosphere of argon. Sealed tubes (13x100 mm) were 
purchased from Fischer Scientific (catalog number 14-959-35C) and were flame dried 
followed by cooling in a desiccator. Anhydrous solvents were transferred by oven-dried 
syringes. Analytical thin-layer chromatography (TLC) was carried out using 0.25 mm 
commercial silica gel plates (Dynanmic Absorbents F254). Visualization was 
accomplished with UV light followed by dipping in KMnO4 stain solution then heating. 
Purification of reactions was carried out by flash chromatography using Silacycle silica gel 
(40-63 μm, unless indicated specifically). All silver salts were purchased from Alfa Aesar, 
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and stored in a desiccator. All alcohol substrates were purchased from commercially 
available sources and purified prior to use. Styrene was purchased from Sigma Aldrich and 
used without further purification. All aldehydes were used from commercially available 
sources, and purified via distillation in a Hickman still or column chromatography prior to 
use.  
 
Spectroscopy, Spectrometry, and Data Collection: 
Infrared spectra were recorded on a Perkin-Elmer 1600 spectrometer. High-resolution mass 
spectra (HRMS) were obtained on an Agilent Technologies 6530 Accurate Mass Q-TOF 
LC/MS instrument and are reported as m/z (relative intensity). Accurate masses are 
reported for the molecular ion (M, M+H, or M-H), or a suitable fragment ion. 1H nuclear 
magnetic resonance spectra were recorded using a 400 MHz spectrometer. Coupling 
constants are reported in Hertz (Hz) for CDCl3 solutions, and chemical shifts are reported 
as parts per million (ppm) relative to residual CHCl3 δH (7.26 ppm). 13C nuclear magnetic 
resonance spectra were recorded using a 100 MHz spectrometer for CDCl3 solutions, and 
chemical shifts are reported as parts per million (ppm) relative to residual CDCl3 δC (77.0 
ppm). The products formed through C-C coupling from the alcohol and aldehyde oxidation 
levels are identical in all respects outside of diastereomeric ratios.  
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Detailed Procedures and Spectral Data for the Coupling Products 5.3a-5.3l: 
1-phenylnonan-3-ol (5.3a) 
 
 
 
From alcohol oxidation level: An oven-dried pressure tube equipped with a magnetic stir 
bar was charged with 1-heptanol (23.2 mg, 0.2 mmol, 100 mol%) and RuHCl(CO)(PCy3)2 
(8.7 mg, 0.012 mmol, 6 mol%). The reaction vessel was placed under an atmosphere of 
argon. Styrene (0.2 mL, 1 M, 870 mol%) was added by syringe followed by HBF4.Et2O 
(5.5 μL, 0.02 mmol, 10 mol%). The reaction vessel was sealed and the reaction mixture 
was allowed to stir at 100 ˚C for 24 h. The reaction was allowed to reach ambient 
temperature. The reaction mixture was concentrated in vacuo. The residue was subjected 
to column chromatography (SiO2: hexanes:ethyl acetate, 40:1) to furnish the title 
compound (32.2 mg, 0.146 mmol) as a colorless oil in 73% yield.  
 
From aldehyde oxidation level: An oven-dried pressure tube equipped with a magnetic stir 
bar was charged with heptanal (22.8 mg, 0.2 mmol, 100 mol%) and RuHCl(CO)(PCy3)2 
(8.7 mg, 0.012 mmol, 6 mol%). The reaction vessel was placed under an atmosphere of 
argon. Styrene (0.2 mL, 1 M, 870 mol%) and 2-propanol (36 mg, 0.6 mmol, 300 mol%) 
were added by syringe followed by HBF4.Et2O (5.5 μL, 0.02 mmol, 10 mol%). The reaction 
vessel was sealed and the reaction mixture was allowed to stir at 100 ˚C for 24 h. The 
reaction was allowed to reach ambient temperature. The reaction mixture was concentrated 
in vacuo. The residue was subjected to column chromatography (SiO2: hexanes:ethyl 
acetate, 40:1) to furnish the title compound (27.3 mg, 0.124 mmol) as a colorless oil in 
62% yield.  
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1H NMR: (400 MHz, CDCl3) δ7.32–7.26 (m, 2H), 7.24–7.16 (m, 3H), 3.63 (dq, J = 8.2, 
3.9 Hz, 1H), 2.80 (ddd, J = 13.9, 9.7, 5.8 Hz, 1H), 2.68 (ddd, J = 13.8, 9.6, 6.6 Hz, 1H), 
1.87–1.67 (m, 2H), 1.55–1.24 (m, 11H), 0.96–0.83 (m, 3H). 
 
13C NMR: (100 MHz, CDCl3) δ 142.2, 128.4, 128.4, 125.8, 71.4, 39.1, 37.6, 32.1, 31.8, 
29.4, 25.6, 22.6, 14.1. 
 
HRMS: (CI) Calcd. For C15H23O [M-H]
- 219.1749, Found 219.1750. 
 
FTIR: (neat): 3345, 2927, 2855, 1494, 1453, 1029, 746, 698 cm-1.  
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1,5-diphenylpentan-3-ol (5.3b) 
 
 
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 3-
phenylpropan-1-ol (27.2 mg, 0.2 mmol, 100 mol%) and RuHCl(CO)(PCy3)2 (8.7 mg, 0.012 
mmol, 6 mol%). The reaction vessel was placed under an atmosphere of argon. Styrene 
(0.2 mL, 1 M, 870 mol%) was added by syringe followed by HBF4.Et2O (5.5 μL, 0.02 
mmol, 10 mol%). The reaction vessel was sealed and the reaction mixture was allowed to 
stir at 100 ˚ C for 24 h. The reaction was allowed to reach ambient temperature. The reaction 
mixture was concentrated in vacuo. The residue was subjected to column chromatography 
(SiO2: hexanes:ethyl acetate, 20:1) to furnish the title compound (34.1 mg, 0.142 mmol) as 
a colorless oil in 71% yield.  
 
1H NMR: (400 MHz, CDCl3) δ7.32–7.27 (m, 4H), 7.23–7.18 (m, 6H), 3.68 (tt, J = 7.8, 4.5 
Hz, 1H), 2.80 (ddd, J = 13.6, 9.5, 6.1 Hz, 2H), 2.68 (ddd, J = 13.7, 9.5, 6.8 Hz, 2H), 1.90–
1.72 (m, 4H), 1.60 (s, 1H). 
 
13C NMR: (100 MHz, CDCl3) δ 142.0, 128.4, 128.4, 125.9, 70.9, 39.2, 32.1. 
 
HRMS: (CI) Calcd. For C17H21O [M+H]
+ 241.1592, Found 241.1591. 
 
FTIR: (neat): 3382, 3025, 2930, 2856, 1602, 1495, 1453, 1261, 1091, 1030, 800, 747, 698 
cm-1.  
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8-(benzyloxy)-1-phenyloctan-3-ol (5.3c) 
 
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 6-
(benzyloxy)hexan-1-ol (41.7 mg, 0.2 mmol, 100 mol%) and RuHCl(CO)(PCy3)2 (14.5 mg, 
0.02 mmol, 10 mol%). The reaction vessel was placed under an atmosphere of argon. 
Styrene (0.4 mL, 0.5 M) was added by syringe followed by HBF4.Et2O (8.3 μL, 0.03 mmol, 
15 mol%). The reaction vessel was sealed and the reaction mixture was allowed to stir at 
120 ˚C for 24 h. The reaction was allowed to reach ambient temperature. The reaction 
mixture was concentrated in vacuo. The residue was subjected to column chromatography 
(SiO2: hexanes:ethyl acetate, 20:1) to furnish the title compound (42.5 mg, 0.136 mmol) as 
a colorless oil in 68% yield 
 
1H NMR: (400 MHz, CDCl3) δ 7.36–7.27 (m, 7H), 7.21 (dt, J = 8.1, 2.0 Hz, 3H), 4.51 (s, 
2H), 3.63 (tt, J = 8.5, 4.2 Hz, 1H), 3.47 (t, J = 6.6 Hz, 2H), 2.80 (ddd, J = 13.8, 9.6, 5.9 Hz, 
1H), 2.67 (ddd, J = 13.7, 9.6, 6.7 Hz, 1H), 1.81–1.73 (m, 2H), 1.63 (dd, J = 8.7, 5.0 Hz, 
3H), 1.50–1.38 (m, 6H). 
 
13C NMR: (101 MHz, CDCl3) δ 142.2, 138.6, 128.4, 128.3, 127.6, 127.5, 125.8, 72.9, 71.3, 
70.3, 39.1, 37.5, 32.1, 29.7, 26.3, 25.4. 
 
HRMS: (CI) Calcd. For C21H29O2 [M+H]
+ 313.2168, Found 313.2174. 
 
FTIR: (neat): 3406, 3060, 3025, 2929, 2855, 1567, 1493, 1452, 1364, 1098, 1028, 857, 
797, 745, 698 cm-1.  
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1-cyclohexyl-4-phenylbutan-2-ol (5.3d) 
 
 
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 2-
cyclohexylethan-1-ol (25.6 mg, 0.2 mmol, 100 mol%) and RuHCl(CO)(PCy3)2 (8.7 mg, 
0.012 mmol, 6 mol%). The reaction vessel was placed under an atmosphere of argon. 
Styrene (0.2 mL, 1 M, 870 mol%) was added by syringe followed by HBF4.Et2O (5.5 μL, 
0.02 mmol, 10 mol%). The reaction vessel was sealed and the reaction mixture was allowed 
to stir at 100 ˚C for 24 h. The reaction was allowed to reach ambient temperature. The 
reaction mixture was concentrated in vacuo. The residue was subjected to column 
chromatography (SiO2: hexanes:ethyl acetate, 40:1) to furnish the title compound (29.8 
mg, 0.128 mmol) as a colorless oil in 64% yield.  
 
1H NMR: (400 MHz, Chloroform-d) δ 3.74 (t, J = 6.5 Hz, 1H), 2.79 (ddd, J = 13.7, 9.7, 
6.0 Hz, 1H), 2.67 (ddd, J = 13.8, 9.7, 6.6 Hz, 1H), 1.81–1.63 (m, 5H), 1.50–1.09 (m, 6H), 
1.01–0.77 (m, 2H). 
 
13C NMR: (100 MHz, CDCl3) δ 142.2, 128.4, 125.8, 68.9, 45.5, 39.7, 34.2, 34.2, 33.0, 
32.1, 26.6, 26.4, 26.2. 
 
HRMS: (CI) Calcd. For C16H23O [M-H]
+ 231.1749, Found 231.1746. 
 
FTIR: (neat): 3336, 2919, 2850, 1494, 1448, 1068, 1046, 1000, 931, 745, 697 cm-1.  
             295 
 
 
  
             296 
 
1-cyclohexyl-3-phenylpropan-1-ol (5.3e) 
 
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
cyclohexylmethanol (22.8 mg, 0.2 mmol, 100 mol%) and RuHCl(CO)(PCy3)2 (14.5 mg, 
0.02 mmol, 10 mol%). The reaction vessel was placed under an atmosphere of argon. 
Styrene (0.2 mL, 1 M, 870 mol%) was added by syringe followed by HBF4.Et2O (8.3 μL, 
0.03 mmol, 15 mol%). The reaction vessel was sealed and the reaction mixture was allowed 
to stir at 100 ˚C for 24 h. The reaction was allowed to reach ambient temperature. The 
reaction mixture was concentrated in vacuo. The residue was subjected to column 
chromatography (SiO2: hexanes:ethyl acetate, 40:1) to furnish the title compound (27.1 
mg, 0.124 mmol) as a colorless oil in 62% yield. 
 
1H NMR: (400 MHz, CDCl3) δ 7.32–7.27 (m, 2H), 7.24–7.16 (m, 3H), 3.44–3.36 (m, 1H), 
2.85 (ddd, J = 13.7, 10.1, 5.3 Hz, 1H), 2.66 (ddd, J = 13.7, 9.8, 6.6 Hz, 1H), 1.92–1.62 (m, 
7H), 1.39–0.98 (m, 7H). 
 
13C NMR: (100 MHz, CDCl3) δ 142.4, 128.4, 128.4, 125.7, 75.6, 43.8, 35.9, 32.4, 29.2, 
27.8, 26.5, 26.3, 26.2. 
 
HRMS: (CI) Calcd. For C15H21O [M-H]
- 217.1592, Found 217.1601. 
 
FTIR: (neat): 3365, 3026, 2923, 2851, 1602, 1494, 1451, 1064, 1030, 748, 698 cm-1.  
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5,5-dimethyl-1-phenylhexan-3-ol (5.3f) 
 
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 3,3-
dimethylbutan-1-ol (20.4 mg, 0.2 mmol, 100 mol%) and RuHCl(CO)(PCy3)2 (8.7 mg, 
0.012 mmol, 6 mol%). The reaction vessel was placed under an atmosphere of argon, 
isopropyl alcohol (12 mg, 15μL, 0.2 mmol, 100 mol%) was added by syringe. Styrene (0.2 
mL, 1 M, 870 mol%) was added by syringe followed by HBF4.Et2O (5.5 μL, 0.02 mmol, 
10 mol%). The reaction vessel was sealed and the reaction mixture was allowed to stir at 
100 ˚C for 24 h. The reaction was allowed to reach ambient temperature. The reaction 
mixture was concentrated in vacuo. The residue was subjected to column chromatography 
(SiO2: hexanes:ethyl acetate, 40:1) to furnish the title compound (27.2 mg, 0.132 mmol) as 
a colorless oil in 66% yield. 
 
1H NMR: (400 MHz, CDCl3) δ 7.33–7.26 (m, 2H), 7.24–7.16 (m, 3H), 3.80 (h, J = 5.8 Hz, 
1H), 2.82–2.73 (m, 1H), 2.72–2.63 (m, 1H), 1.80–1.72 (m, 2H), 1.45–1.38 (m, 2H), 0.97 
(d, J = 0.9 Hz, 9H). 
 
13C NMR: (101 MHz, CDCl3) δ 142.2, 128.4, 125.8, 69.2, 51.4, 41.3, 32.1, 30.3, 30.1. 
 
HRMS: (CI) Calcd. For C14H22O [M-H]
- 206.1671, Found 206.1679. 
 
FTIR: (neat): 3394, 3026, 2950, 2865, 1495, 1474, 1454, 1364, 1249, 1060, 1029, 743, 
698 cm-1.  
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2-phenyl-1-(4-(trifluoromethyl)phenyl)propan-1-ol (5.3g) 
 
 
From alcohol oxidation level: An oven-dried pressure tube equipped with a magnetic stir 
bar was charged with 4-(trifluoromethyl)benzyl alcohol (35.2 mg, 0.2 mmol, 100 mol%), 
RuHCl(CO)(PCy3)2 (8.7 mg, 0.012 mmol, 6 mol%), and AgOTf (2.6 mg, 0.01 mmol, 5 
mol%). The reaction vessel was placed under an atmosphere of argon. Styrene (0.2 mL, 1 
M, 870 mol%) was added by syringe. The reaction vessel was sealed and the reaction 
mixture was allowed to stir at 100 ˚C for 24 h. The reaction was allowed to reach ambient 
temperature. The reaction was concentrated in vacuo. The residue was subjected to column 
chromatography (SiO2: hexanes:ethyl acetate, 30:1) to furnish the title compound (46.5 
mg, 0.166 mmol, dr: 2:1) as a colorless oil in 83% yield. 
 
From aldehyde oxidation level: An oven-dried pressure tube equipped with a magnetic stir 
bar was charged with 4-(trifluoromethyl)benzyl aldehyde (34.8 mg, 0.2 mmol, 100 mol%), 
RuHCl(CO)(PCy3)2 (14.5 mg, 0.02 mmol, 10 mol%), and AgOTf (4.7 mg, 0.018 mmol, 9 
mol%). The reaction vessel was placed under an atmosphere of argon. Styrene (0.2 mL, 1 
M, 870 mol%) and isopropyl alcohol (24 mg, 0.4 mmol, 200 mol%) were added by syringe. 
The reaction vessel was sealed and the reaction mixture was allowed to stir at 100 ˚C for 
24 h. The reaction was allowed to reach ambient temperature. The reaction mixture was 
concentrated in vacuo. The residue was subjected to column chromatography (SiO2: 
hexanes:ethyl acetate, 30:1) to furnish the title compound (37.5 mg, 0.134 mmol, dr: 1.6:1) 
as a colorless oil (37.5 mg, dr: 1.6:1) in 67 % yield.  
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1H NMR: (400 MHz, CDCl3) for the 2:1 mixture of diastereomers: δ 7.57 (ddt, J = 34.2, 
7.9, 0.8 Hz, 2H), 7.49–7.27 (m, 5H), 7.25–7.13 (m, 2H), 4.87 (dd, J = 5.6, 3.0 Hz, 0.64H), 
4.73 (dd, J = 8.5, 2.2 Hz, 0.36H), 3.11 (qd, J = 7.0, 5.5 Hz, 0.65H), 3.01 (dq, J = 8.5, 7.1 
Hz, 0.36H), 1.96 (ddd, J = 9.7, 3.0, 1.8 Hz, 1H), 1.29 (d, J = 7.1 Hz, 2H), 1.12 (d, J = 7.1 
Hz, 1H). 
 
13C NMR: (100 MHz, CDCl3) δ 146.7 (d, J = 1.5 Hz), 146.4 (d, J = 1.5 Hz), 142.9, 142.5, 
128.8, 128.4, 128.1, 128.0, 127.3, 127.2, 126.8, 126.6, 125.2 (q, J = 3.8 Hz), 124.9 (q, J = 
3.7 Hz), 79.0, 78.1, 48.2, 47.1, 18.0, 14.5. 
 
HRMS: (CI) Calcd. For C16H15F3O [M+H]
+ 281.1153, Found 281.1160. 
 
FTIR: (neat): 3425, 2970, 1619, 1494, 1453, 1324, 1122, 1067, 1016, 841, 760, 700 cm-1.  
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1-(4-bromophenyl)-2-phenylpropan-1-ol (5.3h) 
 
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 4-
bromobenzyl alcohol (37.4 mg, 0.2 mmol, 100 mol%), RuHCl(CO)(PCy3)2 (14.5 mg, 0.02 
mmol, 10 mol%), and AgOTf (4.6 mg, 0.018 mmol, 9 mol%). The reaction vessel was 
placed under an atmosphere of argon. Styrene (0.2 mL, 1 M, 870 mol%) was added by 
syringe. The reaction vessel was sealed and the reaction mixture was allowed to stir at 100 
˚C for 24 h. The reaction was allowed to reach ambient temperature. The reaction mixture 
was concentrated in vacuo. The residue was subjected to column chromatography (SiO2: 
hexanes:ethyl acetate, 30:1) to furnish the title compound (40.5 mg, 0.140 mmol, dr: 2:1) 
as a colorless oil in 70% yield.  
 
1H NMR: (400 MHz, CDCl3) for the 3:2 mixture of diastereomers: δ7.51–7.26 (m, 4H), 
7.26–7.03 (m, 5H), 4.76 (dd, J = 5.9, 2.7 Hz, 0.67H), 4.63 (dd, J = 8.5, 2.1 Hz, 0.33H), 
3.11–3.02 (m, 0.67H), 2.96 (dq, J = 8.5, 7.1 Hz, 0.33H), 1.87 (dd, J = 9.4, 2.8 Hz, 1H), 
1.29 (d, J = 7.1 Hz, 2.13H), 1.09 (d, J = 7.1 Hz, 0.87H). 
13C NMR: (100 MHz, CDCl3) δ 143.0, 142.8, 141.8, 141.5, 131.3, 131.0, 128.7, 128.7, 
128.3, 128.0 (d, J = 1.4 Hz), 127.1, 126.6, 79.0, 78.1, 48.1, 47.1, 18.1, 14.9. 
HRMS: (CI) Calcd. For C15H16OBr [M+H]
+ 291.0385, Found 291.0369. 
FTIR: (neat): 3411, 3026, 2964, 2927, 1592, 1486, 1452, 1403, 1183, 1070, 1024, 1008, 
909, 820, 759, 699 cm-1.  
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Methyl 4-(1-hydroxy-2-phenylpropyl)benzoate (5.3i) 
 
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with methyl 4-
(hydroxymethyl)benzoate (33.2 mg, 0.2 mmol, 100 mol%), RuHCl(CO)(PCy3)2 (8.7 mg, 
0.02 mmol, 6 mol%), and AgOTf (2.6 mg, 0.01 mmol, 5 mol%). The reaction vessel was 
placed under an atmosphere of argon. Styrene (0.2 mL, 1 M, 870 mol%) was added by 
syringe. The reaction vessel was sealed and the reaction mixture was allowed to stir at 100 
˚C for 24 h. The reaction was allowed to reach ambient temperature. The reaction mixture 
was concentrated in vacuo. The residue was subjected to column chromatography (SiO2: 
hexanes:ethyl acetate, 30:1) to furnish the title compound (42.2 mg, 0.156 mmol, dr: 1:1) 
as a colorless oil in 78% yield.  
 
1H NMR: (400 MHz, CDCl3) δ 8.01 (d, J = 7.9 Hz, 1H), 7.93 (d, J = 8.0 Hz, 1H), 7.37 (dd, 
J = 21.1, 7.6 Hz, 2H), 7.24–7.30 (m, 3H), 7.23–7.10 (m, 2H), 4.84 (d, J = 5.7 Hz, 0.54H), 
4.73 (d, J = 8.2 Hz, 0.46H), 3.91 (d, J = 10.1 Hz, 3H), 3.21 – 3.04 (m, 0.55H), 3.02 (t, J = 
7.4 Hz, 0.45H), 2.24–2.03 (m, 1H), 1.30 (d, J = 7.0 Hz, 1.6H), 1.11 (d, J = 7.0 Hz, 1.4H). 
13C NMR: (100 MHz, CDCl3) δ 167.0 (d, J=2.9 Hz), 148.1, 147.7, 143.0, 142.6, 129.5, 
129.3, 128.7, 128.3, 128.1, 128.0, 127.1, 126.9, 126.7, 126.3, 79.1, 78.3, 52.1 (d, J=5.7 
Hz), 48.1, 47.2, 18.0, 14.8. 
HRMS: (CI) Calcd. For C17H19O3 [M-H]
- 271.1334, Found 219.1750. 
FTIR: (neat): 3468, 2926, 1717, 1610, 1494, 1435, 1277, 1177, 1109, 1018, 967, 910, 859, 
771, 733, 699 cm-1.  
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1-(3,5-dichlorophenyl)-2-phenylpropan-1-ol (5.3j) 
 
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 3,5-
dichlorobenzyl alcohol (35.4 mg, 0.2 mmol, 100 mol%), RuHCl(CO)(PCy3)2 (8.7 mg, 0.01 
mmol, 6 mol%), and AgOTf (2.6 mg, 0.01 mmol, 5 mol%). The reaction vessel was placed 
under an atmosphere of argon. Styrene (0.2 mL, 1 M, 870 mol%) was added by syringe. 
The reaction vessel was sealed and the reaction mixture was allowed to stir at 100 ˚C for 
24 h. The reaction was allowed to reach ambient temperature. The reaction mixture was 
concentrated in vacuo. The residue was subjected to column chromatography (SiO2: 
hexanes:ethyl acetate, 30:1) to furnish the title compound (52.1 mg, 0.186 mmol, dr: 1.5:1) 
as a colorless oil in 93% yield.  
 
1H NMR: (400 MHz, CDCl3) for the 3:2 mixture of diastereomers: δ 7.40–7.21 (m, 6H), 
7.19–7.15 (m, 1H), 7.11 (dd, J = 1.9, 0.7 Hz, 1H), 4.75 (dd, J = 5.3, 3.0 Hz, 0.6H), 4.59 
(dd, J = 8.5, 2.2 Hz, 0.4H), 3.06 (qd, J = 7.1, 5.1 Hz, 0.6H), 2.94 (dq, J = 8.6, 7.1 Hz, 0.4H), 
1.95 (dd, J = 8.9, 2.9 Hz, 2H), 1.26 (d, J = 7.1 Hz, 1.8H), 1.12 (d, J = 7.1 Hz, 1.2H). 
13C NMR: (100 MHz, CDCl3) δ 146.3, 145.9, 142.6, 142.2, 134.8, 134.6, 128.9, 128.6, 
128.0, 127.9, 127.9, 127.3, 127.2, 126.9, 125.6, 124.8, 78.6, 77.4, 48.1, 46.9, 18.0, 14.1. 
HRMS: (ESI) Calcd. For C15H14Cl2OAg [M+Ag]
+: 386.9467, Found, 386.9467. 
FTIR: (neat): 3424, 3082, 3028, 2974, 1588, 1567, 1494, 1452, 1432, 1380, 1200, 1063, 
1008, 857, 797, 699 cm-1.  
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1-(3,5-bis(trifluoromethyl)phenyl)-2-phenylpropan-1-ol (5.3k) 
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with (3,5-
bis(trifluoromethyl)phenyl)methanol (48.8 mg, 0.2 mmol, 100 mol%), RuHCl(CO)(PCy3)2 
(8.7 mg, 0.01 mmol, 6 mol%), and AgOTf (2.6 mg, 0.01 mmol, 5 mol%). The reaction 
vessel was placed under an atmosphere of argon. Styrene (0.2 mL, 1 M, 870 mol%) was 
added by syringe. The reaction vessel was sealed and the reaction mixture was allowed to 
stir at 100 ˚ C for 24 h. The reaction was allowed to reach ambient temperature. The reaction 
mixture was concentrated in vacuo. The residue was subjected to column chromatography 
(SiO2: hexanes:ethyl acetate, 30:1) to furnish the title compound (50.2 mg, 0.144 mmol, 
dr: 2.2:1) as a colorless oil in 72% yield. 
 
1H NMR (400 MHz, CDCl3): δ 7.85–7.55 (m, 3H), 7.41–7.19 (m, 4H), 7.12–7.09 (m, 1H), 
4.90 (dd, J = 5.8, 2.2 Hz, 0.7H), 4.83–4.79 (m, 0.3H), 3.13–3.04 (m, 0.7H), 3.00 (p, J = 7.2 
Hz, 0.3H), 2.10 (dd, J = 25.7, 2.9 Hz, 1H), 1.30 (d, J = 7.0 Hz, 2.08H), 1.15 (d, J = 7.1 Hz, 
0.92H). 
13C NMR: (100 MHz, CDCl3) δ 145.2, 144.9, 142.0, 141.5, 131.6 (d, J = 3.5 Hz), 131.2 
(d, J = 3.5 Hz), 130.9 (d, J = 3.7 Hz), 130.6, 128.89, 128.6, 128.1, 127.9, 127.5, 127.1, 
126.5, 126.5, 126.4, 126.4, 124.7, 121.6 (t, J = 3.8 Hz), 121.0 (p, J = 3.9 Hz), 119.2, 78.4, 
77.7, 48.1, 47.3, 17.5, 14.5. 
HRMS: (CI) Calcd. For C17H13F6O [M-H]
+: 347.0871, Found, 347.0868. 
FTIR: (neat): 3458, 2967, 1624, 1495, 1453, 1365, 1275, 1168, 1126, 1024, 1009, 899, 
874, 842, 761, 700, 681 cm-1.  
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1-(naphthalen-2-yl)-2-phenylethan-1-ol (5.3l) 
 
 
An oven-dried pressure tube equipped with a magnetic stir bar was charged with 
naphthalen-2-ylmethanol (31.6 mg, 0.2 mmol, 100 mol%), RuHCl(CO)(PCy3)2 (14.5 mg, 
0.02 mmol, 10 mol%), and AgOTf (4.6 mg, 0.018 mmol, 9 mol%). The reaction vessel was 
placed under an atmosphere of argon. Styrene (0.2 mL, 1 M, 870 mol%) was added by 
syringe. The reaction vessel was sealed and the reaction mixture was allowed to stir at 100 
˚C for 24 h. The reaction was allowed to reach ambient temperature. The reaction mixture 
was concentrated in vacuo. The residue was subjected to column chromatography (SiO2: 
hexanes:ethyl acetate, 30:1) to furnish the title compound (31.5 mg, 0.120 mmol, dr: 2.3:1) 
as a colorless oil in 60% yield. 
 
1H NMR: (400 MHz, CDCl3) for the 2.6:1 mixture of diastereomers:  δ 7.90–7.68 (m, 
4H), 7.57–7.27 (m, 7H), 7.25–7.18 (m, 1H), 5.00 (dd, J = 5.6, 3.1 Hz, 0.27H), 4.84 (dd, J 
= 8.8, 2.2 Hz, 0.72H), 3.24 (qd, J = 7.0, 5.4 Hz, 0.28H), 3.14 (dq, J = 8.8, 7.1 Hz, 0.72H), 
1.98 (dd, J = 7.8, 2.9 Hz, 1H), 1.33 (d, J = 7.0 Hz, 0.83H), 1.11 (d, J = 7.1 Hz, 2.18H). 
13C NMR: (100 MHz, CDCl3) δ 143.5, 143.3, 140.3, 139.9, 133.2 (d, J = 2.3 Hz), 133.1, 
132.8, 128.7, 128.3, 128.1, 128.1, 128.0 (d, J = 1.5 Hz), 127.7, 127.6, 127.0, 126.5, 126.2, 
126.1, 125.9, 125.9, 125.7, 125.1, 124.7, 124.5, 79.9, 78.7, 48.1, 47.0, 18.4, 14.8. 
HRMS: (CI) Calcd. For C19H18O [M]
+ 262.1358, Found 262.1354. 
FTIR: (neat): 3414, 3056, 3026, 2964, 2925, 1601, 1493, 1451, 1374, 1269, 1164, 1091, 
1022, 1008, 891, 856, 799, 747, 699, 666 cm-1.  
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Isotopic Labelling Studies: 
Deuterium labelling studies of 5.1h: 
 
 
 
 
1H NMR: (400 MHz, CDCl3) for the 1.5:1 mixture of diastereomers: δ 7.51–7.26 (m, 4H), 
7.25–7.02 (m, 5H), 4.75 (dd, J=5.8, 3.3 Hz, 0.22H), 4.62 (dd, J=8.5, 2.4 Hz, 0.17H), 3.05 
(q, J=7.0 Hz, 0.59H), 3.00–2.90 (m, 0.40H), 1.99–1.80 (m, 1H), 1.28 (d, J=7.1 Hz, 1.72H), 
1.08 (d, J=7.0 Hz, 1.17H). 
 
2H NMR: (77 MHz, CDCl3) for the 1.5:1 mixture of diastereomers: δ 4.69 (d, J=9.5 Hz, 
0.61H), 1.20 (d, J=15.8 Hz, 0.11H). 
 
HRMS: (ESI): Calcd. For C15H12DBr [M-OH]
+ 274.0336, Found 274.0336.  
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Deuterium labelling studies of 5.1a: 
 
 
 
1H NMR: (400 MHz, CDCl3) δ 7.33–7.25 (m, 2H), 7.23–7.15 (m, 3H), 3.63 (s, 0.03H), 
2.82–2.73 (m, 0.2H), 2.73–2.57 (m, 0.8H), 1.75 (qd, J = 13.8, 8.1 Hz, 2H), 1.51–1.22 (m, 
11H), 0.92–0.83 (m, 3H). 
 
2H NMR: (77 MHz, CDCl3) δ 3.62 (s, 1H), 2.79 (s, 1H). 
 
HRMS: (ESI): Calcd. For C15H22D2O [M+Na]
+ 245.1845, Found 245.1850.  
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Deuterium labelling studies of 5.1a with d8-Styrene: 
 
 
1H NMR: (400 MHz, CDCl3): δ 3.61 (s, 1H), 2.76 (s, 0.79H), 2.65 (d, J=13.4 Hz, 0.21H), 
1.52–1.17 (m, 11H), 0.95–0.82 (m, 3H). 
 
2H NMR: (92 MHz, CH2Cl2): δ 7.30 (d, J=7.3 Hz, 5H), 2.73 (d, J=11.0 Hz, 1H), 1.75 (d, 
J=5.1 Hz, 2H). 
 
HRMS: (ESI): Calcd. For C15H16D8NaO [M+Na]
+ 251.2222, Found 251.2229. 
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Deuterium labelling studies of 5.1h with d8-Styrene: 
 
 
Spectrum of deuterio-5.3h 
 
1H NMR: (400 MHz, CDCl3) for the 1:1 mixture of diastereomers: δ 7.48–7.43 (m, 1H), 
7.39–7.33 (m, 1H), 7.21–7.15 (m, 1H), 7.05–7.01 (m, 1H), 4.65 (dd, J=47.5, 2.9 Hz, 
0.56H), 2.97 (dd, J=34.9, 5.6 Hz, 0.15H), 2.12–1.81 (m, 1H), 1.38–0.96 (m, 0.73H). 
 
2H NMR: (92 MHz, CH2Cl2) for the 1:1 mixture of diastereomers: δ 7.27 (dd, J=13.1, 6.4 
Hz, 5H), 4.68 (d, J=9.6 Hz, 0.44H), 2.98 (d, J=7.8 Hz, 0.84H), 1.15 (dd, J=19.4, 1.7 Hz, 
2.29H). 
 
HRMS: (ESI): Calcd. For C15H6D8Br [M-OH]
+ 281.0776, Found 281.0779.  
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Spectrum of recovered styrene 
 
2H NMR: (92 MHz, CHCl3) δ 7.64–7.27 (m, 5H), 6.77 (s, 1H), 5.78 (s, 1H), 5.28 (s, 1H). 
 
HRMS: (CI): Calcd. For C8D8 M
+ 112.1128, Found 112.1127. 
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Appendix 
List of Abbreviations and Acronyms 
PG             protecting group 
DMB             2,4-dimethoxybenzyl 
Cbz             carboxybenzyl 
Dba             dibenzylideneacetone 
9-BBN             9-borabicyclo[3.3.1]nonane 
ee   enantiomeric excess 
dr   diastereomeric ratio 
acac   acetylacetonate 
DCE   1,2-dichloroethane 
HMDS   bis(trimethylsilyl)amide 
cod   1,4-cyclooctadiene 
LLS   longest linear steps  
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